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INTROUDUCTION 
 
Siddhars are super human beings to whom mastering the winds, 
waves, tides, gravity and other elements and forces of nature.  
We are all tourists on this earth which we should leave sooner or later 
quitling every thing hired to us, having a good time on this trip making 
ourselves and the fellow tourists happy, and keeping unsuilled the things 
hired to us. 
 As the physical body plays an important role in our tour, it 
becomes our duty to keep it pure and perfect by regulating energy forces 
existing in every individual, supplying necessary fuel to achieve proper 
balance which is health and avoiding imbalances which is illness. 
 In siddha system of medicine several herbs are used as medicine 
for various diseases.  Mostly single herbs are used to cure several diseases.  
There are various herbal remedies, which have been used for thousands of 
years for the treatment for arthritis.  
 Keeping this in mind, the author has done this maximum effort in 
proving the therapeutic values of Kandubarangi a herb with a very old 
tradition and significance in the treatment of Azhal keel vayu to unfold the 
hidden to the medical world.         
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AIM AND OBJECTIVE 
 
 The aim of this dissertation is to establish that the drug  
Kandubarangi an effective remedy for the disease of Azhal keel vayu. It is 
one of the vadha diseases in siddha system of medicine and can be compared 
to the Osteo arthritis in modern medicine. The disease is also termed  as 
Degenerative Joint Disease of the human being,a leading cause of disability 
in the elderly.       
 The progressive prevalence of Azhal keel vayu is seen with increase 
in age.  In a random survey , people affected by Azhal keel vayu below 45 
years of age is only 2% between the age of 45 to 64 years the prevalence is 
30% and above the age of 65 years it is 68%.     
 The number of Azhal keel vayu patients attending Govt. Siddha 
Medical College hospital is very much increasing.  So the author aimed at 
finding an effective and economic medicine for this common disease. 
 The aim of this dissertation is to study the efficacy of Kandubarangi.  
Hence this drug has been studied under following aspects. 
 Botanical aspect  
 Gunapadam aspect  
 Bio Chemical analysis 
 Pharmacological analysis 
 Anti Microbial suceptiblity test 
 Bio statistical analysis 
 Clinical trials 
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REVIEW OF LITERATURE 
BOTANICAL ASPECT 
Clerodendron serratum 
TAXONOMY  
Domain  :  Eukaryota 
Kingdom  :  Plantae 
Subkingdom :  Viridaeplantae 
Phylum  :  Tracheophyta 
Subphylum  :  Spermatophytina 
Infraphylum :  Angiospermae 
Class   : Magnoliopsida 
Subclass  : Lamiidae 
Superorder  :  lamianae  
Order  :  Lamiales 
Family  :  Verbenaceae 
Genus  :  Clerodendron 
Species  :  Serratum 
VERNACULAR NAMES 
TAMIL  - Sirutekku, Angaravalli, Kandubaranki ,Vadamadakk. 
MALAYALAM - Cherrutekka ,Cherrtekka, Kankabharani, Kantani,  
   Napalu 
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TELUGU  - Gantu Bharang, Barangi, Bharangi, Bhramaramari,  
  Chiruteka, Panja Suvvipi. 
KANNADAM - Bharangi 
SANSKRIT  - Bharangi, Barbara, Angaravalli, Angaravalarai, Beleya,  
  Barbara, Bhargavi, Bhargi, Bhramareshta, Bhigubnava,  
  Bhigrija, Bhingaja, Bramharayashtika, Bramhani,  
  Bramhi, Brambika, Durva, Dvidandi, Gardabhashaka,    
  Hanjika, Kalingavalli, Kasaghni, Kasajita, Kharashaka,  
  Mukhadhanta, Padma, Phanji, Phanjika, Shakramata,  
  Svarupa, Saramlutu. 
HINDI  - Gant – Bhawngi 
BENGALI  - Barnanhati 
BOMBAY  - Bharang, Bharangi 
BURMA  - Baikyo, Bebya, Begyo 
GUJARAT  - Bharungi 
MALAY  - Lampinbudak, Matakesing 
MARATHY  - Bharangi 
NEPAL  - Andekhi, Chua 
ORIYA  - Chinde, Penjuva 
SINHALA  - Kenhenda 
URDU  - Bharangi 
           Ref. Indian Medicinal plants P.No. 1949 Kirtikar & Basu 
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DISTRIBUITION  
 fz;Lghuq;fp ,e;jpahtpd; c~;z gpuNjrq;fspy; gapuhFk;.  
Ref: Fzghlk; %ypif  tFg;G P.No.215 
 Clerodendron serratum is distributed throughout India, in forests upto 
1,500m. elevation. 
Ref. Indian Medicinal Plants Vol II.  
P.No. 121 Orient Longman 
 It is found in Sub Himalayan tract, and outer ranges ascending to 
5,000ft, Assam. Bengal. 
          Ref. Indian trees. Dietrich Brandis Kcie.     
P.No. 508 
 It is growing in more or less throughout India, Ceylon, Malay 
Peninsula.  
   Ref. Indian Medicinal plants Vol III  
   Kiritikar & Basu P.No. 1948 
 It is found in Eastern India, especially Bengal. 
   Ref. Indian Materia medica Vol I.    
   Dr. K.M. Nadkarni P.No. 354 
 Clerodendron Serratum is distributed from the himalays yast of the 
sutlej to Ceylon and Tenasserim, alt. 0-4000 it is frequent, very 
common in Bengal. 
    Ref. Hooker flora of India Vol IV. P.No. 592 
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IDENTIFYING CHARACTERS 
DESCRIPTION  
ROOT 
a. Macroscopic: 
 Mature root hard, woody cylindrical upto 5cm thickness, external 
surface is light brown having, elongated lenticles, bark, thin and easily 
separated from a broad wood which shows marked medullary rays and 
concentric growth rings in a transversely cut surface, fracture, short, acrid. 
b. Microscopic 
 Mature root shows stratified work composed of 14-20 layers of thin 
walled tangentially elongated cells, each stratification consists of 3-5 layers 
of cells; Secondary cortex wide, outer 2 or 3 layers radially arranged and 
tangentially elongated innercells polyhedral or circular to ellipsoidal with 
intercellular spaces; a few cells modified into stone cells with greatly 
thickened wall having concentric striations and radiating canals with narrow 
lumen; Some cells contain aricular crystals of calcium oxalate a few contain 
brown colouring matter secondary phloem consists of sieve elements and 
parenchyma mostly collapsed in outer region. Forming ceratenchyma some 
phloem parenchymatous cells modified into stone sells similar to those in 
secondary cortex but some what smaller and with greater thickening of 
 7
walls;  secondary xylem diffused porous consisting of vessels trachids, fibres 
and xylem parenchyma traversed by xylem rays; macerated preparation 
show wider vessels. Cylindrical, drum- Shaped, some being  elongated at 
one end having bordered pits, rarely reticulated or pitted, while narrower  
ones elongated with spiral to reticulate thickened tracheids  long, cylindrical 
with tapering ends and borded  pits; xylem fibres moderately thick walled 
with mostly tapering, pointed ends and oblique bordered pits; xylem 
parenchyma square to rectangular with simple pits on their walls medullary 
rays 1-4 cells wide and 2-50 cells high. 2 or 3 cell wide rays more common, 
having simple pits on their walls, acicilar crystals and abundant simple and 
compound starch grains measuring upto 20 µ in dia. Present in a number of 
cells throughout the region.  
 Ref. The Ayurvedic pharmacopoeia of India Vol. III P.No.25 
STEM  
Usually 2-8 ft. Simple, hardly, woody, 
LEAVES 
 Usually some of them ternate commonly 6 by 2 in.. narrowly obovate 
– oblong or subelliptic base cuneate, mature glabrate puberulous pubescent 
or closely villous on the lancina beneath. 
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PETIOLE   : 0-1/4 in…  
PANICLE   : 6 by 1 inc…  Sublinear or 10 by 5in.  
  Sub pyramidal pubescent often villous 
PEDICLES  : Patently shortly hair, 
BRACTS  : ½ -11/2 inc.. from obovate to lanceolate, pubescent, sub  
   persistent  often coloured. 
PEDICLES  : 0-1/4 inch 
CALYX  : 1/5 inc … Cup shaped pubescent and puberulous, limb  
  very shortly 5 – lobed slightly enlarged in fruit. 
COROLLA  : Nearly glabrous without hairy at the base of the  
stamens, from purplish – blue and  white to nearly     
white, tube – 1/3 -1/2 in… narrow cylindric; mouth  
oblique, 2 lipped; lobes 1/3-1//2 inc.. Oblong or elliptic 
FILAMENTS  : Much curved densely hairy at the base  
OVARY & STYLE - Glabrous 
FRUIT: Drupe ¼ by 1/6 -1/3 in.. Succulent purple – black, 4-1 pyrenes. 
     Ref: Hooker flora of India Vol IV P.No. 592 
      Indian Medicinal plants Vol III P.No. 1948.   
      Kiritikar & Basu  
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PHYTO CHEMISTRY 
 
Clerodendron Serratum has saponins caused distruption of mast 
cells of rat  mesentry which was proportional to dose upto 40 μg and 
maximum distruption effect was exerted in 30 min. 
Ref. Compendium of Indian Medicinal 
Plants Vol II P.No. 195 Ramp. Rastogi. 
Root Bark: 
 It contains glucose D- (-) mannitol. 
Hydrolysis of crude saponin from bark yielded 
 Oleanolic acid 
 Queretaric acid 
 Serratagenic acid 
Ref. Medicinal Plants of India Vol II. 
P.No. 145, S.N. Yoga narasimhan 
 Alcoholic extract and saponin isolated from root bark caused release 
of histamine from lung tissue. 
Ref: Compendium of Indian Medicinal 
Plants, Ram P Rastogi, B.N. Mehrotera 
The root contains stigmasterol.  
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Root consists of starch a peculiar bitter principle, acrid resin and fatty 
matter.  The leaves contain  
 (+) – Catechin 
 u- Spinasterol  
 Luteoline  
 Glucuronide 
         Ref. Medicinal plants and Raw drug of India 
         P.No. 431, Purushotam Kaushik, Anil Kumar  
      Materia medica of Indian and other  
therapeutics P.No.470 
          Ruspomjee Naserwanjee Khory Nanabhai  
Nawrosji katrak. 
IDENTITY PURITY AND STRENGTH 
 Foreign Matter   - Not more than 2 percent 
 Total ash    - Not More than 11 percent 
 Acrid - Insoluble ash   - Not more than 1 percent 
 Alcohol- Soluble extractive  - Not less than 6 percent 
 Water – Soluble extractive  - Not less than 12 percent 
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T.L.C. 
 T.L.C. of the alcoholic extract on silica gel G plate using N – Butane: 
Acetic acid: water (4:1:5) shows in visible light two spots at R.f.0.62 and 
0.74 (both dirty yellow). 
 Under UV light (366 mnm) three fluorescent zones are visible at  
Ref. 0.62 (yellowish green) 
0.68 (blue) 
0.74 and (yellowish green) 
 On spraying with 5% Methanolic sulphuric acid and heating the plate 
for ten minutes at 1100C two spots appea at Rf. 0.62 and 0.74 (both grey). 
     Ref: The Ayurvedic Pharmacopoeia of India  
Vol III, P.no.26 
Two new iridoid glucosides, named 7 B – coumaroyloxyugandosids 
(1) and 7 B connamoylox yugandoside (2) were isolated from the leaves of 
Clerodendrum Serratum, and their structures were elucidated by spectral 
means. 
Ref: Chinese Chemical Letters Vol. No. 5,  
The study of the plant led to the isolation of a new compound named 
Serrutamin A – C 16 H22 08 
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Five Known Compounds  
 2 Flavonoids 
 3 Phenolic acids 
Flavonoids 
 5,7,8,4, tetrahydroxy -6 – methoxy – flavone – C16 H12 07 
 5,6,7 trihydroxy -4 –methoxy – flavone 7-glucopyranoside C22 
H22 011  
Phenolic acids 
 Cis – Cinnamic acid C9 H8 02 
 Trans Cinnamic acid C9 H8 02 
 Coumaric acid C9 H8 03 
 
AQUEOUS SOLVENT EXTRACT OF CLERODENDRON 
SERRATUM 
PHYSICAL PARAMETERS 
PARAMETERS SPECIFICATION TESTING METHOD 
Color Brown Visual 
Particle Type Coarse Powder Visual 
Taste Bitter Taste 
Odour Slightly aromatic Smell 
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ASSAY FOR ACTIVITY 
PARAMETERS SPECIFICATION RESULT 
TESTING 
MEHTOD 
Sapogenins, 
Serratogenic acid 
- - - 
Loss on drying NMT 5% Confirms 3.6% 5g/1050C/3Hrs 
Additive Nil Nil Nil 
Solubility in 
Alcohol 80% 
MIN 75% Confirms 81% Lab Test 
Ash contents NMT 5% Confirms 3.2%
5g/6000C/6-
8Hrs 
 
LIMITTESTS 
IMPURITIES 
(AS PER USP) 
LIMIT RESULTS TESTS 
Heavy metals NMT 10 PPM 1.8 PPM Atomic Absorption 
Arsenic NMT 2 PPM 0.4 PPM Atomic Absorption 
Lead MIN 2 PPM 0.6 PPM Atomic Absorption 
Mercury NMT 2 PPM 0.6 PPM Atomic Absorption 
Organic residual 0.02% 0.01% (G.C) 
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MICROBIOLOGICAL PROFILE 
Total Plate Count NMT 5000C fu LT 1000 Cfu/g Confirms 
Yeast & Mould Absent Absent Confirms 
Salmonella Absent Absent Confirms 
Staphylococcus aureus Absent Absent Confirms 
Pseudomonas aeruginosa Absent Absent Confirms 
 
Ref: Specification sheet: Aysh herbs 
Dr. M.C. Dass (Ph.D Chemistry)        
Mr. Sanjeev Sharma M.Sc. P.hd. 
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GUNAPADAM ASPECT 
 
NtWngah; (Synonyms) – rpWNjf;F 
 ‘rpWNjf;fpd; Ngh;jidNa nrg;gf;NfS 
  nrakhd nfw;jg rhjQ; rkhFk; 
 gWNjf;Fg; guq;fpg; gJkpahFk; 
  ghq;fhdg; gpwhkda \fkhFk; 
 kWNjf;F ahq;fhu ty;ypahF 
  kbfhd Rf;fpw khjhrkhFq; 
 fWNjf;F fhrj;jpg; guKkhFq; 
  fhl;ba Njhh; rpWNjf;fpd; fzf;F khNk.” 
ciu 
 nfw;jgrhjQ;rk; 
 guq;fpg;gJkp 
 gpwhkda\fk; 
 Mq;fhuty;yp 
 Rf;fpwkhjhrk; 
 rj;jpg;guk; 
Ref: Fzghlk; - %ypif 215. 
Nghfh; epfz;L 1200 g. vz; : 202. 
tshpay;G (Habitat) 
 rpWkuk; 
gad;gLk; cWg;G (Part Used) 
 ,iy 
 Nth; 
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ORGANOLEPTIC CHARACTERS 
Rit : (Taste) 
 ifg;G 
 Jth;g;G 
 fhh;g;G  
jd;ik (Potence) 
 ntg;gk; 
 twl;rpj;jd;ik 
 ,yFFzk; 
gphpT : (Therapeutic Classification) 
 fhh;g;G 
nra;if: 
 ntg;gKz;lhf;fp (Stimulant) 
 jhJntg;gfw;wp (Sedative) 
Ref: Fzghlk; %ypif g.vz;. 215 
rufrk;fpij - 3k; ghfk; g.vz;. 335 
It consists of following actions: 
 Anti histaminic 
 Anti biotic 
 Hypotensive 
Ref: Pharmacological investigation of certain medicinal  
plants and compound formulations used in Siddha and  
Ayurveda P. No : 67 
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Kandubarangi contains 
 Thermogenic 
 Digestive 
 Carminative 
 Stomachic 
 Anthelmintic 
 Depurative 
 Expectorant 
 Sudorific 
 Antispasmodic 
 Stimulant 
 Febrifuge 
Ref: Indian Medicinal plants Vol II P. No. 121 
Orient Longman 
Ethanol extract of clerodendron serratum roots shows 
 Anti – inflammatory 
 Antinociceptive 
 Anti pyretic - effects 
  Ref:  Journal of Ethnopharmacology Vol. 65                 
  No. 3 P. No. 237 – 241. ISSN – 0378 – 8741 
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It has 
 Appetizer 
 Blood purifier 
 Kapha vata Samak. Actions. 
Aqueous extract of clerodendron serratum roots contains 
 Immunomodulatory activity 
Bharangi is a  
 Lactative. 
Ref: www.crossrefmember.com 
Fzk; (Therapeutic efficacy): 
 ‘fz;Lgh uq;fpnaDQ; rpWNjf; Fz;Nly; 
  fhnyq;f gpj;jnkq;Nf fge;jh ndq;Nf 
 njhz;Lnjhl;Lj; njhlh;Rthr fhr nkq;Nf 
  Ruknkq;Nf ntwpnaq;Nf njhdpNeh naq;Nf 
kpz;LGhp gPerePh;f; Nfhit naq;Nf 
  ntspePUz; zPnuq;Nf tpww;fh nyq;Nf 
 mz;Lglhr; rPjRuq; fLg;G nkq;Nf 
  aoiyaf Nehnaq;Nf aiwF tPNu” 
ciu: 
 ,jdhy; Kf;Fw;wk; ,iug;gpUky;> cs;ntg;G> ntwpNeha; (igj;jpak;).  
Ruk;> %f;fpy; Kd; ePh;f;Nfhit> gpd; ePh;f;Nfhit> ehl;gl;l tspNeha;> 
Fsph;fha;r;ry;> cly;typ> cl;fhe;jy;> kdj;jLkhw;wk; Nghk; 
        Ref: Fzghlk; - %ypif tFg;G P. No: 215 
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 ‘rpWNjf;fpd; RitNa jpf;j fLFzk; yF&\k; 
  cWK\;zq; fLtp ghfk; Xq;FW fgQ;R th]k; 
  ngWFd;kQ; RuNk thjk; gPd]k; uh[ a\;kh 
  njWuf;j tpfhuk; ahTk; nrwpj;jpLk; Gtpapd;khNjh.” 
ciu: 
 rpWNjf;F fgk;> Rth]k;> Fd;kk;> Ruk;> thjk;> gPd]k; \ak; ,uj;j 
tpfhuk; ,tw;iw ed;F fz;bf;Fk;. 
 ‘Fuw;fk;ky; Nghf;Fq; Fsph;Ruj;ij ePf;Fk;  
  Rpuf;fLNeh Al;RuKe; jPh;f;Fk; - Guf;Fhpa 
  Gd;fLg;ig khw;Wk; Gfo;Nrh; rpWNjf;fpd; 
  ,d;Fzj;ij ed;ndQ;Nr Naj;J.” 
ciu: 
 ,d;Dk; Fuw;fk;ky; Fsph;Ruk;> jiytyp> cl;Ruk;> Njff; fLg;G.  
,tw;iwAk; rpWNjf;F fz;bf;F nkd;f. 
         Ref: gjhh;j;j gQ;r Fz kQ;rhp P. NO: 27. 
 ‘rpWNjf;Ff; fLg;Gg; gpj;jQ; Nrl;Lk; Koiy thA 
  Fiwtpf;F nkd;g” 
        Ref: mkph;jrhfuk; - gjhh;j;j #lhkzp g. vz;. 92. 
 ‘rluhf;fpdpia tsh;f;;Fk; fgthjq;fis jzpf;Fk;” 
         Ref: rufrk;fpij %d;whk; ghfk; g. vz; 335. 
 20
It is useful in inflammation, dyspepsia, anorexia, colic, flatulence, 
helminthiasis, cough, asthma, bronchitis, hiccough, tumours, tubercular 
gland, dropsy, consumption, skin diseases, leucoderma, leprosy and fever.  
Ref: Indian Medicinal plants vol II                
P. No. 121, Orient Longman  
It is used in intermittent fever, worms, Burning Sensation, wasting 
diseases, wounds, diseases of head sprue. 
It cures mental disordes and dropsy  
   Ref: Flora of coorg P.No. 578, 619 
      K. R. Kesava Moorthy, S. N. Yoha narasimhan 
Bharangi is used in anaphylactic shock, rheumatism, malaria, snake 
bite, hemiplegia, fistula, cholera, protracted labour. 
Ref: Pharmacological investigations of  
certain medicinal plants and compound  
formulations used in Ayurveda and siddha  
P.No. 67 
msT: 
 2 - 4 fpuhk; 
Rj;jp: 
 fz;L ghuq;fp Ntiu Mw;W ePhpy; fOtpf; nfhs;s Rj;jpahFk;.  
        rpfpr;rhuj;ejPgk; g. vz;: 28 fz;Zrhkpg; gps;is 
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kUj;Jt gad;fs;: 
 ,iyia miuj;J tPf;fk; fl;b KjypaitfSf;Fg; gw;wpl mit 
gOj;J cilAk;. 
 ,iyia Kg;giyf; FbePhpy; miuj;J Nkw;gb Neha;fSf;Fg; 
gw;wplyhk;. 
 ,jd; Nth;nghb. Rf;Fj;J}s; ,itfis Xusthf vLj;Jj; Njdpw; 
fye;J nfhLf;f ,iug;gpUky; jPUk;. 
 ,ijf; fhy; gynkLj;Jr; (8.7 fpuhk;) rpijj;Jf; FbePhpl;L tbfl;b.  
,jpy; rpwpJ NfhNuhrdk; Nrh;j;Jf; nfhLj;Jtu. ehl;gl;l tspNeha;> 
Fsph;fha;r;ry;> cly;typ> cl;fhe;jy;> kdj;jLkhw;wk; Nghk;. 
            Ref: Fzghlk; %ypif tFg;G g. vz;. 215 
 jphpfLF fPo;f;fha; ney;yp> rpWNjf;F. fz;lq;fj;jphpNth;. rq;fk;Nth;. 
ney;yp tw;wy; tiff;F fhy;gyk; (8.7 fpuhk;)  ,bj;J ,uz;Lgb (4 
ypl;lh;) jz;zPhpy; Nghl;L Mohf;fha; tw;w itj;J 7 ehl;fs; 
cl;nfhs;s. rpNyj;Jk Neha;fs; jPUk;. 
      Ref: Mtpaspf;Fk; mKj KiwRUf;fk; g. vz; - 378 
 fw;flfrpq;fp> rpWNjf;F. jphpgiy> jphpfLF> nrq;fOePh;> Nfh\;lk;> 
kukQ;rs;> rpWtOjiyNth; tiff;F rk vil vLj;J #uzpj;J 
jphpfb gpukhzk; NjdpyhtJ> nte;ePhpyhtJ nfhLf;f ,iug;gpUky; 
jPUk;. 
         Ref: Mj;kul;rhkph;j itj;jpa rhurq;fpufk;  
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 rpWNjf;F> Rf;F vd;Dk; ,tw;iw ,sQ;#Lila ePUld; 
cl;nfhs;sr; nra;jhy; ,Uky; jPUk;. 
 Ref: ru`rk;`pij ,uz;lhk; ghfk; g. vz;. 336 
 rq;fk;Nth;> Kf;nfhOQ;rp nfhbNtyp> guq;fpg;gl;il> Rf;F> 
tha;tpsq;fk; rpWNjf;F. nfhj;jky;yp tiff;F tuhfndil - 2 (8.2 
fpuhk;).  ,itfis rpijj;J    1 gb (2 ypl;lh;) [yj;jpw; Nghl;L 1/8 
gbaha; (250 kp.yp) tw;w itj;J mjpy; 1 tuhfndil (4.1 fpuhk;) 
kpsF nghbAk; xU Jl;L vil tpsf;nfznzAQ; Nrh;j;J 6 Ntis 
nfhLf;f thjNeha; jPUk;. 
   Ref: itj;jpa rhu rq;fpufk; g. vz; . 309  
 Bharangi leaves are applied in the form of poultice to hasten 
suppuration  
   Ref: Indian material medical P.No. 354 
        Dr. K. M. Natkarni 
 A decoction of the root is given for asthma, bronchitis, and other 
catarrhal affections of the lungs. 
 According to chopra, leaves are used in fevers and boiled with oil and 
butter are made into an ointment which is applied externally in 
cephalagia and ophthalmia 
 An ethyl alcohol (50%) extract of its aerial parts possesses 
spermicidal activity. 
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 In typhoid fever, young shoots and roots are ground in equal 
quantities and little sugar is added to make it tasty.  This preparation is 
given 25 gm thrice a day for 7 days by the tribes   in bihar.  (singh and 
khan 1990)  
  Ref:  Medicinal plants and raw drugs of India 431. 
   Purushotam kaushik Anil kumar, Dhiman 
 The paste of Bharangi with honey is prepared and 3gm of paste is 
taken in an interval of ½ hour and should be consumed within 2-3 
hours, asthma is controlled. 
 Two parts of bharangi juice and 4 parts of curd are mixed together.  It 
is given for 4 days, to reduce cough. 
   Ref: Medicinal plants P.No. 184 
         A. K. Chopra, D.R. Khanna. G. Prasad, D. S. Malik 
 A decoction of the root with ginger and coriander is taken for 
relieving nausea. 
    Ref: The wealth of India vol. II P.No. 232 
 The root increases appetite, lessens expectoration  
 The root is used in febrile and catarrhal affection.  Ratnagiri people 
consider it is very effective in malarial fever. 
 24
 The seeds bruised and boiled in butter milk are used as aperients and 
in dropsy. 
 The leaves are one of the snake remedies (Sushruta, Bapat), and the 
root is used for scorpion - sting (Sushruta), but they are no antidote to 
either snake – venom (Mhaskar and cairus) or scorpion venom. 
            Ref: Indian medicinal plants vol. III P.No. 1948 
 Kiritikar Basu 
 Kannis and palliyans, a jungle tribal people of southern western Ghats 
region of the Tirunelveli district in Tamil Nadu  use this plant for 
treating leach bite snake bite scorpion – sting, rate- bite and insect 
bite. 
     Ref: Medicinal & aromatic plants abstracts                   
P. No. 48 
 The pulp of the leaves applied externally, mitigates the glandular 
swellings and hastens the wound healing.  The juice of its leaves is 
applied on the lesions in erysipelas.  The root paste applied on the 
forehead alleviates headache. 
 The decoction of bharngi root is extremely effective in oedema over 
body, especially due to kapha. The decoction of sesame seeds (tila), 
mixed with ghee, jaggery, trikatu powder (sunthi, marica and pippali) 
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and bharngi root powder is the best medicament for amenorrhea and 
uterine tumours (rakta gulma). 
 Traditionally in Konkan, the leaves are used as vegetables in malarial 
fever.  As bharngi effectively liquefies the mucous. 
 In cough due to kapha and vata, the jam prepared of sesame oil, 
jaggery, bharngi and sunthi is beneficial.  It works well with pippali, 
sunthi and jaggery to curb the spasms and bouts of cough.  
 In hiccup, the root powder is given along with sugar, or its jam.  The 
combination of bharngi and pippali (2:1) with honey, is also an 
effective remedy, for hiccup. 
 The decoction of bharngi roots is benevolent in worm infestations. 
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fz;Lghuq;fp NrUk; 
thjNeha;f;fhd kUe;Jfs; 
I. mfj;jpah; - 2000 - %d;whk; ghfk;.      P. No. 
1. kh\ijyk;       266 
msT: jiyapy; Nja;j;Jf; nfhz;L cs;Sf;Fk;  
1 ];G+d; juyhk;. 
2. nfhbNtyp nea; - ntspg; gpuNahfk;   313 
II. jd;te;jphp - ijyk; - 500. 
3. rh;thq;f uh[Nahf ijyk;     116 
 1 kz;lyk; jiyKOfTk;. 
4. kfhee;jpj; ijyk;;      117 
 msT - 1 fuz;b 2 Ntis (cs;Sf;F) 
III.  rpfpr;rhuj;ejPgk;. 
5. thjNuhf rpfpr;ir (xw;wlk;)    296 
  ntspg;gpuNahfk; 
IV. mfj;jpah; itj;jpa rpe;jhkzp - kzp 4000 IIk; ghfk;. 
6. NahfuhrFf;FY      168 
msT: 1 ];g+d; ,U Ntis 
7.  fe;jfurhadk;      214 
msT: 2 fpuhk; ,U Ntis 
8. Fz;lyhjp Nyfpak;     215 
msT: 5 fpuhk; ,U Ntis 
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V. rpj;jitj;jpaj;jpul;L            P. No 
9. ,urfe;jp nkOF      175 
 msT Rz;ilf;fha; gpukhzk.; (500 kp.fp) ,U Ntis. 
10. ee;jpik       187 
 msT: Njw;whd; tpij msT. ,U Ntis. 
 mDghdk;: gidnty;yk; ghf;fsT. 
11. thjRuf;FbePh;      293 
 msT: 30 kpyp. ,U Ntis. 
mDghdk;: thj uhl;rf; Fspif gzntil nghbj;J Njd; 
foQ;R Nrh;j;J ,ioj;j fw;fk;. 
12. Fd;wpg;gw;W       309 
  ntspg;gpuNahfk; 
VI. fz;Zrhkp guk;giuitj;jpak; 
13. rpfhkzpr; #uzk;     119 
 msT: jphpfb gpukhzk; me;jp> re;jp 20 ehs; 
VII. A+ehep jhJtpHj;jp Nghjpdp 
14. Rf;fpy th;j;jp Nyfpak;      415 
 msT: 12 - 15 fpuhk;. ,U Ntis. 
15. Foe;ijfSf;F fhuTz;il 
 msT: 7-8 Kiw ciuj;J juTk;. 
 mDghdk;: jha;g;ghy; 
 gad;: thjNuhfj;ij mZf nthl;lJ. 
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VIII. rpNuhuj;jpd itj;jpa G+\zk;          P. No 
16. jphpfLF Nyfpak;      64 
 msT: fow;rpf;fhasT ,U Ntis. 
 mDghdk;: fy;ehh; gw;gk; 
17. rfyNkf Nuhf epthuz nkOF    114 
 msT: nfhl;ilg; ghf;F gpukhzk;  
 ,U Ntis. fhy; - miukz;lyk;  
 gj;jpak;: ,r;rhgj;jpak;. 
fz;Lghuq;fp NrUk; gpwNeha;f;fhd kUe;Jfs; 
I. mfj;jpah; - 2000 %d;whk; ghfk;.     
  1. jr%yhjp nea;      45 
  msT: 1 fuz;b ,UNtis 
  mDghdk;: ghy; 
  jPUk; Neha;fs;;: ePh;gpsit> ghz;L> tpg;GUjp> Fd;kk;>  
kUe;jPL> fy;yilg;G> ngUtapW> Fl;lk;> Kayf re;ep> fhrk;> 
tplghfk;> Mde;jthA. 
  2. Ntyk;gl;ilnaz;nza;    59 
  ntspg;gpuNahfk.;  
jPUk; Neha;fs;: tpuzq;fs; 
  3. Vyhjp #uzk;      124 
  msT: %tpuysT ,U Ntis. 
  mDghdk;: Njd; 
  jPUk; Neha;fs;: Nkfk;> gpj;jrak;> ghz;L> mj;jpRuk;> jhfk;>  
vhpr;ry;. 
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II. mfj;jpah; ml;ltiz thflk;                            P. No 
4. fh;g;g,Uky; jPuf;fpahok;;     39 
 msT: 30 - 60 kpyp. ,U Ntis. 
5. kzpke;jpur; #uzk;     69 
 msT 1 - 2 fpuhk; ,U Ntis. 
mDghdk;: Njd; 
jPUk; Neha;fs;: vy;yhtpjf; fopr;ry;fs;> mrPuzk;> Ngjp> 
fpufzp. 
6. %yk; jPu vz;nza;     255 
 msT: %d;W fhnril ,U Ntis. 
 mDghdk;: nte;ePH; 
III.  jd;te;jphp ijyk; - 500 
7. kfhre;jdhjp ijyk;      94 
jPUk; Neha;fs;: 1 kz;lyk; (48 ehl;fs;) jiyKOf                    
4>400 tpahjpfs; jPUk;. 
8. Nrhif fhkhiy ijyk;      103 
jPUk; Neha;fs;: 1 kz;lyk; (48 ehl;fs;) jiyKOfpl fhkhiy> 
tha;T> Fd;kk;> ePH nrhpg;G> mf;dpke;jk;> neQ;nrhpr;ry; jPUk;. 
9. Nkfk; 21f;F ijyk;;     105 
jPUk; NeHa;fs;: 1 kz;lyk; (48 ehl;fs;) KOfpl gpukpak;> jPuhj 
gy gpzpfs;> nrhwp Nkfg;gl;il> Njhy; tpahjpfs; jPUk;. 
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IV. rpfpr;rhuj;ejPgk;            P. No 
10. gwq;fpr;rf;if #uzk;     115 
 msT: ¼ (3 fpuhk;) my;yJ ½ (6 fpuhk;) Njhyh. ,U  
 Ntis. 20 - 40 ehs;. 
jPUk; Neha;fs;: #jfthA> glh;fpue;jp> iffhy; gpbg;G> ntl;il> 
gil> tz;Lfb> fUNkfk;> nka;ntSg;G> nrhwprpuq;F> 
fug;ghd;. 
11. fha ,Nyfpak;      156 
msT: ½ Njhyh (6 fpuhk;). ,U Ntis. 
jPUk; Neha;fs;: gpurtpj;j ];jPhpfSf;F cjpur;rpf;fy; 
cz;lhapd; mjid ntspg;gLj;jp rPjs rk;ge;jkhd 
tpahjpfs; jPUk;. 
12. tpahf;fphp fpUjk;: 
  msT: 1 fuz;b. ,U Ntis. 
  jPUk; Neha;fs;: fhrk;> Fd;kk;> kNfhjuk;>  
  Foe;ijfSf;Fz;lhFk; ff;Fthd;. 
V. ruNge;jpuh; - itj;jpa Kiw - Ruk; 
 13. Rf;fhjp frhak;      134 
   msT: 30 - 60 kpyp. ,U Ntis 
 jPUk; Neha;fs;: neQ;Rtyp> ,Uky;> Rthr fhrk;> thjRuk; 
 14. ghh;q;fpahjp frhak;     168 
   msT: 30 - 60 kpyp. ,U Ntis 
        jPUk; Neha;fs;: fgRuq;fs; 
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VI. fz;Zrhkp guk;giu itj;jpak;         P. No 
 15. MNlhNjhil #uzk;     5 
   msT: ¼ (3fpuhk;) my;yJ ½ (6 fpuhk;) Njhyh. ,U Ntis 
        jPUk; Neha;fs;: Rthrfhrk;. 
VII. Fzghlk; - jhJ 
 16. rh;ttplhhp Fspif     589 
 msT:1- 2. ,U Ntis  
      jPUk; Neha;fs;: ehfk;> Njs;> ez;L> nra;ahd; eQ;R. 
VIII.  mfj;jpah; gs;S - 200 
 17. Ruf;FbePH ;      111 
   msT: 1½ gyk; (52 kp.yp) ,U Ntis. 
   jPUk; Neha;fs;: thjRuk;> fgRuk;> thjfg Ruk;>   
   ryNjhlk;> clw;fLg;G 
 18. rh;tRuf; FbePh;      112 
   msT: 1 gyk; (35 kp.yp) ,U Ntis 
        jPUk; Neha;fs;: thjRuk;> gpj;jRuk;> fgRuk;> rd;dp  
   thjq;fs;. 
IX. gpukKdp itj;jpa #j;jpuk; - II. 
 19. #jf tha;Tf;F Nyfpak;     21 
  msT: nfhl;ilg;ghf;fsT> fhiy> khiy 15 ehl;fs; 
 jPUk; Neha;fs;: #jftha;T> Nahdp#iy> cjpuk; jilgly;. 
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                P. No 
 20. fhrNeha; Nyfpak;      32 
   msT: ghf;fsT> ,UNtis 1 kz;lyk;. 
   jPUk; Neha;fs;: ,Uky; 
 21. Ngjpkhj;jpiu       96 
   msT: ,uz;L Fspif mDghdk;: rPdp 
 22. tpy;thjp ijyk;      166 
jPUk; Neha;fs;: 1 kz;lyk; (48 ehl;fs;) KOfpl 
gpj;jNeha;> Nrj;Jk Neha;> fghy #L> gPdprNuhfk;> 
ntl;ilr; #L> c\;zthA jPUk;.  
 23. fUq;Nfhopr; #uzk;      180 
msT: gzntil (488 kp.fpuhk;)> fhiy> khiy> 
1kz;lyk; (48 ehl;fs;). 
   jPUk; Neha;fs;;: gTj;jpuk;> #iyfl;L> rpye;jpfb. 
X. fz;Zrhkpg; guk;giu itj;jpak;. 
 24. jUz Ruf; fpahok;     64 
   msT: 2 mTd;] (60 kp.yp) 3 Ntis 
   jPUk; Neha;fs;: gytpjkhd njhe;j Ruq;fs; 
 25. NkfthAtpw;F fpahok;     69 
    msT: 1mTd;]; (30 kp.yp) 3 Ntis 
       26. jpg;gpyp #uzk;      108 
   msT: jphpfb gpukhzk; 2Ntis. 
   jPUk; Neha;fs;: <is> ,Uky;> rak;> mNuhrfk;> the;jp  
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                 P. No 
 27. fz;lhj;jphp Nyfpak;     165 
   msT: rpWnfhl;il ghf;fsT. 2Ntis. 
jPUk; Neha;fs;: ,Uky;> nrhpahik> the;jp> Fd;kk;;> 
cl;Ruk;> jhgRuk;> fpuhzp> Ngjp jPUk;. 
28. f];J}hp nkOF      216 
  msT: cSe;J gpukhzk; (130 kp. fpuhk;) ,U Ntis 
  jPUk; Neha;fs;: rd;dp> Ruk;> rapj;jpak; 
XI. rpNuhuj;jpd itj;jpa G+\zk; 
 29. epyg;gid fpUjk;     70 
  msT: cr;rpf;fuz;basT (16 kp.yp)> ,UNtis 
   fhy;kz;lyk; (12 ehl;fs;).  
   jPUk; Neha;fs;: ePh;RUf;F> ePh;nrhpg;G 
 30. rh;t ghz fpahok;      158 
msT: cr;rpf;fuz;bsasT (16 kp.yp)> ,UNtis  
 fhy;kz;lyk; (12 ehl;fs;) 
 jPUk; Neha;fs;: gpuNkfk; 
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MATERIALS AND METHODS 
 
 In this dissertation the Kandubarangi ver chooranam was taken as a 
single drug study. This drug was prepared as per specification given in the 
literature Gunapadam Mooligi Vaguppu Page No: 215.   
COLLECTION OF THE DRUG 
 Kandubarangi Root was collected from the Raw drug store.  
Government Siddha Medical College, Palayamkottai. 
PREPARATION OF THE TEST DRUG 
 The collected Kandabarangi Root was washed in fresh water and dried 
in the shadow to remove its moisture content.  Then made into a fine powder 
and fittered by a white clean, cloth (Vasthira Kayam) 
PURIFICATION OF THE CHOORANAM 
An earthen pot was taken and was filled with equal parts of milk and 
water.  A thin white cloth tied around the mouth of the pot.  The prepared 
chooranam was placed over the cloth and then it was covered with another 
suitable earthen pot.  It was kept on the fire until the milk level decreased.  
The chooranam was taken out, dried and filtered through a clean white cloth.  
The chooranam thus obtained was stored in a clean dry container.  The 
contents of the container was inspected from time to time to safe guard 
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against moisture and insects since life time of chooranam is three months, it 
was used within the period. 
ROUTE 
 Enteral route. 
DOSE 
2 grams twice a day with hot water after food.
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BIO – CHEMICAL ANALYSIS 
BIO – CHEMICAL ANALYSIS OF KANDUBARANGI VER 
CHOORANAM 
 
Preparation of the Extract  
 5gms of Chooranam was weighed accurately and placed in a 250ml 
clean beaker.  Then 50ml distilled water is added and dissolved well.  Then 
it is boiled well for about 10 minutes.  It was cooled and filtered in a 100ml 
volumetric flask and then it is made up to 100ml with distilled water.  This 
fluid is taken for analysis 
QUALITATIVE ANALYSIS 
S. 
No 
Experiment Observation Inference 
1. Test for calcium 
2ml of the above prepared extract is 
taken in a clean test tube.  To this add 
2 ml of 4% ammonium oxalate 
solution. 
white 
precipitate is 
formed. 
Indicates 
the  
presence of 
calcium. 
2. Test for sulphate: 
2ml of the extract is added to 5% 
barium chloride solution. 
No white 
precipitate is 
formed. 
Absence of  
sulphate. 
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3. Test for chloride 
The extract is treated with silver 
nitrate solution. 
No white 
precipitate is 
formed. 
Absence of 
chloride. 
4. Test for carbonate 
The substance is treated with 
concentrated Hcl. 
No brisk 
effervescence 
is formed. 
Absence of 
carbonate. 
5. Test for Starch 
The extract is added with weak iodine 
solution. 
No blue colour 
is formed 
Absence of 
starch. 
6. Test for iron 
Ferric 
The extract is treated with 
concentrated glacial acetic acid and 
potassium ferro cyanide.                    
No blue colour 
is formed. 
Absence of 
ferric iron. 
7. Test of iron : 
Ferrous: 
The extract is treated with 
concentrated Nitric acid and 
ammonium thio cynate. 
No Blood red 
colour is 
formed. 
Absence of 
ferrous iron. 
8. Test for phosphate 
The extract is treated with ammonium 
molybdate and concentrated nitric 
acid. 
No Yellow 
precipitate is 
formed. 
Absence of 
phosphate. 
9. Test for albumin  
The extract is treated with Esbach’s 
reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
albumin. 
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10. Test for Tannic acid 
The extract is treated with ferric 
chloride reagent. 
No blue black 
precipitate is 
formed. 
Absence of 
Tannic acid. 
11. Test for unsaturation 
Potassium permanganate solution is 
added to the extract. 
It gets 
decolourised. 
Indicate the 
Presence of 
unsaturated 
compound. 
12. Test for the reducing sugar 
5ml of benedict’s qualitative solution 
is taken in a test tube and allowed to 
boil for 2 mts and added 8-10 drops of 
the extract and again boil it for 2 mts. 
No colour 
change occurs. 
Absence of 
reducing 
sugar. 
13. Test for amino acid: 
One or two drops of the extract is 
placed on a filter paper and dried it  
well. After drying, 1% ninhydrin is 
sprayed over the same and dried it 
well. 
No Violet 
colour is 
formed. 
Absence of 
amino acid. 
 
INFERENCE 
 The given sample of Kandubarangi ver chooranam contain calcium 
and unsaturated compound. 
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PHARMACOLOGICAL STUDIES 
ANALGESIC STUDY OF KANDUBARANGI VER 
CHOORANAM ON ALBINO RATS BY TAIL-FLICK METHOD 
AIM 
 To study the analgesic effect of Kandubarangi ver Chooranam on 
albino rats by Tail-flick method. 
MATERIALS AND METHODS 
PREPARATION OF THE TEST DRUG 
 1 gm of Kandubarangi ver Chooranam was suspended in 10ml of 
distilled water using as suspending agent.  This 1ml contains 100mg of the 
test drug. 
INSTRUMENT 
 Hot water bath maintained at 550c + 0.50c was used as the source of 
stimulus. 
PROCEDURE 
 Healthy albino rats weighing 100-200gms of both sexes were selected.  
The tail of each rat was dipped in the hot water bath and time taken for the 
rat to remove the tail from the water bath was noted.  The rats that take more 
than 5 seconds to remove the tail are excluded form the equipment.  Then 
the rats were dividend into 3 equal groups, each group having 2 rats.                  
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The first group was given the solvent used to suspended the drug and kept as 
untreated control.  The second group was given the standard drug and kept 
as treated control.  The third group was given the test drug 100mg/100gm, ½ 
hr and 1hr after drug administration the rats are again tested by dipping the 
tail in the hot water bath.  The time taken for the rat to remove the tail was 
noted as done initially. 
 The result of control group, standard group and drug treated group 
were tabulated and compared. 
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ANALGESIC EFFECT OF KANDU BARANGI VER 
CHOORANAM 
S.No. 
Name of 
Drugs / 
Groups 
Dose / 
100 
gram 
body 
weight 
Initial 
Reading
After Drug Administration 
Mean 
Difference
½ hr. 
Average
1 hr. 
Average
1 ½ hr. 
Average 
1. Control 2ml 2secs 2.5secs 2.5secs 2.5secs 2.5sec 
2 
Standard 
Paracetamol 
20mg 2secs 2.5secs 4secs 6.7secs 6.7secs 
3. 
Test Drug 
Kandubarangi 
ver 
Chooranam 
200mg 2secs 2.5secs 4secs 5secs 5secs 
 
INFERENCE 
  The test drug Kandubarangi ver Chooranam has got 
significant Analgesic Activity. 
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ANTI – INFLAMMATORY STUDIES 
ACUTE ANTI-INFLAMMATORY STUDIES - 
CARRAGEENIN INDUCED HINDPAW EDEMA METHOD 
METHOD  
              Carrageenin induced Hind paw edema method in Albino rats. 
AIM 
 To evaluate the acute anti – inflammatory effect of Kandubarangi 
ver Chooranam by carrageenin induced oedema method in albino rats. 
DRUG PREPARATION 
 1gm of Kandubarangi ver Chooranam was suspended in 10ml of 
distilled water using as suspending agent.  This 1ml contains 100mg of 
the test drug. 
PROCEDURE 
 Six healthy albino rats of either sex weighing between 100-120gm 
were selected.  The volume of each hind paw was measured by using the 
mercury plethysmograph. 
 After the measurement of hindpaw of all the rats, they were divided 
into three groups each containing two rats. 
 First group was kept as control by giving distilled water of 
2ml/100mg of body weight.  The second group was given ibuprofen 
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20mg/100gm body weight and kept as standard.  Third group was given 
test drug Kandubarangi ver Chooranam 100mg/100gm body weight. 
 The drugs were administered orally, one hour after drug 
administration, 0.1ml 1% (W/V) of carrageenin suspension in water was 
injected in the plantar surface of hind paw of rats. 
 All the animals were given carrageenin injection subcutaneously.  
Three hour after carrageenin injection, the hindpaw volume was 
measured from the differences in the initial and final hind paw volume, 
the degree of the inflammation was calculated by taking the volume in the 
untreated control group as 100%. 
 The percentage of inflammation of the other group was calculated 
from the degree of anti – inflammatory effect of the treated and the test 
groups were calculated. 
RESULTS 
The details of the experiment results are shown in the table. 
 44
 
ACUTE ANTI INFLAMMATORY EFFECT OF KANBARANGI 
VER CHOORANAM 
 
Group Drug 
Dose/100gm 
of body 
weight 
Initial 
Reading 
Average
Finial 
Reading 
Average
Mean 
Difference
Percentage 
inflammation 
Percentage 
inhibition 
Control 
Standard 
Test 
drug 
Water 
Ibuprofen 
Kandu 
barangi 
ver 
chooranam 
1ml 
20mg 
 
 
200mg 
 
1.1 
1.3 
 
 
1.0 
1.85 
1.35 
 
 
1.2 
0.75 
0.05 
 
 
0.2 
100 
6.6 
 
 
26.6 
 
93.4 
 
 
73.4 
 
INFERENCE 
 Thus Kandubarangi ver Chooranam has got significant acute anti 
inflammatory effect.  
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CHRONIC ANTI – INFLAMMATORY EFFECT OF 
KANDUBARANGI VER CHOORANAM IN RATS BY 
COTTON PELLETS GRANULOMA METHOD 
AIM 
 Chronic Anti – Inflammatory effect of Kandu Barangi ver 
chooranam. 
DRUG PREPARATION 
 1gm of Kandubarangi ver Chooranam was suspended in 10ml of 
distilled water.  This 1ml contains 100mg of the test drug. 
PROCEDURE 
 Six healthy albino rats weighing 100 – 150gms were taken and 
divided in to three groups, each consisting of two rats. 
 In this procedure, the drugs were given daily for 7 days.  Before 
giving the drug cotton pellets each weighing 10mg were prepared and 
sterilised in the autoclave for about 1hr under 15Hg atmospheric 
pressures, on the day of experiment, each rat was anasthetised with ether 
to implant 10mg of sterilised cotton pellets subcutaneously in the lower 
abdomen two on each side after making suitable incision and sutured 
carefully. 
 First group was kept as control by giving distilled water of 
2ml/100gm of body weight.  To the second group, the standard drug 
lbuprofen in a dose of 20mg/100gm body weight was given.  The third 
group of animals was given tested drug Kandubarangi ver Chooranam in 
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a dose of 200mg/100gm of body weight.  On the 8th day of the 
experiment, all the rats were sacrificed and cotton pellets found to be 
surrounded by granulation tissue were removed and dried in hot air ovun 
at 550c - 600c. 
 The average weight of granuloma of control group and treated 
group give an estimation of degree of Inhibitory activity of test drug. 
RESULTS 
 The details of the experiment result are shown in the table. 
CHRONIC ANTI INFLAMMATORY EFFECT OF KANDU 
BARANGI VER CHOORANAM 
Group 
Dose/100gm 
of body 
weight 
Cotton 
Pellet 
weight
Pellet 
weight to 
the 
Granuloma 
of drugs 
Percentage of 
Inflammation 
Percentage 
of 
Inhibition 
Control 
(water) 
Standard 
(Ibuprofen) 
Test drug 
(Kandu 
Barangi ver 
chooranam) 
1ml 
 
20mg 
 
 
100mg 
10mg 
 
10mg 
 
 
10mg 
250mg 
 
55mg 
 
 
120mg 
100 
 
22 
 
 
48 
NIL 
 
78 
 
 
52 
 
INFERENCE 
The test drug Kandubarangi ver Chooranam has got significant 
chronic Anti-Inflammatory Effect. 
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ANTIPYRETIC STUDY OF KANDUBARANGI VER 
CHOORANAM IN YEAST INDUCED HYPER PYREXIA 
ALBINO RATS 
 The test drug Kandubarangi ver Chooranam was screened for its 
antipyretic activity with the help of yeast induced hyperpyrexia albino 
rats. 
AIM 
 To evaluate antipyretic activity of Kandubarangi ver Chooranam.  
PREPARATION OF THE TEST DURG 
 1gm of Kandubarangi ver Chooranam was dissolved in 10ml of 
water.  1ml of this preparation contains 100mg of the test drug. 
YEAST INDUCED HYPERPYREXIA 
 Six healthy albino rats of either sex, weighing between 80-100gm 
were selected.  They were divided into 3 groups of 2 rats in each group.  
All the rats were made hyperthermic by giving subcutaneous injection of 
12% of yeast in distilled water 1ml/100gm of body weight. 
 After 10 hours, the initial temperature (0 hr) was taken for all the 
rats.  First group of rats were given 2ml of water and kept as control.  The 
second group received 20mg/100gm of body weight of Paracetamol and 
the third one received the test drug Kandubarangi ver Chooranam 
200mg/100gm body weight. 
 The mean rectal temperatures for all the rats were recorded at 1 1/2 
hr, 3hr, and 41/2 hours after the drug administration. 
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 The difference between the 3 groups are measured and compared. 
RESULTS 
The details of the experiment and the results were shown in the 
table. 
ANTIPYRETIC EFFECT OF KANDU BARANGI VER 
CHOORANAM 
S. 
No. 
Name of Drug 
/ Groups 
Dose / 
100 
gm 
body 
weight
Initial 
Temperature 
in centigrade 
After Drug 
Administration 
Remarks 
1 ½ 
hour
3.0 
hour
4 ½ 
hour 
1. 
 
Control 
(Water) 
1ml 
36.0 
37.0 
36.0 
37.0 
36.0 
38.0 
37.0 
39.0 
38.0 - 
2. 
Standard 
(Paracetamol) 
20mg  
37.0 
38.0 
37.0 
37.0 
36.5 
36.5 
35.0 
35.0 
34.5 - 
3. 
Kandubarangi 
ver 
Chooranam 
200ml 
38.0 
38.0 
37.0 
37.0 
36.0 
36.0 
35.5 
35.5 
35.5 - 
 
INFERENCE 
  The test drug Kandubarangi ver Chooranam has got 
significant Anti Pyretic activity. 
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ANTI-MICROBIAL SUSCEPTIBILITY TEST  FOR 
KANDUBARANGI VER CHOORANAM 
Aim: 
 To identify the anti-microbial (Bacterial) activity of Kandubarangi 
ver chooranam against Streptococcus, Staphylococcus, proteus, 
Psuedomonas, E.coli and Klebsiella.  
Method :  Kirby bauer disc diffusion method 
Medium : Muller Hinton agar 
Components of Medium: 
 Beef extract   : 300gms /lit 
 Agar    : 17gms /lit 
 Starch   : 1.50gms /lit 
 Casein Hydroxylate : 17.50gms /lit 
 Distilled Water  : 1000 ml 
 pH     : 7.6 
Procedure: 
 The media was prepared from the above components and poured 
and dried on a Petri dish. The organism was streaked on the medium and 
the test drug (1 gm drug in 10 ml of Water) was placed on the medium. 
This is incubated at 370C for one over night and observed for the 
susceptibility  shown up clearance around the drug. 
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Table: Anti-microbial Susceptibility Test Report 
No. Organism Susceptibility 
1. Staphylococcus Resistant 
2. Pseudomonas Resistant 
3. E. coli Resistant 
4. Klebsiella Resistant 
5. Proteus Resistant 
6. Streptococcus Resistant 
 
Result: 
  The test drug Kandubarangi ver Chooranam was resistant for all 
the  organisms. 
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CLINICAL ASSESSMENT 
 
 In siddha literatures 10 types of keelvayu have been recoginsed.  
Azhal Keelvayu is the common type of these 10.  The author of this 
dissertation selected Kandubarangi ver Chooranam to asses clinically 
for Azhal keelvayu. 
 Azhal keelvayu is a disease mainly affecting the major weight 
bearing joints like knee joint. 
 Normally this is a change in the joints at certain age group. 
 This type of arthritis produces socio-economic problems in human 
being. 
 The main changes of joints are wear and tear reactions in the 
components of the joints producing pain, swelling, tenderness and 
limitations of movement. 
 There is no specific curative treatment to restore the changes in the 
joints.  But surgical and medical management can be obtained.  The drug 
therapy holds good. 
 In order to assess the efficacy of Kandubarangi ver Chooranam 
for Azhal keelvayu, it was tried clinically on 10 inpatients and 30 out 
patients in the post graduate department of Gunapadam, Government 
Siddha Medical College hospital, Palayamkottai.  Patients of both sexes 
were selected for this clinical trial. 
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 All the cases were selected by the inclusion criteria.  The selected 
patients for this study had been investigated for the following complaints, 
present history, past history, family history, personal history and habits. 
 Blood picture studies of total white blood cells count, Differential 
count.  Erythrocyte sedimentation rate, and Haemoglobin estimation, Bio 
chemical tests like blood sugar, Cholestrol and Urea were estimated to all 
patients in the laboratory of Government Siddha Medical College 
hospital.  Complete urine analysis has also been done. 
 All the patients of Azhal keelvayu were subjected to x-ray findings 
in the Radiology department of Government Siddha Medical College 
Hospital Palayamkottai. 
 These clinical parameters had been repeated after the end of 
treatment.  Joint size and swelling had been measured at the beginning 
and at end of treatment. 
 The test drug was administered in the dose of 2grams two times a 
day with hot water after diet. 
 For the I.P patients it was given daily and for O.P patients, it was 
given for 7 days.  Patients those who were having the following all or 
some symptoms had been selected for the study. 
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INCLUDING CRITERIA 
 Pain 
 Swelling – measurement of the both knee joints noted. 
 Morning stiffness. 
 Limitation of movement. 
 Joint tenderness. 
 Crepitations while walking. 
 Walking difficulties. 
EXCLUDING CRITERIA 
 Sudden onset of excruciating pain and marked swelling. 
 Redness of the big toe with increased level of blood uric acid. 
 Younger age group. 
 History of involvement of smaller joint followed by major joints 
with complaining of migrating joint pain. 
 Patients of sputum positive for AFB. 
 Positive VDRL test. 
LINE OF TREATMENT 
 Kandubarangi ver Chooranam was administered orally 2grams two 
times a day with hot water after meals for each case for 10-40 days. 
 The duration of treatment varied according to the severity of signs 
and symptoms. 
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DIET RESTRICTION AND MEDICAL ADVICE 
1. The patients were advised to take easily digestiable and highly 
nutritive foods. 
2. They were advised to avoid food like potato, dhal, curd, and egg, 
etc., which would increas the vayukutram. 
3. Advised to avoid exposure to cold damp climate. 
4. Obese patients were advised to reduce their weight inorder to avoid 
stress.  To avoid stress, walking is reduced; if they walk they are 
advised to use the stick for support. 
5. Prolonged immobilization must be avoided as it further incapitate 
the patient to walk. 
Exercise for Strengthening Muscles around the knee joint 
 Simple exercise that promote flexibility and strengthen the muscles 
around the knee can go long way towards warding off problems. In many 
cases, these excerise can also help hasten recovery after a knee injury. 
Weak or tight muscles are an important cause of knee injuries. 
  Hence, it is advisable to make the time and effort to strengthen the 
muscle around the knee. However, if one is already suffering from pain in 
the knee, these exercises should be performed after consulting a doctor. 
To derive maximum benefit from the following exercise, they should be 
performed once or twice a day, repeating every exercise five to ten times 
for each knee. 
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Thigh Firmer: 
 
  
 
 
 
 
Sit on the edge of a chair with one leg stretched out in front and the 
heel resting on the floor; tighten the muscle that runs across in front of the 
knee by flexing the toes back. Simultaneously, push the back of the knee 
towards the floor and feel the stretch there as well as at the back of the 
ankle. Hold for 5 seconds. Repeat the same with the other leg. 
Knee flexion and extension: 
 
  
 
 
 
Sit straight on chair and bend the knee by pulling heel under the 
chair. Rest the foot on the toes. Hold for 5 seconds. Keep the foot relaxed 
and slowly raise it up to straighten the knee. Hold for 5 seconds and then 
slowly lower the foot to the floor. Repeat the same with the other leg. 
 56
Straight Leg lift: 
 
  
 
 
Lie flat on the back with the stomach pulled in, the knee of one leg 
bent and the foot flat on the floor. Extend the other leg and lift it slowly 
as far as is comfortably possible, without bending the knee. Hold for 5 
seconds and slowly lower the leg. Repeat the same with the other leg.  
OBSERVATION 
 The result was observed on the basis of the symptomatic relief 
obtained by the patients. 
RESULTS 
 Out of the 40 cases administered with Kandubarangi ver 
Chooranam 29 cases (72.5%) showed significant relief from pain, 
swelling and restricted movements, and 9 cases (22.5%) showed partial 
relief and 2 cases (5%) showed poor relief. 
 Duration of the treatment was varied from 15 to 40 days according 
to the severity of the signs and symptoms. 
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BIO - STATISTICAL ANALYSIS 
 
 The analysis of the effectiveness of the drug done in terms of 
mean, STD deviation and percentages.  The likely percentages were made 
through paired and unpaired‘t’ test.  The S.P.S.S percentage version 13.0 
was used for making analysis and test of significance.  
Results and Discussions 
 The drug was administered to Azhal keevayu was Kandubarangi 
Ver Chooranam.  The studies were analysed choosed on their age and 
sex. 
Age and Sex 
 Table – 1 Age and sex wise distribution of the study subjects 
S. No. Sex n 
Age 
‘t’ Significance
Mean S.D 
1 Male 18 59.56 9.67 0.575 P>0.05 
2 Female 22 57.86 8.96 - - 
3 Total 40 58.60 9.20 - - 
 
 The analysis showed in the above table clearly explains the mean 
ages of the study subjects and the difference age between sexes.  The age 
differences between the sexes are not statistically significant. The 
population age will be 55.7 to 61.7 years.   
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Parameters Analysed 
 The various parameters which are related to the disease and 
effectiveness of the drug for controlling and management were analysed.  
The results of them are furnished as follows:  
Table – 2 Related parameters results before and after administration of 
the drug. 
S. 
No. 
Variable 
Signs 
n Leg 
Before After 
‘t’ Significance
Mean S.D Mean S.D
1 Pain 40 
Right 2.6 0.83 0.75 0.90 11.907 P< 0.000 
Left 2.27 0.82 0.53 0.82 11.601 P< 0.000 
2 Stiffness 40 
Right 0.95 0.32 0.10 0.30 12.599 P< 0.000 
Left 0.93 0.27 0.25 0.16 18.735 P< 0.000 
3 
Measurement 
(c.m) 
40 
Right 35.75 2.86 34.23 2.23 2.179 P< 0.05 
Left 35.70 3.03 34.13 2.20 2.269 P< 0.05 
4 Tenderness 40 
Right 0.93 0.27 0.05 0.22 16.523 P< 0.000 
Left 0.93 0.27 0.07 0.27 14.866 P< 0.000 
5 Swelling 40 
Right 0.63 0.49 0.03 0.16 7.649 P< 0.000 
Left 0.60 0.50 0.07 0.27 6.565 P< 0.000 
6 
100 feet 
Walking 
time (sec) 
40 - 59.85 4.21 51.53 6.71 10.664 P< 0.000 
  
The variables analysed in the above table which are namely pain, 
stiffness, measurement of swelling and duration of 100 feet walk are 
showed significant difference between before treatment and after 
treatment (P<0.000).  The significant reduction of the above symptoms is 
undoubtedly due to the effect of the drug Kandubarangi ver chooranam. 
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Response of the drug 
 The response of drug was grated good, fair and poor based on the 
observed symptoms. 
S. No Response grade N 
Response 
No. % 
1 Good 40 29 72.5 
2 Fair 40 9 22.5 
3 Poor 40 2 5.0 
 
 After administration of the drug the study subjects are observed 
good, fair and poor responses of percentages 72.5%, 22.5% and 5% 
respectively.  The good response of the 72.5% is also supported the 
effectiveness of the drug.  
RESPONSE 
In the clinical trials done for 40 patients good response is obtained 
in 9 patients (22.5%) cases showed fair response, 2 (5%) cases showed 
poor response.  
 
RESPONSE IN PERCENTAGE 
Sl. No Response No. of patients Percentage  
1. Good 29 72.5% 
2. Fair 9 22.5% 
3. Poor 2 5% 
 Total 40 100% 
 
 
 60
DISCUSSION 
 
 The therapeutic efficacy of Kandubarangi ver chooranam in the 
disease of Azhal keel vayu is related to exploring pharmacological action 
like anti – inflammatory, analgesic and antipyretic action through clinical 
trials. From various literatures and informations, the author has come to 
an idea about Kandubaragi ver chooranam and its efficacy in  Azhal keel 
Vayu. 
 Bio chemical and pharmacological studies, botanical aspects, 
gunapadam aspects and method of preparation of the drug are described 
in this dissertation. 
 Bio chemical analysis showed that the drug contained calcium, 
unsaturated compound. 
Regarding Azhal keelvayu patients they are generally seemed to be 
weakened due to disability to walk which disturbs their day to day 
activities. Most of them are deficient of calcium particularly in women 
during menopause there is likelihood of depletion of calcium and iron. It 
leads to friability and porosity of bones often causing cracks and fractures 
of bones. In Kandubarangi ver chooranam due to presence of calcium ion 
it can be used as a supportive therapy for compensation of density loss in 
bones and joints. 
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In pharmacological studies, this drug has got significant analgesic, 
significant acute and significant chronic anti-inflammatory and 
significant anti pyretic activities. It helps to relieve pain (analgesic) and 
reduce the inflammation (anti – inflammatory) in soft tissues. 
 About 40 patients with Azhal keel vayu were taken in this study 
out of these,  
  Good response - 72.5% 
  Fair response - 22.5% 
  Poor response - 5% 
During the treatment, the patients had no signs and symptoms of 
toxic effects. 
Bio statistical analysis also proved that this drug has got 
significant effect in treating Azhal Keel Vayu.  
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SUMMARY 
 
 The drug Kandubarangiver has been selected for the study to 
establish its efficacy in treating Azhal Keel Vayu.  
 A brief description pertaining to its botanical aspect, phytochemical 
constituents and gunapadam aspect has been referred. 
 A review of the literatures about the drug and its significance in 
medicine since ancient period has been done. 
 Collected information about the drug from various literatures and 
websites have been referred.  
 Bio-chemical analysis of the drug shows the presence of calcium 
unsaturated compounds. 
 Pharmacological analysis shows that the drug has got significant 
acute anti-inflammatory activity, Chronic anti-inflammatory 
activity, Analgesic activity and anti-Pyretic activity. 
 Anti Microbial Susceptility test report shows that the drug has got 
resistance to micro organisms.    
 From the clinical assessment, it is inferred that Kandubarangiver 
Chooranam has good efficacy in treating Azhal Keel Vayu. During 
the clinical trial the patients showed no untoward effects. 
 Biostatistical analysis also proved that this drug has got significant 
effect in treating Azhal Keel Vayu. 
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CONCLUSION 
 
 It is concluded that the drug Kandubarangi ver Chooranam is 
an effective drug in Azhal Keel Vayu for reducing its severity and 
difficulties without producing any untoward effects.  
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INTRODUCTION 
 
 
 The Siddha System of medicine is regarded as the most unique 
system especially in the preparation of “Kaya Kalpa” drugs.  One may 
wonder what is the remarkable thing in the Siddha System that is capable 
of curing many chronic and degenerative diseases.  It may surprice one to 
know that the fundamental principles of Siddha system are not to be 
found in any other medical systems of the world. 
 The scope of the Kaya Kalpa treatment is two fold, one is to cure 
degenerative diseases and the other is to prolong the life span.  It goes 
without saying that a cure for degenerated diseases will naturally ensure 
longevity. 
 William A. R. Thomson says that immortality can be left as an 
inspiration for the artistic temperament.  A study of the Siddha science 
for longer life and “Kaya Kalpa” treatment is a weapon which is 
preventive as well as constructive. 
 Anaemia is one such condition which has to be treated promptly 
with utmost care and requires a pragmatic approach.  Any failure to treat 
anaemia can lead to dangerous and often fatal consequences. 
 So the author has selected Aya Bringa Raja Karpam to study its 
therapeutic efficacy in Pandu Noi. 
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AIM AND OBJECTIIVE 
 
 
 The main aim and objective of this dissertation work is to do a 
scientific review of Aya BringaRaja Karpam and its efficacy in treating 
Pandu Noi. (Anaemia) 
Pandu Noi is one of the common diseases affecting millions of 
people all over the world. Aya BringaRaja Karpam is suggested as an 
effective drug for Pandu Noi in Gunapadam Thathu Vaguppu (Page 
No 75 . ) Siddha Vaithiya Thirattu (Page 232). 
The scope of research aspects are more in Gunapadam Thathu 
Vaguppu especially for Aya BringaRaja Karpam.No one has been 
attempted to study its efficacy in Pandu Noi. Therefore, the author has 
chosen Aya BringaRaja Karpam as her dissertation subject. 
The study is done in the following aspects. 
 Chemical aspect 
 Gunapadam aspect 
 Bio-chemical analysis 
 Pharmacological analysis 
 Toxicity studies 
 Antimicrobial suceptbility test. 
 Heavy metal analysis by AAS 
 Clinical assessment. 
 Bio statistical analysis 
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REVIEW OF LITERATURE  
CHEMICAL ASPECT 
FERRUM 
 Iron is the fourth most abundant element.  Second most abundant 
metal.  The first three elements being. 
 Oxygen 
 Silicon 
 Aluminium 
                                                           Ref: Modern Inorganic Chemistry  
P. No. 1447 R.D. Madan S. Chand. 
It is found mainly in the following forms. 
 Magnetite 
 Hematite 
 Limonite 
 Siderite 
 Laterite 
 Illmenite 
 Pyrite 
Magnetite:            
 Fe304 
 Fe – 72.4% 
 Sp. gr – 5.17 – 5.18 
 H - 5.5 – 6.5  
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 It is of igneous replacement or metamorphic origin. 
 It is isometric. 
 The commonest crystal form being the octahedran. 
 In the form of load stone, magnetite is sometimes used as a 
magnet. 
Hematite: 
 Fe203 
 Fe – 70% 
 Sp. gr – 4.9 – 5.3  
 H – 5.5 – 6.5 
 It is the red oxide of Iron. 
 The crystalline rhombohedeal form (Specular hematite) may be 
nearly as black as magnetite. 
 Its cherry – red streak and non-magnetite characters distinguish 
it from magnetite. 
 When earthy or granular, it is red. 
 Large ore bodies of sedimentary origin (eg) banded hematite 
jasper) occur extensively. 
Limonite: 
 The brown ore of iron. 
 It is now known to consist of only  
Ferric oxide monohydrate.  Fe2o3. H2o. Fe – 59.8%. 
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 It contains absorbed and capillary water. 
 It occurs in amorphous form (Limonite)  
 It crystallizes in the orthorhombic form (goethite and 
lepidocrocite)  
 Lepidocrocite (Sp. gr. – 4.09) has a red colour and goethite (Sp. 
gr. 4.28) is yellowish brown. 
 Limonite and the crystalline monohydrates may have been 
derived from surface weathering of iron – bearing sulphides, 
iron bearing silicates, or iron  carbonates. 
 They are less hard than hematite.  
Siderite: 
 FeCo3 
 Fe – 48.2% 
 Sp. gr, 3.83 – 3.88: 
 H  3.5 – 4  
 It is commercially known as spathi Iron. 
 It is dark brown to black in colour. 
 It crystallizes as rhombo hedra  in the hexagonal system. 
 Siderite occurs as sedimentary or replacement deposits. 
 Sometimes associated with other carbonates like calcite. 
 Though it contains less iron than hematite, it is self-flexing and 
is there fore considered a very desirable one for metallargical 
purposes. 
 Its grade may be raised to that of hematite by calcination. 
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Laterites: 
 They are porous brown hydrated iron oxide rocks, turning dark 
and hard at the surface. 
 The iron content of the ore is low. 
 Some of the deposits contain deleterious impurities. 
Ilmentite: 
 FeO. Ti. O2 
 Fe – 36.8% 
 Sp. gr – 4.5 – 5  
 H – 5  – 6  
 It is iron black with a black to brownish streak. 
 It has a variable iron – titanium ratio. 
 It is not an important iron ore. 
Pyrite: 
 FeS2 
 Fe – 46.6% 
 Sp. gr – 5.0 – 5.1 
 H– 6 – 6.5. 
 It is of golden yellow colour with metallic lusture. 
 It is not usually considered as iron ore. 
                             Ref: Wealth of India Vol V P. No: 256    
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Commercial forms of Iron     
 There are three forms of Iron which differ in their carbon content. 
 Wrought iron or Malleable iron. 
 Steel. 
 Cast iron or pig iron. 
General properties of Iron. 
Chemical Symbol Fe 
Mineral 
Iron oxides: 
e.g hematite and magnetite 
Relative density 7.87 
Malleability High 
Ductility High 
Melting point 15350C 
Atomic Mass 55.85 
Chemical series Transition metals 
Group, period, block 8,4,d 
Appearance 
Lustrous metallic with a grayish 
tinge 
 
Physical properties: 
Phase Solid 
Boiling point 3134 K (28620C, 51820F) 
Heat of fusion 13.81 KJ. Mol-1 
Heat of vaporization 340 KJ. Mol-1 
Heat capacity (250C) 25.10 J. mol-1.K-1 
Vapor pressure 
P/Pa 1 10 100 1K 10K 100K 
at T/K 1728 1890 2091 2346 2679 3132 
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Atomic properties: 
Crystal structure 
Body-centered cubic a=286.65 pm; face-
centered cubic between 1185-1667 K 
Oxidation states 
 
6,5 [2],4,3,2,1 [3] (amphoteric oxide) 
 
Electronegativity 1.83 (Pauling scale) 
Ionization energies 
(more) 
1st: 762.5 KJ.mol-1 
2nd: 1561.9KJ.mol-1 
3rd: 2957 KJ.mol-1 
Atomic radius 140 pm 
Atomic radius (calc.) 156 pm 
Covalent radius 125 pm 
 
Chemical properties  
 
Atomic number 26 
Atomic mass 55.85 g.mol-1 
Density 7.8 g.cm-3 at 20°C 
Vanderwaalsradius 
0.126 nm 
0.076 nm (+2) ; 0.064 
Ionic radius Mm (+3) 
Isotopes 8 
Electronic shell [Ar] 3d6 4s2 
Energy of first inoisation 761 kJ.mol-1 
Energy of second ionisation 1556.5 kJ.mol-1 
Energy of third ionization 2951 kJ.mol-1 
Standard potential 
-0.44 V (Fe2+ / Fe); 
0.77 V (Fe3+ / Fe2+) 
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Miscellaneous 
 
Magnetic ordering 
Ferromagnetic 
1043 K 
Electrical resistivity (20°C) 96.1 nΩ-m 
Thermal conductivity (300 K) 80.4 W.m-1. K-1 
Thermal expansion (25°C) 11.8 μm.m-1.K-1 
Speed of sound (thin rod) (r.t.) (electrolytic) 5120 m.s-1 
Young’s modulus 211 GPa 
Shear modulus 82 GPa 
Bulk modulus 170 GPa 
Poisson ratio 0.29 
Mohs hardness 4.0 
Vickers hardness 608 MPa 
Brinell hardness 490 MPa 
CAS registry number 7439-89-6 
 
Ref . www.wikipedia.com 
BIO-CHEMICAL ASPECT 
 
 
 The total content of iron in an adult body is 3 – 5gm.  About 70% 
of this occurs in the erythrocytes of blood as a constituent of 
haemoglobin.  Haeme is the most predominant iron containing substance.  
It is a constituent of several proteins / enzymes.  
                                      Ref:  Bio-Chemistry Sathya Narayana P. No: 457 
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Iron containing mammalian enzymes and other proteins: 
Haemoglobin cytochromes  xanthine oxidase 
Myoglobin  cytochrome reductase Homogentisicase 
Ferritin  Cytochrome oxidase Hydroxyanthranilic oxidase 
Hemosiderin catalase   phenylalanine hydroxylase 
Siderofilin            Peroxidases   Tryptophan oxidase.  
                                             Ref:  Text book of Bio-Chemistry P. No:1389 
Bio-Chemical functions of Iron: 
 Iron mainly exerts its functions through the compounds in which it 
is present.  Haemoglobin and myoglobin are required for the 
transport of O2 and Co2. 
 Cytochromes and certain non-haeme proteins are necessary for 
electron transport chain and oxidative phosphorylation. 
 Peroxidase, the lysosomal enzyme, is required for phagocytosis 
and killing of bacteria by neutrophils. 
 Iron is associated with effective immuno competence of the body. 
Daily requirements: 
Age RNI Age RNI 
0 to 3 months 1.7mg Men 11 – 18yrs 11.3mg 
4 to 6 months 4.3mg Men 19 + yrs 8.7mg 
7 to 12 months 7.8mg Women 11 – 49 yrs 14.8mg 
1 to 3 yrs 6.9mg Women 50 + yrs 8.7mg 
4 to 6 yrs 6.1mg 7 to 10 yrs 8.7mg 
 
RNI – Reference Nutrient Intakes for iron, mg/per day 
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SOURCES OF IRON 
Good sources Fair sources Poor sources 
Chick peas 
(200g or 
7oz) 
6.2mg Egg, boiled 1.3mg
Banana (120g or 
4¼oz 
0.48mg
Bran flakes 
(45g or 
1½oz) 
5.3mg 
Avocado 
(75g or 
2¾oz) 
1.1mg
Yoghurt (150g or 
5½oz) 
0.36mg
Spinach, 
boiled 
(100g or 
3½oz) 
4.0mg 
Asparagus 
(125g or 
4¾oz) 
1.1mg
Cow’s milk (1/2 
pint) 
0.12mg
Baked 
beans (225g 
or 8oz) 
3.2mg 
I slice 
wholemeal 
bread (40g) 
1.0mg
Hard cheese (30g 
or 1oz) 
0.12mg
Black 
treacle (35g 
or 1¼oz) 
3.2mg 
Broccoli, 
boiled 
(100g or 
3½oz) 
1.0mg
Margarine (7g or 
¼ oz) 
0.02mg
Muesli (60g 
or 2 ¼ oz) 
2.76mg 
Brown rice 
(200g or 
7oz) 
0.9mg - - 
4 dried figs 
(60g or 2oz) 
2.1mg 
Peanut 
butter (20g 
or ½ oz) 
0.5mg - - 
8 dried 
apricots 
(50g or 1 ¾ 
oz) 
2.1mg - - - - 
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NORMAL VALUE FOR HAEMOGLOBIN 
 At birth – 20gm/dl. 
 At 3 months of age – 10gm/dl 
 In male – 14gm/dl 
 In female – 12gm/dl 
                         Ref: Manual of practical medicine P. No: 245. 
Alagappan 
Ordinarily, less than 10% of the ingested amount is absorbed by a 
normal person. 
 The iron that is not absorbed is excreted in faeces. 
 The rate of iron absorption is increased in children and in 
conditions of iron deficiency. 
 Prior administration of iron hinders subsequent absorption for 
12-24 hours. 
  Absorption of iron occurs mainly in stomach and duodenum.  It 
is controlled by a regulatory mechanism which exists within the 
intestinal mucosal cells. 
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ILLUSTRATION OF THE MECHANISM OF ABSORPTION 
AND TRANSPORT OF IRON 
Intestional 
Lumen 
Mucosal cells Plasma 
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TRANSPORT OF IRON IN THE PLASMA 
Ferritin 
 Reduction 
Ferrous Iron 
 Leaves 
The Intestine  
And Enters 
the plasma 
Ferrous Iron 
 Rexidation 
Ferric form 
 Combined 
 With 
Siderophilin or transferrin (Ferric form). 
 
Red ferric protein complex. 
Transferrin is a glycoprotein.It is the main form in which iron is 
transported in the blood. 
Iron content of whole blood is 40-60 mg per 100ml and most of it 
is present in haemoglobin. 
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If the iron present in the blood exceeds the capacity of the body to 
store it as ferritin. It accumulates in the liver as minute microscopic 
particles called haemosiderin which is similar to ferritin.  
                                     Ref: Fundamentals of Biochemistry.P.No:669  
EXCRETION 
Men:      About 0.5 to 1.15 mg of Iron/per day 
Women: Double the amount due to menstrual bleeding 
                Some amount is lost in faeces and sweat 
       Ref: Fundamentals of Biochemistry.P.No:669  
DISEASE STATE 
IRON DEFECIENY ANAEMIA 
Causes :  
1. Increased Iron utilization 
 Postnatal growth spurt. 
 Adolescent growth spurt. 
2. Physiologic iron loss 
 Menstruation 
 Pregnancy 
3. Pathologic Iron loss 
 Gastro intestinal bleeding 
 Genito Urinary bleeding 
 Pulmonay haemosiderosis 
 Intravascular haemolysis 
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4. Decreased Iron Intake 
 Cereal rich diets 
 Pica, food fads, malabsoption 
5. Other causes 
 Hookworm infestation 
 Schistosomiasis 
CLINICAL FEATURES 
Patients may have 
 Angular stomatitis 
 Atrophic glossitis 
 Koilonychia   
 Brittle hair 
 Pruritus 
 Pica 
 Menorrhagia 
INVESTIGATION 
1. Haemoglobin level 
 When Hb<10gm /dl, symptoms 
           Develop only on exertion 
 If Hb<7 gm/dl, patient is symptomatic even at rest. 
2. Microcytic hypochromic (McHc<32) 
3. Raised platelet count may suggest bleeding. 
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4. Serum ferritin level is low. It is often less than 12mg/l, 
values>80mg rules out of Iron defeciency anaemia. 
5. Iron absorption is increased, and the total Iron binding capacity 
raises.  
PHARMACOLOGICAL ASPECT 
 The Iron deficiency anaemia is characterised by the presence of 
small erythrocytes (mircrocytosis), poorly filled with haemoglobin 
(hypochromia) and many cells of bizar shapes (poikilocytosis) and 
variable sizes (anisocytosis)  
 Even in the absence of anaemia, Iron deficiency can produce 
adverse effects on brain function and abnormalities in behaviours, mental 
performance in children with iron defeciency improves after iron therapy 
INDICATIONS FOR IRON THERAPY 
PROPHYLATIC 
 Pregnancy – women should receive oral Iron 
 Supplements from the IV month of pregnancy. 
 Growing children 
 Menstruating women 
 Professional blood donors- they should receive routinely 
300mg of ferrous sulphate/day for 1 month after each 
donation of 500 ml. 
 Following partial gastrectomy 
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THERAPEUTC 
 To treat existing iron deficiency anaemia  
NUTRITIONAL DEFECIENCY 
 Due to defecient intake or decreased absorption 
 Anaemia of infancy and pregnancy. 
 Anaemia due to acute or chronic blood loss as 
 Menorrhagia  
 Peptic ulcer. 
 Hook worm infestation 
 The response to oral iron is considered satisfactory when the 
haemoglobin level increases by about 1 percent (sahlis method) per day 
with rise of at least 10 percent within 3 weeks. Most of patients respond 
to oral therapy satisfactorily if iron is taken regularly and it is absorbed. 
CAUSES FOR FAILURE OF ORAL IRON THERAY 
 Incorrect diagnosis 
 Non – compliance 
 Continued loss of blood 
 Defective iron absorption 
 Superimposed infection or Inflammation 
 Underlying Uremia or malignancy. 
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ADVERSE REACTIONS TO ORAL IRON 
 All iron preparations are probably equally toxic per unit mass of 
soluble iron. They produce gastro intestinal disturbances. 
Characterised by 
 Colicky pain 
 Nausea 
 Vomiting 
 Diarrhoea 
 Constipation 
 Gastric distress 
INDICATIONS FOR PARENTERAL IRON THERAY 
 Failure to absorb adequate amounts of oral iron (eg) 
malabsorption or extensive bowel resection 
 Inabitity to tolerate oral iorn 
 Ulcerative colitis 
 Intestinal shunts 
 Depleted Iron stores as in patients with chronic bleeding, 
Ref: Pharmacology and Pharmacotherapeutics. 
P.No.494 
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TOXICITY OF IRON 
 It is less common. But when the iron tablets are taken in over dose. 
They induce 
 Vomiting 
 Haematemesis 
 Abdominal pain 
 Coma 
 Convulsions. 
 Shock 
 Metabolic acidosis 
 Hepatic failure 
Ref: Davidsons Priciples and Practice of Medicine. 
P.No.212  
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GUNAPADAM ASPECT 
mak; 
     mak; gjpNdhU tif cNyhfq;fspy; xd;W. ,J 
,aw;if cNyhfg;gphpitr; Nrh;e ;jJ. thA G+j cNyhfk; MFk;.  
NtW ngah;fs;: (Synonyms ) 
‘mj;jnkd;w thjpg ; gr;irf;F fUk;nghd;ndd;Wk; 
   mlyhd epUk;nghd; ndd;W kjw;Fg;NgU  
 mj;jnkd;w fUk;nghd; ndd;wjw;Fg; NgU  
   trdpj;Njhk; JUk; nghd;ndd;Wk; jw;Fg; NgU 
 epjnkd;w khrw;w fjf nkd;Wk; NgU 
   epiyahd jhk;gurq;fnkd;Wk; NgU 
 mjPjnkd;Wk; jpUk;gndd;W kjw;Fg; NgU 
   rhw;wpNdhk; me;jg;Ngh; ,Uk;gpd; NgNu” 
ciu :  
 thjg;gr;ir 
 epUk;nghd; 
 RUk;nghd; 
 JUk;nghd; 
 fjfk; 
 jhk;gurq;fk; 
 jpUk;gd; 
              Ref: gQ;r fhtpa epfz;L Page No : 109 
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NkYk; 
    ‘,Uk;gpDil Ngh;jidNa ,aw;wf; NfS 
        ,NaR Tl nrakhFQ; rj;JkhFk; 
      kUk;ghd marhFq; fWg;gpahF 
        khjpah tho;G+kp dhjkhFk; 
      fUk;gpnad;Wk; Nyhfnkd;Wk; gpz;lJj;jnkd;Wk; 
        faRj;r Nuhr ukhzf;fhhp nefpse;jhd; 
      jpUk;gpDk; fpl;lkhq; fpU\;z makhFk; 
        nrg;gpaNjhh; Ngnuy;yh kpUk;Gf;fhNk.” 
ciu:  
 mfp                    fUk;nghd; 
 maR               faR 
 mapy;              fpU\;zitak; 
 ,b        fhypy; nefpsk; 
 ,Uk;G          Mjp  
 <rnrak;            rj;J 
 fUq;nfhy;         rpNuhruk; 
 fUg;gp                 rpl;lk; 
 fUk;G                  jpUk;gp 
 fUg;G                 Jz;lk; 
 fUkzy;               nghd;kzy; 
 tho;G+kpehjk;           Nyhfk; 
 fUe;jhJ 
vd;w NtW ngah;fshYk; toq;fg;gLk;. 
Ref : Nghfh; epfz;L. Page No. 105 
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NkYk; maj;jpw ;F  
 ma]; 
 Nyhfk; 
          vd;w ngah;fSk; cz;L. 
Ref: ,uruj;d rKr;rak ; Page No : 62 
‘maR fUg;G tlh;e ;j fUkzy; 
   taR nfhLf;Fk; tho;G+kp ehjkhk; 
   faRr;r Nuhruq; fhypy; nefpspe ;jhd;” 
Ref: rl;ilKdp epfz;L Page No : 65 
VERNACULAR NAME 
Sans                  -  Lauha, hyam 
Eng                    -  Iron 
Arab                   -  Hadida 
Pers                    -  Ahana 
Urudu                 -  Lohchun 
Hind, Ben& Duk  -  Loha 
Guj                     -   Lodhun  
Mah& Koh          -   Lokhand 
Tam                    -   Irimbu 
Tel                      -  Inumu 
Sinh                   -  Yehada 
Burm                   -  Than 
Malay                 -  Basi 
Ref: Indian Materia Medica Page No : 54 
Dr.K.M.Nadkarni Vol II 
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Njhw;wk; : 
1) ‘<zTNk ,Uk;gpdJ Njhw;wq;NfS 
  Vw;wjpUg; ghw;flypy; G+U tj;jpy; 
MzTNk mkph ;je;jhd; filAk;NghJ 
  mirke;jpu fphpiakj; jhf ehl;b 
thzTNk thRfpiaf; fapwha;g ; G+l;b 
  tpl;LZTk; $h;kkhf mbahdhNu 
mbahdhh; kj;Jf;fh jhukhf  
  mkh;e ;jhh;fs; Njth;fSk; xUG we;jhd; 
gpbahd uhl;rrh;fs; xUgf; fe;jhd;  
  ngUq;$l;l kkph ;je;jhd; filAk;NghJ 
Jbahd jptiyaJ fiuNah uj;jpy; 
  njwpf;fTNk ghpjpajpd; fjphp dhNy 
fbahff; fha;e ;JNkjhd; G+kpapy;jhd; 
  fl;bahf fdKkhf ,Uk;Gz; lhr;Nr.” 
Ref: Nghfh; 7000 %d;whk; ghfk; Page No : 272 
2) Kd;G Njth;fshy; nfhy;yg;gl;l Nyhkpd; vDk; 
muf;fdpd; clypypUe;J gytif ,Uk;Gfs; Njhd;wpd.  
Ref: rufrk;fpij 3 k; ghfk ; Page No : 148 
3) mak; vy;yh kiyfspYk;> epyq;fspYk; mNefkhff; 
fe;jfk; Nghd;w rpy nghUs;fSld; fyg;Gw;Wf; 
fpilf;fpd;wJ. ,J jhJ jhtu [Ptg; nghUs;fspy; 
rpwpjsT fye;Jk; ,Uf;fpd;wJ. 
Ref: Fzghlk; - jhJ - 89 
4) Fw;wKs;s ,urk; rpWmstpYk;> Fw;wKs;s fe;jp 
ngUkstpYk; Nru maKz;lhk;. 
Ref: Fzghlk; - jhJ Page No. 244. 
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5) Iron – Rarely met with free in nature, through very 
widely distributed in both the organic and inorganic 
kingdoms. Found in nearly all rocks, soils, etc. It is 
found as carbonate in Spathi iron. It is found in the ashes 
of plants, red corpuscles of the blood of animals, also in 
the bile, chyle, gastric juice, lymph, milk and pigment of 
the eye and in the urine. 
Ref: Indian Materia Medica – Vol II 
A.K. Nadkarni Page No. 54 
6) India is fortunate to have rich mineral resources. Since  
our country is gifted by nature with rich mineral 
resources.  
Places of occurence in India. 
 Mayurbhanj 
 Singbhum 
 Mysore 
 Madhya Pradesh  
 Bombay 
 Madras 
 Andhra 
Ref: Modern Inorganic Chemistry 735 
R.D.Madan   S.Chand. Wealth of India 258 Vol - V 
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7) Iron is not found in the metallic form. Sometimes, it is  
obtained as a by product in the working of pyrites and 
ilmenite. 
Ref: Wealth of India Vol V Page No : 256 
,Uk;G rj;JU kpj;JU 
gifr;ruf;Ffs;                  
 mz;lNthL            rpyhrj;J 
 mg;gpufk;               rpiy 
 fe;jfk;          juh 
 fpspQ;rNyhL      epkpis 
 nfshp                G+e PW 
 rt;tPuk ;               tq;fk; 
 rhuk;                  ntq;fhuk; 
 rpq;fp              ntz;fyk; 
                              nts;isg;ghlhzk;                        
el;Gr ;ruf;Ffs; 
 ,uh[th;j ;jk;          ehfk; 
 fhe;jk;               G+ehfk; 
 nfe;jpr ;nrk;G           G+uk ; 
 #ld;                 kA+ur;nrk;G 
 nrk;G                   nts;sp 
 jq;fk; 
  Ref: ,ahNfhG vd;Dk; ,uhkNjth;  
     itj;jpa fhtpak; 1000,Page No: 230 
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ORGANOLEPTIC CHARACTERS 
Rit (Taste) 
ngUk;ghd;ik 
 Jth;g ;G (Astringent) 
rpWghd;ik 
 Gspg ;G  (Sour) 
 ifg;G  (Bitter) 
Iron is sweet to the taste. 
- Pharmacopeia  Indica   Page No : 21 
tPhpak ; (Potence) 
 ntg;gk; . 
jd;ik: 
 jP\;zk;. 
 FUj;jd;ikAilaJ. 
rufrk;fpij 3 k; ghfk; Page No : 148 
nra;if  (Therapeutic actions) 
 FUjpg ;ngUf;fp   (Haematinic) 
 grpAz;lhf;fp    (Stomachic) 
 cly; cukhf;fp  (Tonic) 
 cly; Njw;wp  (Alternative)  
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mak; FUjpapd; jd;ikia Nkk;gLj;Jk; ma 
rk;ge ;jg ;gl;l kUe;Jfs; kyf;fl;il cz;L gz;Zk;. mij 
jtph ;f ;f Kg;giy $l;bf; nfhLg;gJ tof;fk;. clypd; vy;yh 
cWg;Gfspd; njhopy;fisAk; Jhz;Ltpf;Fk;. ,jdhy; ,J 
cly;Njw;wpahf njhopy; Ghpfpd;wJ.  
It has  
 Laxative 
 Cooling 
Ref: Fzghlk; jhJ  Page No : 90 
Fzk;: (Therapeutic efficacy) 
‘ghz;L ntz; Fl;lk; gUe;Jhy Neha;Nrhig  
 khz;blr;nra; ke;jq;fh khiyFd;kk; - G+z;l  
 ngUe;jhJ el;lKk;Nghk; Ngjp grp Az;lhq;  
 fUe;jhJ el;lkpLq; fhy;. (m.F)” 
(ciu) ,Uk;gpdhy; 
      gpj ;jghz;L> ntz;Fl;lk;> mjpJhyNeha;> Nrhig> ke;jk; > 
fopr ;ry; ,it ePq;Fk; grpAz;lhFk;.  
kw;Wk;> 
    “,isj;jth; ,Uk;ig cz;z Ntz;Lk;” vd;w tpjpapid 
“va;Glw; fpUk;ig Az;kpd;” vd;Dk; gonkhopahy; mwpf. 
Ref: Fzghlk; jhJ  Page No : 90 
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‘gdKkhd NrhigNahL ghz;L jhDk;  
   glh;fpd;w thjgpj ;j Nrj;J kj;ij”…  
‘Mf;FkNj fharpj;jp Nyhf rpj ;jp 
   Mjpahd urf;fphpia jdf;F khFk;”… 
 ‘cj;jke;jhd; fhkhiyg; ghz;L Nrhif 
  tapWfl;b jidg;Nghf;Fk; FUjp A+Wk”… 
Ref: Nghfh; 7000 3 k; ghfk ;  Page No : 275 
‘fuk;nghd;fh khiy fhrq; fa kNfh juK khw;Wk;” 
  ,Uk;gpdhy; fhkhiy> fhrk;> fak; kNfhjuk; jPUk;. 
Ref: mkph ;jrhfuk; gjhh;j ;j #lhkzp Page No : 100 
‘fUe;jhJ nrhy;yaKk; fhhpUk;gpd; ehkk;  
   mUe;jhf ntl;il mdyhFk; - tpUe;jpd; 
   ghz;LNuhfk;> rpNyj;Jkk; ghwpapLk; cw;gd 
   Jhz;Lk; gapj;jpaj;ij nrhy;.” 
    - maj;jpdhy; jhfk;> ntl;il> mdy;> ghz;L> 
rpNyj;Jkk; j PUk; ;  
Ref :  mfj;jpah ; kzp 4000 vd;Dk; itj;jpa 
rpe ;jhkzp ntz;gh- ,uz;lhk; ghfk; Page No : 296 
Iron increases longevity. It is good for the eye-sight. It 
improves “the wind”. It cures the affections of phlegm and 
bile. It is an antidote to poison. It has great value in treatment 
of colic, ascites, piles, jaundice, gonorrhea, worms and 
leprosy.  
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            Iron improves the quality of the blood. It situates 
the functional activity of all the organs of the body. It is a 
valuable general tonic. 
            As a haematinic tonic, it has great value in anaemia 
caused by malaria, kala-azar etc. 
Ref: Pharmacopeia Indica    Page No : 21 
Kartick Chandra Bose 
maj;jpd; Njhlq;fSk; mtw;iw ePf ;Fk; KiwfSk;  
‘thWNf spUk;Gf;ifq; Fzq;f Sz;L 
    tifahfr; nrhy;YfpNwd; ed;wha;f ; NfSk; 
   thW Nfs; Fsk;ntl;l T+w;Wg; Nghy  
    tk;kk;kh tpUk;G+wy; mUfh njd;d 
   mUfhj tpUk;G+w yWf;ff; NfSk; 
    milthd rhukpb yWF %wy; 
   jUfhj rtplWf;fr; rhw;wf; NfSk; 
    jaq;fhj fy;Yg;ghy; rtpL NghFk; 
   kUfhj jpiuNghf thpir NfSk; 
    tskhd tPukpbd; kzp NghyhFk; 
   cUfhj [Puzpg;Gg; Nghf ntd;why; 
    XNfhNfh #jkpl;N ;l cUf;fpg ; ghNu 
   ghug;gh Tile;jnjd;why; ehdj;jhJ 
    gUtKl dQ;Rf;Fk; gaDQ; nrhd;Ndd;” 
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ciu: 
      tPukpbd;       - jpiu NghFk; 
      fy;Yg;ghy;     - rtpL NghFk;  
      Rf;fpdhy;    - cilr;ry; NghFk; 
      etr;rhuj;jhy;   - Cwy; NghFk; 
  R+jj;jhy;  -rurk; NghFk; 
Ref: Fzghlk; jhJ   Page No :91 
maj;jpd; Fw;wq;fs; - VO 
 gSthf ,Uj;jy;. 
 jplkhf ,Uj;jy;. 
 Nrhh;itj; Njhw;Wtpj;jy;. 
 %h;r;ir kw;Wk; vhpr ;riyj; Njhw;Wtpj;jy;. 
 fy;iyg; Nghy; MFjy;. 
 nfl;l ehw;wk; nfhz;bUj;jy;. 
Ref: rufrk;fpij 3 k; ghfk ; Page No : 148 
,Uk;gpd; tiffs; & Fzq;fs; 
 Kz;lk;. 
 jP\;zk;. 
 fhe;jk; . 
Kz;lk; %d;W tifg;gLk; 
 kpUJ. 
 Fz;lk;. 
 flhuk;. 
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kpUJNyh`k; 
 vspjpy; cUFk;. 
 tphptilahJ. 
 kpUJj;jd;ikAilaJ. 
 ,e;j mak; rpwe;jJ. 
Fz;lNyh`k; 
 rk;kl;bahy; mbf;fg;gLifapy; vspjpy; 
mfYtjpy;iy. 
 Fzj;jpy; kj;jpkkhdJ. 
flhuNyh`k; 
 rk;kl;bahy; mbf;fg;gLifapy; vspjpy; tphpe ;J 
tpLk;. 
 gpse;jtplj;jpy; fUepwkhapUf;Fk;. 
 ,opthd FzKs;sJ. 
Kz;lNyh`j;jpd; Fzq;fs;  
kpUJ Nyh`k; 
fgNjh\k;> thjNjh\k;> #ynkd;Dk; tapw ;WNeha;> 
%yNuhfk;> MkNjh\k;> Nk`Nuh`fk;> fhkhiy> ghz;L> 
Fy;kk;> Mkthjk; vd;Dk; fPy;thjNeha;> kN`hjuk; 
Mfpatw;iwj; jPh ;f ;Fk;. 
 [luhf;fpdpia tpUj;jp nra;Ak;. 
 Nrhgnkd;Dk; tPf ;fj;ijg; Nghf;Fk;.  
 ,uj;jj;ij tpUj;jp nra;Ak;.  
 Fliy Rj;jp nra;Ak;.  
Ref: ,uruj;d rKr;rak; Page No : 62 
Tikshanam  – It has six varieties 
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Khara:  
 Rough. 
 Free from hair-like lines. 
 On breaking shows the lusture of quick silver. 
 Break easily by bending. 
Sara: 
 Breaks in the sides by hammering.  
 It has hair- like lines.  
 It is a product of brown – soil. 
Hinnala:  
 Black in colour.  
 Shows seed or break like lines.  
 Very difficult to cut. 
Baji Lauha: 
 Sky colour.  
 Shows thin lines.  
Kala & Kalyasa 
 Blue –black colour. 
 Brilliant. 
 Plain & Heavy. 
 Does not break even by striking with iron hammer. 
Ref: Indian Materia Medica Vol  II Page no :55 
 fuNyh`k; 
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 ghz;LNuhfk;. 
 Fzj;jpy; &\ khdJ. 
 tpghfj;jpy; kpfTk; kJukhapUf;Fk;. 
 rPjtPh ;ak; . 
 rpwpJ ifg;Gk; c\;z FzKk; cs;sJ. 
 fg`uk;. 
 gpj;j`uk;. 
 F\;lk; . 
 kN`huk;. 
 gPtP`Nuhfk;. 
 MkNjh\k;> 
,tw;wpy; cgNahfkhFk;. 
 #yk; vd;Dk; tapw ;WNeha;> af;Uj; vd;Dk; fy;y Puiyg; 
gw;wpa tpahjpfs; \ak; - ,tw;iw Jhpjkhf 
ept;Uj;jpf ;f ty;yJ. 
 fpoj;jdj;ij vspjpy; tuhky; jLf;Fk;. 
 Nk`Nuh`q;fs;> Mkthjk; ,tw;iwAk; j Ph ;f ;Fk;. 
 mf;dpjPgdk; cz;L gz;Zk;.  
 rpwe;j ,u]haeFzKk; gyj;ij tpUj;jp nra;Ak; 
jd;ikAk; cilaJ. 
 %yNuhfj;ijAk; mow;rpiaAk; Nghf;Fk;. 
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 fuNyh`j;jpDk; kw;w Ie;J tpj jP\;z Nyh`q;fSk; 
xd;iw tpl kw;nwhd;W Nkd;NkYk; KiwNa 
Fzq;fSilad.                                
 fhe;jk; . 
 gpuhKfk;. 
 Rk;gfk;. 
 fh;\fk;. 
 jpuhtfk;. 
 cNuhkfhe;jk;. 
       - vd Ie;J tifg;gLk;. 
Ref: ,uruj;d rKr;rak;  Page No : 63 -65. 
Rj;jp Kiwfs; 
 xU gyk; (35 fpuhk;) mag;nghbf;F MW gyk; (210 
fpuhk;) ,Yg;igg;G+r ;rhW tpl;L fhiy Kjy; khiy 
tiu ntapypy; itf;f Ntz;Lk;. ,t;tpjk; MWehs; 
nra;J ,uz;L ehs; rhW tplhky; cyh;j ;jp gpd;Dk;> 
,ijg;Nghy ,UKiw nra;J 25k; ehs; Kjy; gj;J 
ehl;fs; ,iltplhky; Nkw;gb rhWtplhky; ,uz;Lehs; 
cyh;j;jp e Ph ;tpl ;Lf; fOtp vLf;fr; Rj;jpahk; . 
 xU gyk; maj;ijg; ghz;lj;jpypl;L mj;Jld; 
my;ypNth; vl;L gyKk; (280 fpuhk;) Gd;id Nth; 
vl;LgyKk;(280 fpuhk;) ,bj;Jg;Nghl;L gjpdhW gyk; 
(560 fpuhk;) fhb tpl;L ,uTk; gfYk; j Pghf;fpdpaha; 
vhpf;f Ntz;Lk; mg;gb vhpf;Fk;NghJ fhb Fiwe;J 
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tpl;lhy; kWgbAk; mNj msT fhbthh;j ;J  vhpf;f 
Ntz;Lk;. mg;gb vhpj;jhy; mak; Rj;jpahFk;. 
 ,Uk;gpd; mug;nghbia vYkpr;rk;gor;rhhW> fhb> 
ehl;Lf; fhl;lhkzf;Fg;ghy; ,it xt;nthd;wpYk; 
%d;W ehs; Cw itj;Jf; fOTf. ,t;tpjk; MW Kiw 
nra;a Rj;jpahk; . 
Ref : Fzghlk; jhJ  Page No : 92 
‘miwfpNwd; maf;fpz;z nkhd;W thq;fp  
    mg;gNd vs;nsz;nza; mjw;Fs; tpl;L  
  Fiwahky; xU rhkk; tWj;J ed;wha;f ; 
    FKwNt fhbtpl;Lf; fOt Rj;jp  
  Kiwahff; fUNtyk;g l;ilr; rhw;wpy; 
    Kwpahky; ,Urhkk; Ntfitj;J 
  epiwahff; fhbapNy fOtpg; Nghl;L 
    e Pl;Ltha; ,e;j Rj;jp epiyj;j Nghf;Nf.” 
Ref: mfj;jpah; itj;jpa fhtpak ; -1500  
Page No: 158 
 ,Uk;gpid muhtpg ; gor;rhw;wpy ; %d;W ehs; Cwg; 
Nghl;liuj;Jf; fOtp vLj;Jf; nfhs;f.  
Ref: rpfpr ;rhuj;ejPgk;  Page No : 39 . 
mDNghf itj;jpa Njtufrpak ; Page No :97 
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 Nyh`j;ij rpW Nuf;Ffsha; jl;bf; nfhz;L> 
vz;nzapy; Ntfitj;J vz;nza; NghFk;gb Ntyd; 
gl;il ,urj;jpy; 1 rhkk; (3 kzp Neuk;) vLj;J 
ntapypy; cyuitj;jhy; Rj;jpahFk;. 
Ref : mDNghf itj;jpa gpuk;k ufrpak ;  
Page No : 168 
 maj;jpd; Nky; Kay; ,uj;jj;ij jltp mf;dpapypl ;Lf; 
fha;r ;rTk;. ,t;tpjk; %d;W Kiw nra;a Kz;lk; 
Kjyhd vy;yh Nyh`Kk; mtw;wpy; mlq;fpa rfy 
Njh\;q;fSk; e Pq;fp tpLk;.  
 gjpdhW gyk; (560 fpuhk;) jphpgiyia vl;L gq;F ePhpy; 
Nrh;j ;J mJ ehypy; xU gq;fhf fha;e ;jJk; mf; ;FbePhpy; 
jfLfshf mbj;j Ie;J gyk; Nyh`j;ij fha;r ;rpj ; 
Njha;f;fTk;. ,t;tpjk; VO Kiw nra;a Rj;jp. 
 maj;jpd; kPJ fwpAg;igf; Fioj;Jg; G+rp mf;dpapw ; 
fha;r ;rp jphpgyh FbePhpy; Njha;f ;f Rj;jpahFk;. 
 Gspak;goj;ijf; fiuj;J nfhjpf ;f itj;J mjpy; 
maj;ij Cw itf;f Rj;jp. 
 gR %j;jpuj;jpy; jphpgyia Nrh;j ;Jf; FbePh ; fha;r ;rp 
mjpy; rpwpJ Neuk; maj;ijg; Nghl;L gf;Ftk; 
nra;aTk;. gpwF FbePiu tbj;J tpl;L maj;ij vLj;J 
xU fg;giuapw; Nghl;L nea; $l;b tWf;fTk;. mjpy; 
,Uk;igapl vhpAk; epiyik tUk; tiuapy; ,Uk;G 
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JLg;ghy; fpswpf; nfhz;bUf;f Ntz;Lk;. ,t;tpjkhf 
kPz;Lk; FbePhpypl ;L nea; fye;J Ie;J Kiw tWj;J 
vLf;fTk;.  
 ney;ypf;fdp urj;jpyhtJ jphpgyh f\haj;jpyhtJ 
maj;ijf; fha;r ;rp> Kd; Nghy; tWj;J Rj;jp nra;ayhk;. 
Ref: ,uruj;d rKr;rak ; Page No : 68 
 Iron is first of all beaten into thin plates, which are 
then heated in fire, and when red-hot, plunged into the 
following liquids one at a time. Oil, whey, conjee, 
cow’s urine, and a decoction of Dolichos uniformis. 
This is repeated three times in succession. 
 To get rid of impurities, boil one and half seer of 
water, reducing to quarter and then soaking in it half a 
seer of thin plates of cast iron which have been 
previously heated. Repeat the process seven times. 
 Leaves of Tikshana iron (steel or cast iron) are 
repeatedly to be heated and plunged into water and 
then to be powdered in a stone mortar with an iron 
pestle. 
Ref: Indian Materia Medica.Dr. Nadkarni 
Page No : 57 
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mak; NrUk; ghz;L Neha;f ;fhd kUe;Jfs; 
I mD Nghf itj;jpa etePjk;                gf;f vz; 
1. Jthjr Nyhf khuz nre;Jhuk; .          22 
  msT - 1/2 -11/2 Fd;wpkzp vil  
  (65kp.fp-195kp.fp) ,U Ntis  
  Jiz kUe;J - Njd;> nea;. 
2. fhuNyhf nre;Jhuk;.      23 
  msT -1-2 Fd;wpkzp vil  
  (130kp.fp.- 260kp.fp) 3Ntis 
  Jiz kUe;J - Njd;> nea;. 
3. Rz;zNyhfr; nre;Jhuk;.      30  
  msT - 11/2 - 3 Fd;wpkzp vil. 
  (195kp.fp-390kp.fp) 3 Ntis 
  Jiz kUe;J - Njd;> nea;> nts;shp tpij> fj;jphp  
   tpij> Kyhk;gotpij> neUQ;rpKs;S  
   ,tw;wpy; xd;wpd; rhW. 
4. mar;rj;J nre;Jhuk;.      32 
  msT - ¾ -1¼ Fd;wpkzp vil  
  (100kp.fp -160kp.fp) ,UNtis 
  Jiz kUe;J - Njd;> nea;. 
5. ma nkOF           33 
  msT - 1/2  (1¾ fpuhk; Kjy; 1(31/2 fpuhk;) tiu  
  JizkUe;J - rh ;f ;fiu> Njd;> nea;. 
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gf;f vz; 
6. mark;g Pufw;gk ;         35  
  msT - 1 tuhfd; (31/2 fpuhk;) - 2 tuhfd; (7 fpuhk;) ;  
         khj;jpiunadpy; 
  Jiz kUe;J - Njd;> rh ;f ;fiu> nea;. 
7. mar;#uzk;        36  
  msT - 10 - Fd;wpkzp vil.  
   (1.3 fpuhk;) 2 Ntis Jiz kUe;J Njd;> nea;. 
8. mag;nghb ,sfk;. 
  msT - ¾ (2 ½ fpuhk;) - 1 ½ (5 ½ fpuhk;) tuhfd;  
 vil. 
II  mfj;jpah; - 2000  %d;whk; ghfk; 
9.  mafhe;jhjp Fspif                 80 
   msT - 1khj;jpiu. 
10. fhe;j gw;gk ;          92 
   msT -1 ½ tuhfd; (5 ½ fpuhk;) vil.  
   ,U Ntis mDghdk; - Njd; 
11. jhthf;fpdp gw ;gk;      366 
   msT - 3 ½ Fd;wp ( 450 kp.fp.) ,UNtis. 
   mDghdk; - Njd;. 
III  mDgt itj;jpa Njtufrpak; . 
12. ghz;LthPurk;       371 
   msT - 1-2 Fd;wpkzp gpukhzk; (130 - 260 kp.fp)  
,UNtis  
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   gf;f vz; 
13. k`hrTghf;fpa Rz;b      379 
   msT - 5 fpuhk; 2 Ntis 
14. v/F nre;Jhuk;      380 
   msT -1/4 -1/2 Fd;wp (32 - 64 kp.fp) 2 Ntis  
   mDghdk; - Njd; my;yJ nea;. 
IV  rpj ;jitj;jpaj;jpul;L.  
15. mafhe;jr; nre;Jhuk;       132 
   msT - 100 -200 kp.fp. 2 Ntis 
   mDghdk; - Njd; 
16. kfhuh[ kpUfhq;fk;       63 
   msT - 1khj;jpiu 
   mDghdk; - nte;e PH 
17. kfh tre;j FRkhfuk;      65 
   msT - 1 khj;jpiu  
   mDghdk; - jphpgiyr; #uzk;. 
V . mfj;jpah; itj;jpa rpe ;jhkzp. - kzp 4000. 
18. vYkpr;rq;fLF               229 
   msT - ghjp vYkpr;ir.  
19. fLf;fha; nea;       286 
   msT - 4kp.yp - 5 kp.yp 2 Ntis 
VI . Fzghlk; - jhJ.  
20. magw;gk;        93 
   msT - rhikahprp msT> 2 Ntis.  
   mDghdk; - jf;Nfhyhjpf;fsp. 
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gf;f vz; 
21. mar;nre;Jhuk;        97 
   msT - rhikahprp msT> 2 Ntis. 
   mDghdk; - thiog;gok;. 
22. magpUq;fuh[ ghzpjk;       103 
   msT - 2 fpuhk; - 5 fpuhk; > 2 Ntis 
23. jphpNyhfr; nre;Jhuk;       115 
   msT - gzntil (488 kp.fp.) 2 Ntis. 
   mDghdk; - rQ;r Ptp #uzj;jpy; > nea;apy; kj;jpj ;Jz;z  
VII . mfj;jpah ; itj;jpa fhtpak; - 1500 
24. #rpfhguzk;         737 
   msT - 1 - 2 fpuhk; > 2 Ntis 
   mDghdk; - nte;e PH 
25. mf;fpdpFkhhp         786 
   msT - 1 - 2 khj;jpiu 3 Ntis. 
   mDghdk; - nfhk;kl;bf;fha; rhW> Fkhpr ;rhW. 
26. tpl;LZ uhr G+gjp         821 
   msT - 1 - 2 khj;jpiu 3 Ntis. 
   Jiz kUe;J - ,Q;rp rhW. 
VIII . mfj;jpah ; gs;S -200 
27. Rakf;fpdpr; nre;Jhuk;                 26 
   msT - 1- 1 ½ Fd;wpnail (130kp.fp. -190 kp.fp.)  
   2 Ntis 
   Jiz kUe;J -Njd;> nea;> ntz;nza; Kjypait. 
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   gf;f vz; 
IX . fz;Zrhkp guk;giuitj;jpak; . 
28. tPu mar;nre;Jhuk;       315 
   msT - ½ -1 Fd;wpnail (65 kp.fp. - 130 kp.fp.)  
   2 Ntis  
   mDghdk; - Njd;> nea;> ntz;nza;. 
29. rj;Jr;nre;Jhuk;  
   msT - ¼ Fd;wpvil (32 kp.fp.) ,UNtis. 
   mDghdk; - Njd; 
30. G+uzre;jpNuhja rr;J nre;Jhuk;     344 
   msT - 2-3 mhprpg ;gpukhzk; (130 kp.fp.- 195 kp.fp.) 
   3 Ntis. mDghdk; - Njd;. 
31. fl;Nyhfr; nre;Jhuk;        346 
   msT -1-2 mhprp gpukhzk; (65 - 130 kp.fp.) 
   mDghdk; - nty;yk;. ,UNtis 3-5 ehs; nfhL;fTk; 
32. ma jq;f nre;Jhuk;                      358 
   msT - ½ - 1 Fd;wpnail (65 - 130 kp.fp.)  
   2 Ntis. 
X  rpNuhuj;jpd itj;jpa G+\zk;. 
33. fUk;nghd; nre;Jhuk;              48 
   msT - 65 - 130 kp.fp. 2 Ntis 
   mDghdk; - Njd;. 
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mak; NrUk; gpw Neha;f ;fhd kUe;Jfs; 
I .  mDNghf itj;jpa etePjk; . ghfk; 1      gf;f vz;    
1. kd;kjNyhf nre;Jhuk;       25 
   msT - 2 - 3 Fd;wpkzp vil (260 kp.fp. - 390 kp.fp) 
   2 Ntis. Jiz kUe;J - thJik my;th> Njd;>  
   nea;> ghNyL> ntz;nza;. 
   gad; - cly; td;ik> Mz;ik cz;lhFk;. 
2.  Rth;zNyhf nre;Jhuk;      27 
   msT - 2-3 Fd;wpkzp vil (260 kp.fp. - 390kp.fp.) 
   2 Ntis 
   Jiz kUe;J & gad;. 
   fhiyapy; - 1 tpuhfndil  (3 ½ fpuhk;) Njdpy; 
   khiyapy; -1tpuhfndil (3½fpuhk;) mKjhjpnaz;nza;  
 cz;zTk;. j PUk; Neha;fs; - ra  
 Neha;fs;> ,Uky; Neha;fs;. 
3.  Rth;zNyhfj; jpuhtfk;      40 
   msT - 1(3 ½ fpuhk;) Kjy; 1 ½ (5 ¼ fpuhk;)  
  tpuhfndil. 
   Jiz kUe;J - jpuhtfj;jpd; vilf;F 10 gq;F  
  jz;zPhpy; fye;J nfhLf;fyhk;. 
   j PUk; Neha; - NkfRuk;> Fsph ;Ruk; > j Puhj Ruk; >  
  ehl;gl;lRuk;. 
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II   mf];jpah ; 2000 %d;whk; ghfk;.     gf;f vz; 
4. fhe;jr;#uzk;        169 
  msT - %tpuy; nfhs;SksT. 
  mDghdk; - nea;. 
  j PUk; Neha; - Fd;kk;. 
5. gQ;rNyhf mQ;rdk;       357 
  msT - ½ gapwsT (65 kp.fp.) 2 Ntis 
  jPUk; Neha; - glyk;> gpy;yk;> Fe;jk; Kjyhd  
 fz;Nzha;fs;. 
  mThpapiyr;rhw;wpy; ,l fz;jbg;Gfs; jPUk;. 
6. rpuRtj;jp mQ;rdk;       359 
msT - 1 gapw ;wk; gUg;gsT ( 160kp.fp.) jz;zPh ; tpl ;L 
,ioj;J ,l Gifr;ry; j PUk;.  ifahe;jfiur;rhw;wpy; ,l - 
gw;gNuhfk; ghh ;it FiwTjPUk;. 
III  mDgtitj;jpa Njtufrpak; . 
7. rq;fuiguturk;        344 
  msT - Fd;wp vil (130 kp.fp.) 2 Ntis 
  mDghdk; - jpg ;gpyp#uzk;> Njd;. 
  j PUk; Neha;fs; - Uj;jh`rd;dp. 
8. mNahu[hjp #uzk;       383 
  msT - 130 kp.fp. - 260 kp.fp. 2 Ntis. 
  mDghdk; - Njd;> nea; my;yJ nty;yk; Njd;  
,tw;Wld; 
  jPUk; Neha; - fhkhiy. 
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IV  rpj ;jitj;jpaj;jpul;L.     gf;f vz; 
9.  Mde;j igut khj;jpiu.        3 
   msT - 1 - 2 khj;jpiu 2 Ntis 
   jPUk; Neha; - r Pjhq;frd;dp. 
10. F\;lf[Nfrhp.          13 
   msT - 1 khj;jpiu 2 Ntis 
   mDghdk; - rh ;f ;fiu>Njd;. 
   j PUk; Neha;- Fl;lk;> Nkfk;. 
11. jphpNyhf ul;rhkzp.       27 
   msT - Fd;wpasT (130 kp.fp.) 2 Ntis. 
   mDghdk; - nte;e PH 
   j PUk; Neha; - Nkfk;> \ak;> jhJ\zk;. 
V  Fzghlk; - jhJ. 
12. matPunre;Jhuk;                 4                          
   msT : Fd;wpkzpasT (130 kp.fp.) 2 Ntis 
   mDghdk; - gidnty;yk;. 
   j PUk; Neha; - #iy> Fl;lk; > thjePh ; > tplf;fb Kjypad 
jPUk;. 
13. etuj;jpd G+gjp          514 
   msT - Fd;wpkzp (130 kp.fp.) 2 Ntis. 
   mDghdk; - nte;e PH. 
   j PUk; Neha; - ngUk;gpzpfs; gyTk; e Pq;Fk;. 
14. nrhh ;dhg;gpufr; nre;Jhuk;      524 
   msT - 65 kp.fp. - 130 kp.fp. 2 Ntis. 
   mDghdk; - r Pe ;jpyhjp Nyfpak;. 
j PUk; Neha; - NkfePhpopT 21 - f;Fk; rpwe;jJ. 
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VI mfj;jpah; itj;jpa rpe ;jhkzp 4000.     gf;f vz; 
15. Fz;lyhjp Nyfpak;          245 
   msT - 4 fpuhk; - 5 fpuhk; > 2 Ntis. 
   j PUk; Neha; - thjf;fl;L> #iy> twl;rp> ,jaNeha;. 
16. ,urG+gjp             350 
   msT -  cSe;jsT (130 kp.fp.) 2 Ntis. 
   mDghdk; - nte;e PH 
   j PUk; Neha; - thj Ruk;> gpj;j Ruk;> NjhlRuk;. 
17. etNyhf mf;fpdpFkhud;        351 
   msT - Fd;wpasT (130 kp.fp.) 2 Ntis. 
   mDghdk; - fha;e ;jhwpa nte;e PH 
   j PUk; Neha; - mjpfRuk;> MkRuk;> rd;dpghjRuk;>   
              jhe;jphpf rd;dp. 
18. cj;jkhf;fpdpFkhud;        350 
   msT - cSe;jsT (130 kp.fp.) 2 Ntis. 
   mDghdk; - Njd; 
   j PUk; Neha; - thj> gpj ;jrd;dp> Ruk;. 
VII mfj;jpah ; itj;jpa fhtpak; 1500. 
19. flhl;ruFkhhp nre;Jhuk;         690 
   msT - gzntil (488 kp.fp.) 2 Ntis  
   1 kz;lyk; tiu. 
   mDghdk; - jphpfLFk;> NjDk;fye;J. 
   j PUk; Neha; - thjk;> thA> ml;lFd;kk;>rd;dpthjk;>  
   gpj ;jk; > rpNyl;Lkk;> Kay;typ> Fjpiutyp> neQ;Rtyp. 
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20. rk;gpujhar; #uz gw;gk;       736 
   msT - 65 kp.fp. -130 kp.fp. 2 Ntis 
   mDghdk; - Njd; 
   j PUk; Neha;fs; - Fd;kq;fs; vl;Ltif> fpuhzp>  
 mf;fpdpke;jk; > midj;Jk; jPUk;. 
21. ,uhrkNfRuk; Fspif           790 
   msT - Fd;wpnail (130 kp.fp.) 2 Ntis. 
   JizkUe;J - Njd;. 
   j PUk; Neha;fs; - rpNyl;Lk Fd;kk; > vYk;GUf;fp>   
   Fd;kk;> nrhpahik> Fly;thjk;> tapw;WNeha;. 
22. <RuG+gjp               790 
   msT - 65 kp.fp. 2 Ntis 
   mDghdk; - nts;Ss;spj ; ijyj;jpYk;> ,Q;rp  
 rhw;wpYk; 
   j PUk; Neha;fs;- rd;dp> gpufpUjp> gpuik> thjk;> rak; 
                        nfhLf;fyhk. 
23. fdfuj;jpdhjp cUz;il      795 
   msT - 1- 2.nte;e Ph py ; ciuj;J ,lTk;. 
   j PUk; Neha;fs; - fz;Nzha;fs;. 
VIII . tPukhKdpth; thflj;jjpul;L. 
24. mf;fpdpFkhur; nre;Jhuk;      75 
   msT - Fd;wpkzpnail (130 kp.fp.) 2 Ntis. 
   mDghdk; - Njd;> nea;> tpy;thjp Nyfpak;>  
   ,Q;rpRurk;. ,Q;rp Nyfpak;. 
   cgNahfk; - Fd;kNuhfq;fs;> kNfhju Nuhfq;fs;> 
jirf;fl;b> nfsirf; fl;b> %yNuhfk;. 
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gf;f vz; 
25. khy;Njtpr ; nre;Jhuk;                     77 
   msT - Fd;wpkzpnail (130 kp.fp.) 2 Ntis. 
   mDghdk; - Fd;kk;> #iy> fhrNuhfq;fs;>  
F\;lNuhfq;fs;> gpj ;jNuhfq;fs;. 
26. rz;lkhUjr; nre;Jhuk;      313 
   msT - ½ - 1 Fd;wpnail(65 kp.fp - 130 kp.fp)  
   2 Ntis 20 ehs; 
   mDghdk; - Njd; 
   j PUk; tpahjp : rh ;tthjNuhfq;fs;> gpj ;jNuhfqfs;>  
 fgNuhfq;fs;> Fd;kk; > tapw ;Wtyp> fTir. 
27. e Pyfz;l nre;Jhuk;       326 
   msT - 2 mhprp vil (130 kp.fp.) 2 Ntis  
   9 ehs; nfhLf;fTk;. 
   mDghdk; - Njd; 
j PUk; tpahjp - ghhprthjk;> Kfthjk;> [pf ;Fthjk;. 
28. tq;fr; re ;jpNuhjak;       337 
   msT - ¼  - ½ Fs;wpnail (32 kp.fp. - 65 kp.fp.)  
   2 Ntis 
   mDghdk; - jphpfLF #uzk;. 
   j PUk; tpahjp - thA> mf;fpdpke;jk; > fhkhiy. 
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CHEMICAL ASPECT 
FERROSO FERRIC OXIDE 
 
Iron (II, III) Oxide is the chemical compound Fe3O4. It is found in 
nature as the mineral magnetite. It contains both Fe2+ and Fe3+ ions and is 
sometimes formulated as FeO.Fe2O3. It is  encountered in the laboratory 
as a black powder. It exhibits permanent magnetism and is ferromagnetic, 
but is sometimes incorrectly described as ferromagnetic. Its most 
extensive use is as a black pigment which is synthesized rather than being 
extracted from the naturally occurring mineral as the particle size and 
shape can be varied. 
Iron (II, III) OXIDE 
IUPAC NAME   Iron (II) Diiron (III) Oxide 
Other Names   Ferrous Ferric Oxide, Ferroso ferric  
oxide, iron (II,III) oxide, magnetite, black 
iron oxide. Lodestone 
CAS number   [1317-61-9 1309-38-2] 
 
Properties 
Molecular Formula  Fe3O4 
Molar Mass    231.533 g/mol 
Appearance    black powder 
Density    5.17g/cm3  
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Mol.weight    231.5 
Oxides entering fusion  Fe3O4 
Mol.Wt.of.Oxides   159.7 
Concersion Fracture  1.035 
Melting Point   1538 
Specific Gravity   5.0-5.4 
USES 
 Fe3O4 is used as a black pigment and is known as C.I pigment 
black. 
 Fe3O4 is used as a catalyst in the Haber Process and in the water 
gas shift reaction. The latter uses an HTS (High Temperature 
shift catalyst) of iron oxide stabilsed by chromium oxide. This 
iron–chrome catalyst is reduced at reactor start up to generate 
Fe3O4 from α - Fe2O3 and Cr2O3 to CrO. 
 Nano Parcticles of Fe3O4 are used as contrast agents in MRI 
scanning. 
 
BIOLOGICAL OCCURRENCE    
 Magnetic has been found as nano – crystals in magnetotactic 
bacteria (42 – 45 μ m) and in homing pigeon beak tissue. 
Ref: http://en.wikipedia.org/wiki/Iron(II,III)_oxide  
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GUNPADAM ASPECT 
 
kz;^uk; 
NtW ngaHfs; 
 fpl;lk;   
 rpl;lk; 
 mNahkyk; 
 Nyhfkz;^ uk; 
 mafpl;lk; 
 mar;rpl;lk; 
 rpl;lhd; 
    Ref: Fzghlk; - jhJ g. vz ; 195 
 fpr;Rfpl;lk; 
 ,Uk;Gf;fpl;lk; 
 ,Uk;Gj;JU 
 ,Uk;Gj;Jfs;  
 goQ;nrq;fw;fpl;lk; 
Ref: jkpo; Mq;fpy mfuhjp 
VERNACULAR NAME: 
 Sans - Manduram 
 Eng - Iron rust  
 Bom - Loheka janga 
 Hind - Lohaka zang 
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 Beng - Loha – ga,  
 Tel - Innupa Chittunu 
 Tam - Irumboo Chittam 
 Lat  - Ferro – Ferric oxide 
Ref - Pharma Copoeia Indica page No. 26 
K.C. Bose 
Indian Materia Medica P.No. 62 
 DOSE: 2-6 grains (130 mg to 390 mg) 
,jd; Rit jd;ik gphpT nra;if maj;jpid xj;jpUf;Fk;. 
Njhw;wk;: 
 ,Uk;ig neUg;gpypl;Lf; fha;r;Rk;NghJ NtwhFk; mRj;jg;nghUs; 
kz;^uk; vdg;gLk;. 
 ,Uk;G> epyj;jpy; Gije;J #l;bdhYk;> kioapdhYk; rpije;J> 
gy;yhz;LfSf;F gpd; kz;^ uk; MfpwJ. E}w;whz;LfSf;F 
Nkw;gl;l kz;^uk; rpwe;j kUe;Jg; nghUshf nfhs;sg;gLk;. 
Ref: rufrk;fpij 3k; ghfk; g.vz ;. 149 
 ,g;nghUs; nfhy;yd; ciyapy; ,Uk;gpdhy; tplg;gl;L> 
mf;fpdpapy; nte;J> nkOfpd; gjj;jpNy fl;bahfpd;wJ. 
 Ref: Fzghlk; - jhJ g.vz;. 195  
 The black forge – scales which collect around the blacksmiths 
anvil are called mandura. 
 Ref: Pharma copeia Indica P.No: 26 
 K.C. Bose 
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Rj;jp 
 maf;fpl;lj;ij cuypypl;L ,bj;J t];jpufhak; nra;J> xU 
gPq;fhd; ghj;jpuj;jpy; ,l;L mjd;Nky; ehd;F mq;Fyk; (10nr.kP.) 
epw;Fk; gbahff; fhukhd rPikj; jpuhl;irf; fhbia tpl;L> 
,uz;L thuk; Cwitj;J> nts;isg;G+z;il ,bj;Jg; gpope;j 
rhw;iw Kd;Nghy tpl;L xU thuk; Cwitf;f Ntz;Lk;. 
Cwitf;Fk; NghJ> %d;W ehisf;nfhU Kiw Cwitj;j 
rhw;iw ,ilapilNa Cw;wptpl;L> mr;rhw;iwNa Gjpjha; tpl 
Ntz;Lk;. ,t;tpjk; KiwNa Kd;rhWfshy; nra;jgpd;G> thJik 
nea;apy; my;yJ gRtpd; nea;apy; fpl;lj;jpid ed;wha; tWj;Jg; 
nghbj;Jf; nfhs;tNj fpl;lj;jpd; Rj;jp. 
 fpl;lj;ij fy;Yuypypl;L ,bj;J thafd;w xU rl;bapypl;L> 
mjd;Nky; ehd;F gq;F vil Gspapiyiag; Nghl;L vz; klq;F 
ePH tpl;L> xU rhkk; (3 kzp) Ntfitj;J Mwpa gpd; 
,iyiaiaAk; nghbiaAk; NrHj;J ed;wha;j; Nja;j;J fOtp 
cyHj;jp Kwj;jpypl;L Gilj;J> ,iyia ePf;fptpLf. gpwF 
fpl;lg;nghbia mk;kpapypl;Lg; nghbj;J> xU rl;bapypl;L 
vl;Lg;gq;F Nfh%j;jpuj;ij tpl;L mLg;Ngw;wpr; rpW jPahy; vhpj;J> 
%j;jpuk; Rz;bagpd; ,wf;fp> ePHtpl;Lf; fOtp vLj;Jf; nfhs;sr; 
Rj;jp. 
Ref: Fzghlk; - jhJ g.vz;. 196 
 jhd;wp kuf;fl;ilfspd; joy;fshy; Nyhf fpl;lj;ij ed;whf Cjp 
vhpj;J> mijnaLj;Jj; jhd;wp kuj;jhyhfpa ghj;jpuj;jpy; cs;s 
gR%j;jpuj;jpy; Njha;f;fTk;> ,t;tpjk; VOKiw nra;a Rj;jp> 
,ij kpfTk; kpUJthfg; nghbj;J maj;ijg; NghyNt 
gpuNahfpf;fTk;. 
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 jphpgiyiag; gRKj;jpuj;jpy; NrHj;Jf; FbePuhff; fha;r;rTk;> 
Nyhffpl;lj;ijg; gOf;f fha;r;rp mf;FbePhpy; nkJthfj; 
Njha;f;fTk;. ,t;tpjk; Rakhfg; nghbg; nghbahfr; rpjWk; 
tiuapy; mijf; fha;r;rpf; FbePhpy; Njha;f;f Ntz;Lk;. me;j 
kz;^ uj;ij ed;whf miuj;J cgNahff;fTk;. 
Ref: ,uruj;jpd rKr;rak; g.vz;.73 
 rpl;lj;ij fUkhd; ciyapy; itj;J jhdpf;fh tpuFfhpahy; 
rptf;ff; fha;r;rp gidkuj;njhl;bapy; Nfh%j;jpuk; tpl;L mjpy; 
VO jlit Jitj;jhy; Rj;jp. mij kWgbAk; ciyapy; itj;J 
Cjp Nfh%j;jpuj;jpy; Njha;j;jhy; Rj;jpahFk;. 
Ref: mDNghf itj;jpa gpuk;kufrpak; g.vz ;. 172 
 ,ij neUg;gpy; fha;r;rp Nfh%j;jpuj;jpy; VOKiw Njha;j;njLf;f 
Rj;jpahFk;. 
Ref: mDgt itj;jpa Njtufrpak; g.vz;. 77 
 Ie;Jgyk; kz;^uj;ij nts;shl;Lf; Nfhkaj;jpy; xU 
eh@witj;J nghw;wiyf; ifahd; rhW> epk;g gor;rhW rkd; 
NrHj;J Rz;l nahpj;njLf;fTk;. 
Ref: rpNuhuj;jpd itj;jpa G+~zk; g.vz;. 30 
nghJf;Fzk; 
‘rpl;lnkhd;whw; Nrhig fpistPf;f kj;jpRuq; 
 Jl;ltpl ghfQ; Rthrikaq; - nfl;l nfhLk; 
 ghz;bUky; ePuhik ghOk; gpukpaKd; 
 jhz;btpL Kz;buj;j jhJ” 
 119
(ngh-iu) kz;^uj;jpdhy; thjNrhig Kjypa tPf;fq;fs;> 
mj;jpRuk; nfhba tplghfk;> ,iug;G> fgNfhgk;> Njfk; ntspwy;> fhrk;> 
ePuhikf;fl;b> gpukpak; ,it ePq;Fk;. ,uj;jk; tpUj;jpahFk;. 
 ehl;;gl;l Neha;fspYk;> grp ke;jj;Jld; kyf;fl;bUf;Fk; nghOJk; 
fhZk; fdy; Ntfk; (cl;fha;r;ry;) ,Uf;Fk; nghOJk; 
kz;^ uj;ij gpuNahfpf;f $lhJ. 
 Ref: Fzghlk; jhJ g.vz;. 195 
 
‘jhH nrwpAk; fpl;lk;jhd; fhl;nrwpA kz;^u 
  NkhpUk;G cs;NshHf;Ff; ,irf;fNt - Nrhu 
  tplg;ghfk; tPf;fk; ntSj;J}Jk; ghz;L 
  elg;ghfk; NghNk etpy”; 
Fzk;: tplghfk;> tPf;fk;> ghz;L ,it jPUk; 
Ref: mfj;jpaH kzp 4000 vd;Dk; itj;jpa  
     rpe;jhkzp ntz;gh ,uz;lhk; ghfk;  
     g.vz;. 295 
 J}a;ikahf;fg;gl;l kz;^uj;ijg; gw;gkhf;fpf;  
    gad;gLj;jpdhy;> ,uj;jj;ijj; J}a;ikg;gLj;Jk;.    
Ref: rufrk;fpij - %d;whk; ghfk; g.vz;. 149 
 Nyhfj;jpw;F nrhy;ypapUf;Fk; rfy Fzq;fSk; ,Uk;G 
rpl;lnkd;w kz;^uj;jpw;Fk; cz;lhapUf;Fk;. 
Ref: mDgt itj;jpa Njtufrpak; g.vz;. 77 
,uruj;jpd rKr;rak; g.vz;. 73 
 ngUk; goq;fpl;lk; ghz;L ngUtap WuKe; jPHf;Fk;  
 Ref:  mkpHj rhfuk; gjhHj;j #lhkzp - g.vz;. 100 
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 Mandoor is used in anaemia, amenorrhoea, dysmenorrhoea, 
menorrhagia and chlorosis. 
 It has great value, in the treatment of neuralgia of the 5th nerve due 
to debility 
 It cures kidney diseases, and albuminuria 
Ref: Pharmacopeia Indica P.No.27 
  K.C. Bose 
kz;^uk; NrUk; ghz;LNeha;f;fhd kUe;Jfs; 
I. Fzghlk; - jhJ tFg;G            gf;f vz; 
1. kfhkz;^ uk;        199 
msT: ,ye;ijf; nfhl;il msT> 2 Ntis. 
Jiz  kUe;J  - rHf;fiu nea; 
2. rpj;j kz;^uk;        200 
msT: fow;rpasT 2 Ntis 
Jiz  kUe;J  : NkhH  
3. jphpfLfhjp kz;^ uk;       200 
msT: ,ye;ij nfhl;il msT 2 Ntis 
Jiz  kUe;J rHf;fiu Njd; 
4. ehuhaz kz;^uk;       201 
msT: Gspaq;nfhl;ilasT> fhiy> khiy ,UNtis 
Jiz  kUe;J  : nte;ePH> NkhH 
5. kz;^ u khj;jpiu        202 
msT - 1tpy;iy> ,UNtis 7 ehs; 
Jiz  kUe;J   - Njd; 
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II. mDNghf itj;jpa etePjk; ghfk; 1    gf;f vz;  
6. kz;^ugw;gk;        42 
msT -1- 2 Fd;wpkzp vil (130 kp.fp. - 260 kp.fp) 2 Ntis. 
Jiz  kUe;J   - miutpuhfndil (1.7 fpuhk;) Nky;Njhy; 
 rPtpd Rf;if vUikNkhiu tpl;L  
 ikNghy; miuj;j fw;fk; 
7. kz;^ur; #uzk;       45 
msT: 1- Kjy; 2 tpuhfndil (4.2 fpuhk; - 8.4 fpuhk;)  
2 Ntis. 
Jiz  kUe;J   nea;> Njd; ehssT miu Kjy; xU kz;lyk; 
8. Nyhf kz;^ u khj;jpiu       47 
msT: 1 khj;jpiu> 10 Ntis (Ie;Jehs;) 
Jiz  kUe;J   - nte;ePH 
9. Nyhfkz;^u ,sfk;       48 
msT 1 ½ - Kjy; 2 ½  tpuhfd; vil (6.3 fpuhk; - 10.5 fpuhk;) 2 
Ntis. 
ehssT - ½ - Kjy; 1 kz;lyk; 
gj;jpak; - ,r;rhgj;jpak; 
10. Nyhfkz;^u tl;L       49 
msT: 3 - 4 Fd;wp kzp vil  (390 kp.fp. - 520 kp.fp.)   
(fhiy>khiy ,UNtis) 
Jiz  kUe;J   - Njd;> nea;> rHf;fiu> japH> 
ehssT - ½ - 1 kz;lyk; 
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  gf;f vz; 
11. kz;^ug;ghtid       41 
msT - 2-4 Fd;wp kzp vil (260 kp.fp. - 520 kp.fp.) 
2 Ntis. 
Jiz  kUe;J   - fhiy - Njd; khiy - nea; 
III. mfj;jpaH - 2000 %d;whk;ghfk;  
12. Gspapiyf; Fok;G       90 
msT - 1¼ tuhfndil (5.25 fpuhk;) 2 Ntis. 
13. ghz;L fhkhiyf;F fLF      93 
msT: 1 ghf;fsT> ,UNtis 10 ehl;fs; 
14. fpl;lhjp kUe;J        94 
msT -1 Rz;ilf;fhasT> ,UNtis> 
Jiz  kUe;J   - fhae;jwpa nte;ePH 
IV. mDNghf itj;jpa Njtufrpak; 
15. kz;^u ytzk;       373 
 msT - 130 kp.fp. - 260 kp.fp. 2 Ntis. 
Jiz  kUe;J   NkhH> Njd; 
16. fpuhjhjp kz;^ uk;       373 
 msT - 65 kp.fp - 130 kp.fp. 2 Ntis. 
 Jiz  kUe;J   - Njd; 
17. mk;rkz;^uk;        373 
msT - 1 khj;jpiu 
Jiz  kUe;J   NkhH 
18. kz;^uf;fhb        384 
msT 1 -2 mTd;R (30 kp.yp. - 60. kp.) 2 Ntis> 10 ehs; 
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V. rpj;jitj;jpaj; jpul;L        gf;f vz;  
19. kz;Luhjp milf;FbePH      295 
msT: ¼ Mohf;F (42 kp.yp.) ,uz;L my;yJ  
%d;W Ntis 
20. cNyhfkz;^ ur; nre;J}uk;      281 
 msT - 65 kp.fp. - 130 kp.fp. 2 Ntis. 
 Jiz  kUe;J   - Njd; 
21. kz;^ur; nre;J}uk;       154 
msT Fd;wpkzpasT (130 kp.fp.) 2 Ntis. 
Jiz  kUe;J   jphpfLFJ}s;> Njd; 
VI. mfj;jpaH kzp 4000 vd;Dk;  
itj;jpa rpe;jhkzp ntz;gh 
22. ghz;L> Nrhigf;fpahok;      138 
 msT - 30 kp.yp. - 60 kp.yp. 2 Ntis. 
23. NyhfhkpHj urhadk;       236 
 msT - 2 fpuhk; - 3 fpuhk;. 3Ntis 
Jiz  kUe;J   ,Q;rpePH> ,sePH> nea;> Njd;> NkhH 
VII. mfj;jpaH itj;jpa fhtpak;  -1500 
24. jphpGuj;jhz;lt nre;J}uk;      700 
msT: gzntil (488 kp.fp.) 2 Ntis 
Jiz  kUe;J   jphpfLFnghb> Njd; 
VIII. fz;Zrhkp guk;giu itj;jpak;  
25. ghz;L> ePHf;Nfhit kNfhjuk; Kjypatw;wpw;F  66  
milf;fpahok;    
msT: 3 mTd;]; (90 kp.yp.) 2 Ntis 
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    gf;f vz; 
26. RaNyhfhf;fpdp       450 
msT - Fd;wpvil (130 kp.fp.) ,UNtis 
Jiz  kUe;J   - nte;ePH 
IX. rpNuhuj;jpd itj;jpa G+~zk;     
27. ghz;lf;fpahok;       151 
msT - miu mohf;F (84 kp.yp.) 2 Ntis. 
28. ghz;L Nuhf fpahok;       152 
msT - miu Mohf;F (84 kp.yp.) 2 Ntis. 
kz;^uk; NrUk; gpw Neha;f;fhd kUe;Jfs; 
I. mfj;jpaH itj;jpa fhtpak; - 1500 
1. rz;lkhUjr; nre;J}uk;      691 
msT gzntil (488 kp.fp.) 2 Ntis. 
Jiz  kUe;J   - Njd; 
jPUk; Neha;: fhkiy> Nrhif> Ruq;fs;  
kfhthjk;> rak;> thA jPUk; 
2. kfhNkf urk;        742 
msT: Fd;wpnail (130 kp.fp.) 2 Ntis 
Jiz  kUe;J   gRtpd; nea;> ntz;nza;> Njd; 
jPUk; Neha; - fgNeha;fs; jPUk; 
3. mkpHj rQ;rPtp Fspif      786 
msT - Fd;wpnail (130 kp.fp) 2 Ntis. 
 Jiz  kUe;J   - gRtpd; ghy; 
jPUk; Neha; Kj;Njhlq;fs;> rd;dp 
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  gf;f vz; 
II. mfj;jpaH gs;S -200 
4. cjpuf;fl;Lf;F eQ;Rf;FbePH      117 
 msT - 30 - 60 kp.yp. 2 Ntis  
jPUk; Neha; - #jfge;jk;> #jfr; #iy>  
III. gpuk Kdp itj;jpa #j;jpuk; II 
5. kQ;rs; fhkhiyf;F kUe;J      42 
msT: ntWfb msT ,UNghJ VOehl;fs; 
Jiz  kUe;J   - nte;ePH 
IV. fz;Zrhkp guk;giu itj;jpak; 
6. FspHRuj;jpw;F fpahok;      65 
 msT 30 kp.yp. - 60 kp.yp. 2 Ntis. 
jPUk; Neha;: FspHRuk;> khwy;Ruk;. 
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vYkpr;ir 
Citrus Limon (Linn) 
tiffs;: (Types) 
 nrb vYkpr;ir  
 nfhb vYkpr;ir 
tshpay;G: (Habitat) 
 ,e;jpah KOtJk; Njhl;lf;fhy; gapuhfr; nra;ag;gfpwJ. 
gad;gLk; cWg;G (Part Used) 
 ,iy> fha;> gok;> gourk;> vz;nza; 
,iy:  
Organo Leptic Characters 
 Rit (Taste)     - Gspg;G 
 jd;ik (Potence)    - ntg;gk; 
 gphpT (Therapeutic Classification) - fhHg;G 
 nra;if (Therapeutic Action)  - FspHr;rpAz;lhf;fp 
fha;> gok; 
 Rit (Taste)    - Gspg;G 
 jd;ik (Potence)    - ntg;gk; 
gphpT (Therapeutic Classification)  - fhHg;G 
nra;if (Therapeutic Action)  - FspHr;rpAz;lhf;fp 
Njhy;: 
 Rit (Taste)    - Gspg;G> fhHg;G 
 jd;ik (Potence)    - ntg;gk; 
 gphpT (Therapeutic Classification) - fhHg;G 
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nra;if: (Therapeutic Action) jbg;Gz;lhf;fp 
 mfl;Ltha;tfw;wp 
 kz%l;b 
gok; 
nra;if (Therapeutic Action) 
 Thermogenic 
 Digestive 
 Carminative 
 Stomachic 
 Laxative 
 Anthelmintic 
 Antiscrobutic 
 Stimulant 
 Antiseptic 
 Mosquito repellent 
gor;rhW 
 Bacterial 
 Astringent 
Ref: Fzghlk; - %ypif tFg;G g.vz; 158 
Indian Medicinal Plants Vol:2 P.No.97  Orient Longman  
Medicinal Plants P.No. 55. 
Clifford A Wright.com 
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Fzk; (Therapeutic efficacy) 
vYkpr;ir 
 ‘rjhgyf; fdpfha r%yK KzNt 
  epjhdkha;g; gapj;jpa epe;ijia afYNk” 
(ngh-iu) vYkpr;rk; gok;> vYkpr;rq;fha;> vYkpr;irNtH> ,iy> 
,itfisf; nfhs;spd;> jPf;Fw;wj;jhy; cz;ghd Neha;fSk; 
ntwpNehAk; Nghk;. 
rk;gPuk; - vYkpr;ir 
 ‘ke;jphpf;F ke;jphpaha; kd;dDf;F kd;dnddj; 
 je;jhpf;F kpj;jpud;Nghw; rhUNk - Ke;jtU” 
 fk;gPu khnkYkpr;ir (Nj.fh) 
vYkpr;irgok; ke;jphp vdf;$Wk; jPf;Fw;wj;ij jzpf;Fk; 
je;jphpahfpa Iaj;jpw;F md;gd;NghypUe;J mdy; tsHf;Fk;. (Iaj;ij 
kpFjpg;gLj;Jk;) Nj.ntz;gh 
vYkpr;rk; gok; 
Fzk;: 
,J kaf;fk;> the;jp> tha; Fkl;ly;> ePHNtl;if> ntwp> fz;Nzha;> 
fhJtyp ,itfisg; Nghf;Fk; efr;Rw;Wf;Fk; ed;ik jPUk;. 
 ‘jhfk; FefNeha; jhohr; rpygj Neha; 
  Ntfq;nfhs; cd;khjk; tpWgpj;jk; - khfz;Nzha; 
  fz;Neha; the;jpAk; Nghq; fl;Lth jpj;njhopypy; 
  kz;ndYkpr; rq;fdpia tho;j;J (m.F)” 
 Ref: Fzghlk; - %ypif g.vz;. 158 -160 
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tof;F 
 Ruj;jpy; cz;lhFk; the;jpfl;Fk;> tha; Fkl;lYf;Fk; 
,g;gourj;jpdhy; nra;ag;gLk; rhjp rk;gPuf;Fok;G ew;gaidj;jUk; 
 ,g;gourj;NjhL rHf;fiu $l;b ePH NrHj;Jg; ngUf;fp ePHtplha;f;F 
mUe;jyhk;. 
 vYkpr;rk; gor;rhw;iw fhiy> khiy gUf Mky gpj;jk; jzpAk;. 
   Ref: ru`rk;`pij - %d;whk;ghfk; g.vz;. 259 
 Local application for warts and Tumours 
Lime juice – 5 parts 
 Carbonate of potash 4 parts 
 Copper sulphate – 3 parts 
 Lemon juice serves as a refrigerant in febrile and inflammatory 
affections, acute rheumatism, dysentery and diarrhea. The juice 
diluted with water is used as a collyrium. 
Ref: Medicinal plants P.No. 55 
Clifford A Wright.com 
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fhpryhq;fz;zp 
Botanical Name: Eclipta prostrata 
NtWngaH: 
 furdhq;fz;zp 
 fhprhiy 
 fhparhiy 
 ifNfrp 
 iftPrp ,iy 
 ifahe;jfiu 
 gpUq;fuh[k; 
 ifahd; 
 Njfuh[k; 
tif (Type) ePyk; kQ;rs;  
rpfg;G    - fpilg;gJ mhpJ 
nts;is   - vq;Fk; fpilf;Fk; 
Propargation - seed 
gad;gLk; cWg;G (Part used) G+z;L 
Rit (Taste) - ifg;G 
jd;ik (Potence) - ntg;gk; 
gphpT (Therapeutic classification) - fhHg;G 
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nra;if (Therapeutic action) 
 gpj;jePHg;ngUf;fp (Bilious)  
 cukhf;fp (Tonic) 
 clw;Nww;wp (Alterative) 
 the;jpAz;lhf;fp (Emetic) 
 ePHkyk; Nghf;fp (Purgative) 
 <uy;Njw;wp (Hepato tonic) 
 Thermogenic 
 Anti inflammatory 
 Anthelmintic 
 Anodyne 
 Vulnerary 
 Ophthalmic 
 Digestive 
 Carminative 
 Haematinic 
 Diuretic 
 Antiseptic 
 Astringent 
 Styptic 
 Aphrodisiac 
 Trichogenous 
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 Deobstruant 
 Depurative 
 Febrifuge 
Root  
 Emetic  
 Purgative 
Fzghlk; %ypif tFg;G g.vz ; 229 
Ref: Medicinal Plants and Rawdrugs of India P.No. 316 
Purushotam Kaushik, Anil Kumar Dhimal 
Indian Medicinal plants Voll II P.No. 350 
Orient Longman  
Fzk;: 
 ,jdhy; FuYWg;G Neha;> fhkhiy> Fl;lk;> tPf;fk;> ghz;L> 
gy;Neha; ,it Nghk; clypw; nghw;rhaYk;> Mspf;Fs;s gyKk; 
cz;lhFk;. 
 ‘Fuy;fk;kw; fhkhiy Fl;lnkhL Nrhig 
  Aww;ghz;L gd;Ndh nahopa- epuw;nrhd;d 
  Nka;ahe; jfiunahj;j kPsp z;Z ew;Gyj;Jf; 
  Ifahe; jfiunahj;jf; fhy; (m.F)” 
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tof;F 
 fhprhiyr; #uzj;ij mar;nre;J}uj;jpw;F mDghdkhff; 
nfhs;s ghz;L Nrhig> fhkhiy> jPUk; 
 ,iyr;rhW 90 Jsp vLj;J mjDld; ePH my;yJ NkhH NrHj;Jr; 
rhg;gpl ghk;gpd;fbeQ;R Nghk; 
 ,iyr;rhW 4 JspAld;> 8 Jsp Njd; fye;J nfhLf;f 
iff;Foe;ijfl;F cz;lhFk; ePHf;Nfhit ([yNjh~k;) jPUk;. 
 ,iyr;rhw;iwf; fhJtypf;Ff; fhJfspy; tplj; jPUk;. 
 ,jid ey;nyz;nzapy; miuj;J ahidf;fhy; Neha;f;F 
NkYf;Fg; G+ryhk;. 
    Reg: Fzghlk; %ypif g.vz;. 231 
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MATERIALS AND METHODS 
 
DRUG PREPARATION  
 Ayabringa Raja Karpam was selected in the accordance with the 
reference in the Gunapadam Thathu Vaguppu P.No. 104 Siddha Vaidhya 
Thirattu Page No: 232 
COLLECTION OF THE TEST DRUGS 
 The drugs were collected from the raw drug store attached to 
pharmacy of Govt Siddha Medical College, Palayamkottai. 
INGREDIENTS: 
 Ayappodi 
 Manduram 
 Karisalai Juice 
 Lemon Juice 
PURIFICATION 
Iron 
Iron filings are taken in a bowl. It is soaked with lemon juice until, 
it completely sinks within it. It is kept for three days. On the fourth day, it 
is taken out and grind well. Then it is washed with water. Thus the iron is 
purified. 
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Manduram 
 Powdered Manduram is taken in a pot and add four parts of 
tamarind leaves and eight parts of water. Boil this mixture for 3 hours, 
then wash the powder and dried in shade. Remove the tamarind leaves.  
Then grind the mandura powder and put in a pot. Add eight parts of 
cow’s urine and heat it. Then wash the powder with fresh water and dried 
in the sunlight 
METHOD 
 Put the first two drugs in karisalai juice and expose it to the sun 
light till the juice dried up. Put the powder in  the lemon juice and 
exposed to the sunlight till the juice dried up. Again pour a half a measure 
of karisalai juice and dried it up in the sunlight. Then powder it well and 
preserv it in a jar.     
Dose: 500 mgm Twice a day with honey after meals  
Route of administration: Enteral route. 
This prepared Ayabringa Raja Karpam is used for  
 Chemical Aspect 
 Gunapadam Aspect 
 Bio – Chemical Analaysis 
 Pharmacological Analaysis 
 Toxicity Studies 
 Anti Micribial Suceptbility Test 
 Heavy metal analysis by AAS 
 Clinical Studies  
 Bio statistical analysis 
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BIO – CHEMICAL ANALYSIS 
BIO – CHEMICAL ANALYSIS OF AYA BRINGA RAJA 
KARPAM 
Preparation of The Extract  
 200mg of Aya Bringa Raja Karpam was weighed accurately and 
placed in a 250ml clean beaker.  Then 50ml distilled water is added and 
dissolved well.  Then it is boiled well for about 10 minutes.  It was cooled 
and filtered in a 100ml volumetric flask and then it is made up to 100ml 
with distilled water.  This fluid is taken for analysis 
QUALITATIVE ANALYSIS 
S. 
No 
Experiment Observation Inference 
1. Test for calcium 
2ml of the above prepared extract is 
taken in a clean test tube.  To this 
add 2 ml of 4% ammonium oxalate 
solution. 
No white 
precipitate is 
formed. 
Absence of 
calcium. 
2. Test for sulphate: 
2ml of the extract is added to 5% 
barium chloride solution. 
White 
precipitate is 
formed. 
Presence 
of 
sulphate. 
3. Test for chloride 
The extract is treated with silver 
nitrate solution. 
White 
precipitate is 
formed. 
Presence 
of 
chloride. 
4. Test for carbonate 
The substance is treated with 
concentrated Hcl. 
No brisk 
effervescence 
is formed. 
Absence of 
carbonate. 
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5. Test for Starch 
The extract is added with weak 
iodine solution. 
No blue colour 
is formed 
Absence of 
starch. 
6. Test for iron 
Ferric 
The extract is treated with 
concentrated glacial acetic acid and 
potassium ferro cyanide.                    
No blue colour 
is formed. 
Absence of 
ferric iron. 
7. Test of iron : 
Ferrous: 
The extract is treated with 
concentrated Nitric acid and 
ammonium thio cynate. 
Blood red 
colour is 
formed. 
Presence 
of ferrous 
iron. 
8. Test for phosphate 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
No Yellow 
precipitate is 
formed. 
Absence of 
phosphate. 
9. Test for albumin  
The extract is treated with Esbach’s 
reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
albumin. 
10. Test for Tannic acid 
The extract is treated with ferric 
chloride reagent. 
No blue black 
precipitate is 
formed. 
Absence of 
Tannic 
acid. 
 
11. Test for unsaturation 
Potassium permanganate solution is 
added to the extract. 
It does not get 
decolorized. 
Absence of 
unsaturated 
compound. 
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12. Test for the reducing sugar 
5ml of benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 mts and added 
8-10 drops of the extract and again 
boil it for 2 mts. 
No colour 
change occurs. 
Absence of 
reducing 
sugar. 
13. Test for amino acid: 
One or two drops of the extract is 
placed on a filter paper and dried 
well. After drying, 1% ninhydrin is 
sprayed over the same and dried 
well. 
No Violet 
colour is 
formed. 
Absence of 
amino 
acid. 
 
INFERENCE 
 The given sample of Aya Bringa Raja Karpam contains Sulphate, 
Chloride, Ferrous iron. 
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PHARMACOLOGICAL ANALYSIS 
 
Pharmacological Analysis of trial medicine 
Study on the haematinic effect of Ayabringa Rajakarpam on 
Albino rats.  To prove its haematinic effect of which Ayabringa 
Rajakarpam an attempt was made to study its effect using “Albino rats.” 
For this purpose rats are made anaemic by the following procedure. 
Artificially induced iron deficiency 
 The albino rats taken for this experiment were kept in aluminum 
cages and provided with drinking water and milk, free from iron.The 
administration of the iron preparation under investigation was started 
when the hemoglobin level fell to 6-6.5gram/100ml. At the beginning of 
the experiment Hb mg% were determined. 
Study on rats  
 The albino rats were first divided into 2 equal groups with five rats 
in each group the first group received Ayabrnga Rajakarpam 
20mg/100gm body  weight with hot water.The second group received 
normal diet. All the above procedures were continued for five weeks in 
once a day the haemoglobin levels of rats were measured I,II,III,IV,V 
weeks. The results observed are tabulated in the following chart.  
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STUDY OF HAEMATINIC EFFECT OF USING THE DRUGS OF 
AYABRINGA RAJAKARPAM 
S.No Drugs Initial 
Reading 
After Drug Administration Remarks
1st  
Week 
2nd
Week 
3rd
Week 
4th
Week 
5th 
Week 
1 
 
 
 
 
2 
 
 
 
 
Control 
 
 
 
 
Ayabringa 
Rajakarpam 
7.2 gm 
6.8 gm 
7.0 gm 
6.7 gm 
6.8 gm 
7.0 gm 
7.2 gm 
7.2 gm 
7.5 gm 
7.1 gm 
7.2 gm 
6.8 gm 
7.0 gm 
6.7 gm 
6.8 gm 
7.5 gm 
7.6 gm 
7.6 gm 
7.8 gm 
7.2 gm 
7.1 gm 
6.5 gm 
6.8 gm 
6.5 gm 
6.5 gm 
8.0 gm 
8.0 gm 
8.4 gm 
8.7 gm 
8.1 gm 
7.1 gm 
6.3 gm 
6.5 gm 
6.4 gm 
6.3 gm 
9.0 gm 
9.2 gm 
9.4 gm 
9.8 gm 
9.0 gm 
7.0 gm 
6.1 gm 
6.3 gm 
6.3 gm 
6.1 gm 
10. gm 
10.5 gm 
10.0 gm 
10.5 gm 
10.2 gm 
6.9 gm 
6.0 gm 
6.1 gm 
6.2 gm 
6.0 gm 
11.0 gm 
11.2 gm 
11.5 gm 
11.5 gm 
11.0 gm 
Average 
6.24 gm 
 
 
 
 
11.2 gm 
 
Result 
 This table shows that Ayabringa Rajakarpam along with honey in 
my research work has  significant haematinic action. 
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TOXICITY STUDY OF “AYA BRINGARAJA KARPAM” 
 
 This result is taken from the studies, conducted at the PG 
Toxicology Department of Government  Siddha Medical College, 
Palayamkottai, during the year 2004. 
STUDY PATTERN 
 Acute and sub acute toxicity studies were carried out using fresh 
wistar albino rats with either sex.  The animals used were four months old 
with more or less equal weights. 
ACUTE TOXICITY STUDY 
 The research work was carried out in the animal house attached to 
the post graduate department of pharmacology, Government Siddha 
Medical College, Palayamkottai.  
SELELECTION OF ANIMALS 
 Fresh animals were selected for the experiment.  They were 
isolated and made accustomed to the laboratory conditions.  10 rats were 
selected and divided into 5 groups, each group consisting of 2 rats. 
Dose Levels 
 Group I : 100mg / animal 
 Group II : 200mg / animal 
 Group III : 400mg / animal 
 Group IV : 800mg / animal 
 Group V  : 1600mg / animal 
Route of administration : Oral. 
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Preparation of the test drug (Aya Bringaraja Karpam) for 
administration. 
 The drug was weighed and suspended with equal quantity of lemon 
juice.  It was ground well and administered.  The preparation was done in 
such a way, so as 1ml of the suspension contained 400mg of the drug. 
 The drug was administered once in the morning and observed. 
Observations: 
 The following details were recorded before the beginning of drug 
administration. 
 Body weight of the animals 
 Haematological investigations 
 The above parameters were recorded upto 14 days and the results 
were tabulated. 
Processing for histopathological study: 
 The above procured organs were sent for the histopathological 
study.  The study report was given by Dr. V. Paramasivam, M.D.(Path) 
M.D. (Foren) HOD of Pathology, Tirunelveli Medical College and also 
visiting professor for pathology of PG students of Government Siddha 
Medical College Palayamkottai. 
 The tabular column shows in tested parameters and changes in 
histopathological specims were also documented. 
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RESULT 
LD50 – 1600 mg / animal 
 The single oral dose upto 1600mg / animal of Aya Bringaraja Karpam 
did not produce any mortality, even within 24 hours and upto 14 days of drug 
administration.  No significant haematological changes occurred.  
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ACUTE TOXICITY STUDY 
Haematological Values of the Test Animals 
Drug: Aya Bringaraja Karpam                                                                                                                                  G - Group 
S. 
No 
Blood Investigations Before the drug administration (mean) After the drug administration (mean) 
G1 G2 G3 G4 G5 G1 G2 G3 G4 G5 
1. TOTAL COUNT – WBC Cells/cumm 8800 8600 8200 8000 8300 8900 8900 8500 10300 8800 
2 DIFFERENTIAL COUNT – WBC 
      Neutrophils (in percentage) 
30 36 40 40 46 21 34 30 30 36 
       Eosinophils (in percentage) 2 4 3 - 3 7 3 4 - - 
        Basophils (in Percentage) - - - - - - - - - - 
       Lymphocytes (in Percentage) 68 60 57 60 51 72 63 66 70 64 
       Monocytes (in Percentage) - - - - - - - - - - 
3.  HAEMOGLOBIN (gm / dl) 12.4 12.6 12.4 12.0 12.6 12.6 12.8 12.6 12.8 13.0 
4 BLOOD PICTURE 
     RBC Distribution 
 
Normocytic Normo Chromic.  No immature cells seen 
NORMAL       WBC Distribution 
      Platelet Distribution 
 WEIGHT OF THE ANIMAL (in gms) 105 120 115 120 105 105 120 120 110 105 
Result: Complete haematological studies reveal a normal morphology of the blood cell.  No significant  
haematological changes occured. 
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SUB ACUTE TOXICITY STUDY 
 The duration of administration was 28 days.  Since the drug is 
usually given for a long term in sub acute ailments, it was decided to find 
out the sub acute toxicity of the drug in experimental animals. 
 The research work was carried out in the animal house attached to 
the post graduate department of pharmacology, Government Siddha 
Medical College, Palayamkottai during the year 2004. 
Selection of Animals 
 Fresh animals were selected for the experiment.  They were 
isolated and made accustomed to the laboratory conditions. 
Selection  of dose levels: 
 Two doses, one 15 times and the other 30 times higher than the 
human dose were selected for sub acute toxicity study 12 rats were 
divided into 3 groups, each group consisting of 4 rats. 
 Group I : Control 
 Group II : 100mg drug / animal 
 Group III : 200 mg drug / animal 
 Route of administration : Oral 
Preparation of the test drug for administration 
 The drug was weighed and suspended with equal quantity of lemon 
juice.  It was ground well before administration.  The preparation was 
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done in such a way so as 1 ml of the suspension contained 100 mg of the 
drug.  The test drug was administered once daily. 
Observations 
 The following details were recorded before the beginning of drug 
administration. 
 Body weight of the animals 
 Haematological investigations 
 The above parameters were recorded at 28 days and the results 
were tabulated. 
 The animals were sacrificed at the end of the experiment, liver, 
kidney and heart were removed from each animal and preserved in 40% 
formalin for histopathological studies. 
Processing for Histopathological study 
 The above procured organs are sent for the histopathological study.  
The study report was given by Dr. V. Paramasivam, M.D.(Path) M.D. 
(Foren) HOD of Pathology, Tirunelveli Medical College and also visiting 
professor for pathology of PG students of Government Siddha Medical 
College Palayamkottai. 
 The tabular column shows in tested parameters and changes in 
histopathological specims were also documented. 
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HISTOPATHOLOGICAL STUDY REPORT 
 
Liver 
 Section studied shows liver cells with hepatocytes arranged in 
trabecular pattern with early cirrohosis. 
Heart: 
 Section shows myocardium with no remarkable pathological 
changes. 
Kidney: 
 Section studied shows renal tissue with tubular, show distention 
vessel change noted. 
Result: 
 The drug did not produce any mortality in sub acute toxic doses, 
histopathology reveals no significant alteration in tissues studied. 
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ACUTE TOXICITY STUDY 
Haematological Values of the Test Animals 
Drug: Aya Bringaraja Karpam                                                                                         G - Group 
S. 
No 
Blood Investigations Before the drug 
administration (mean) 
After the drug  
administration (mean) 
G1 G2 G3 G1 
Control 
G2 G3 
1. TOTAL COUNT – WBC Cells/cumm 9000 7000 7600 9000 7000 7800 
2 DIFFERENTIAL COUNT – WBC 
      Neutrophils (in percentage) 
 
42 
 
30 
 
34 
 
48 
 
36 
 
40 
       Eosinophils (in percentage) - - - - - - 
        Basophils (in Percentage) - - - - - - 
       Lymphocytes (in Percentage) 52 70 66 52 64 60 
       Monocytes (in Percentage) - - - - - - 
3.  HAEMOGLOBIN (gm / dl) 12.6 12.8 12.4 12.4 13.4 13.8 
4 BLOOD PICTURE 
     RBC Distribution 
 
Normocytic Normo Chromic.  No 
immature cells seen 
NORMAL 
      WBC Distribution 
      Platelet Distribution 
 WEIGHT OF THE ANIMAL (in 
gms) 
110 100 120 110 110 120 
Result: Complete haematological studies reveal a normal morphology of the blood cell.   
No significant haematological changes occured. 
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ANTI-MICROBIAL SUSCEPTIBILITY TEST FOR               
AYA BRINGA RAJA KARPAM 
Aim: 
 To identify the anti-microbial (Bacterial) activity of Aya Bringa 
Raja Karpam against Streptococcus, Staphylococcus, proteus, 
Psuedomonas, E.coli and Klebsiella. 
Medium : Muller Hinton agar 
Method :  Kirby - bauer disc diffusion method 
Components of Medium: 
 Beef extract   : 300gms /lit 
 Agar    : 17gms /lit 
 Starch   : 1.50gms /lit 
 Casein Hydroxylate : 17.50gms /lit 
 Distilled Water  : 1000 ml 
 pH     : 7.6 
Procedure: 
 The media was prepared from the above components and poured 
and dried on a Petri dish. The organism was streaked on the medium and 
the test drug (1 gm drug in 10 ml of Water) was placed on the medium. 
This is incubated at 370C for one over night and observed for the 
susceptibility  shown up clearance around the drug. 
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Table: Anti-microbial Susceptibility Test Report 
No. Organism Susceptibility 
1. Staphylococcus Resistant 
2. Pseudomonas Resistant 
3. E. coli Resistant 
4. Klebsiella Resistant 
5. Proteus Resistant 
6. Streptococcus Resistant 
 
Result: 
  The test drug Aya Bringa Raja Karpam was resistant for all the 
organisms. 
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METHODOLOGY FOR ANALYSIS OF METALS BY 
ATOMIC ABSORPTION SPECTROMETER 
Principle 
Atomic absorption is the process that occurs when a ground state 
atom absorbs energy in the form of light of a specific wavelength and is 
elevated to an excited state. The amount of light energy absorbed at this 
wavelength will increase as the number of atoms of the selected element 
in the light path increase. The relationship between the amount of light 
absorbed and the concentration of analyses present in known standards 
can be used to determine unknown sample concentration by measuring 
the amount of light they absorb. 
The absorption of light is proportional to the concentration of free 
atoms in the flame is given by Lambart-beer law.   
Absorbance = log 10 Io/It = k.c.I 
Where,  Io  = intensity of incident radiation emitted by the light 
source. It = intensity of transmitted radiation. C = concentration of sample 
(free atoms). k = consent   I = path length 
Methodology for Metal Analysis 
a) Sample collection 
The samples will be cleaned and dried under shade. The dried 
samples will be then grinded and powdered in an agate pestle and mortar. 
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Samples will be labeled and stored in pre-cleaned polyethylene bottles for 
further analysis. 
b) Reagents and apparatus 
All the reagents such as HNO3, and H2O2 purchased from MERCK 
(Analytical Grade). De-ionized water will be used for all analytical work 
and all the glassware’s, polyethylene bottles, pipette tips and others will 
be washed with 1% HCL, rinsed with de-ionized water before preparing 
standards, reagents and samples. 
c) Digestion of samples( Sample preparation) 
A mulitwave 3000 micro oven system (from Anton paar, USA) 
with 16 position Teflon vessels with capping is being used here. The 
digestion vessels are provided with a controlled pressure, temperature and 
release valve. Before use, all Teflon vessels are soaked with 10% HNO3. 
The system is initially programmed by giving gradual rise of 20%, 40%, 
and 50% power for 5, 15 and 20 minutes respectively for the due 
warming up. The powder samples are being used without any further 
treatment for sample preparation. 0.2 g of sample is weighed into the 
Teflon vessels followed by digestion mixture of HNO3, and H2O2 in the 
ratio of 3:1, according to the nature of samples are being applied. 
The resulting solution after microwave digestion is filtered through 
whatman # 40 filter paper (if necessary) and diluted to 5 ml with de-
ionized water. A sample blank containing only acid mixture is prepared at 
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the same time. The method of standard addition is generally adapted to 
calibrate the instrument before going for the observation of the samples. 
Determination of metals 
All the atomic measurements are carried out with Perkin Elmer 
model 400/HGA900/AS800 coupled with mercury hydride system – 15 
(MHS-15) and Flame Photometer. The lamps of Hallow cathode lamp 
(HCL) for Fe, Cu, Mn, Zn, Ni,Co and Electrodeless Discharge 
Lamp(EDL) for  Cd, Pb, Hg and As, analysis are used as a light source to 
provide specific wavelength of the elements to be determined and high 
purity (99.999%) Acetylene, Nitrous oxide are used to provide constant 
thermal energy for atomization process and Argon gas used for carrier gas 
purging purposes for Graphite furnace.  
Calibration of instruments 
More then three working standard solution of elements to be 
determined are prepared, covering the concentration range as 
recommended by the manufacturer of the instrument for the elements to 
be determined. Before the  analysis of samples, the instruments will be 
calibrated with prepared working standard solution. The calibration 
curves will be obtained for concentration vs. absorbance data statically 
analyzed. Calibration of the instrument will be repeated periodically 
during operations and blanks will be carried with each set of 10 samples 
or aspirate any one of the prepared working standard for every 10 
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samples to check the instrument drift and to validate analytical 
procedures and performance. Regent blank reading will be taken and 
necessary correction will be made during the calculation of concentration 
of various elements. 
Standard Certified Reference SASTRA UNIVERSITY will be used 
for day-to-day evaluation of methods of analysis or test and for long-term 
quality assurance of measurements. A reagent blank reading will be taken 
and necessary corrections will be made during the calculation of 
concentration of various elements.  
Fe, Cu, Mn, Zn, Mg, Mo etc., metals analysis (Flame 
AAS/Graphite furnace) 
After calibrating the instrument with prepared working standard, 
the digests liquid sample’s solution is subjected to analysis of Fe, Cu, 
Mn, Zn, Ni, Co by AAS flame and As by furnace with specific 
instrumental conditions as given by instruments manufacturer. Introduce 
the solution into flame, record the reading, using the mean of the three 
reading and quantified the concentration of the metals in the given 
samples against the standard calibration curve obtained from 
concentration vs. Absorbance of the prepared known concentration on the 
day of the analysis. 
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Hg analysis by cold vapour method 
After calibrating the instrument with prepared working standard, 
the 10 ml of digests liquid sample’s pipette out to a specific container of 
mercury Hydride system analyzer followed by adding 1.5% of Hcl of 10 
ml as diluent for each flask and blank, 3% of NaBH4 solution in 1% of 
NaoH is run through the reaction flask to quartz cell with out heating 
against the calibration curve obtained from concentration vs absorbance 
of the prepared known concentration on the day of the analysis. 
Reference 
1. Analysis, 2000,28,850-854. © EDP Sciences, Wiley – VCH 
2000 
2. Analytical Sciences April 2000 Vol.16, © The Japan Society for 
Analytical Chemistry. 
3. The Sciences, (2); 74-77 March-April 2001. 
Heavy Metal Analysis of the Aya Bringaraja Karpam was 
done in the Bio –Technology Department of Sastra University 
using AAS(Atomic Absorption Spectrometer) and the results are 
given below. 
 156
Centre for Advanced Research in Indian System of Medicine CARISM) 
SASTRA UNIVERSITY, THANJAVUR 613402 
ELEMENT ANALYSIS REPORT 
Authorised Drug Testing laboratory Approved By the Drug Controller, Govt. of Tamilnadu 
Instrument used: Atomic Absorption Spectrometer – Model A Analyst400/HGA900/AS/800- Perkin Elmer 
Name of the trial drug: Aya bringa Raja Karpam 
                    Units in ppm 
Sample. Name Fe Cu Mn Zn Ni Co Cd Pb Hg As 
Aya Bringaraja 
Karpam 
7791 25.6300 32.3800 6.9100 0.1320 0.2560 0.2010 3.8880 0.2886 1.9630
WHO Limit 25 15 5 15 10 1 0.3 10 1 10 
 
Analyst                  Dean
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 Inference: 
From the above Heavy Metal Analysis it is concluded that Aya 
Bringaraja Karpam contains  
Fe – 7791 PPM   Cu – 25.6300 PPM 
Mn – 32.380 PPM            Zn – 6.9100 PPM 
Ni – 0.1320 PPM            Co – 0.2560 PPM 
Cd – 0.2010  PPM            Pb – 3.8880 PPM 
Hg – 0.2886  PPM           As – 1.9630 PPM 
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CLINICAL ASSESSMENT 
 
A clinical trial on Pandu noi was carried out at the Govt. Siddha 
Medical College Hospital, Palayamkottai. 
 40 cases with clinical signs and symptoms of Pandu noi of both 
sexes with age ranging from 14-62 years were selected and treated. 
Case Selection 
The patients were selected as Paandu noi according to the following 
criteria. 
 Pallor of conjunctiva and nail beds 
 Anorexia 
 Ulceration of mouth 
 Diarrhoea 
 Lassitude 
 Emaciation 
 Palpitation 
 Dysnoea on exertion 
 Worm infestation 
EXCLUDING CRITERIA 
 Chronic liver  diseases 
 Chronic renal diseases 
  Myxoedema  
 Thalasemia 
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Clinical Pathological Examination 
Blood Test 
 Total count 
 Differential count 
 Hemoglobin 
 Erythrocyte sedimentation rate 
 Blood sugar 
 Blood urea 
 MCV – Mean Corpuscular Volume 
 PCV – Packed Cell Volume 
URINE EXAMINATION 
 Albumin 
 Sugar 
 Deposits 
MOTION EXAMINATION 
 Ova 
 Cyst 
 Occult Blood 
Line of Treatment 
 The drug Ayabringa Rajakarpam was administered orally in a dose 
of 500gm two times a day with Honey after meals. 
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Diet and Medical Advice: 
 Iron rich diet 
 Green leafy vegetables 
 Fruits 
 Meat 
 Sea foods 
 Nuts 
 Cereals 
 Eggs 
 Citrus fruits, tomatoes helps the body to absorbing  iron from 
food. 
 Increase dietary fibre to prevent constipation. 
 Eat fresh uncooked fruits and vegetables often. Don’t eat over 
cooked food. It may destroy folic acid. 
Observation  
 The haematinic action of Ayabringa Rajakarpam was observed on 
the basis of the relief of symptoms and confirmed by routine lab 
investigations. 
 The clinical improvement was recorded for every seven days. The 
laboratory investigations were done for the patients before and after 
treatment. At last the prognosis was noted. 
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Results: 
 Among the 40 patients selected, 32 patients showed good response, 
6 patients showed fair response and remaining 2 patients showed poor 
response. 
TABLE ILLUSTRATING THE SEX DISTRIBUTION 
S.No Sex No.of Patients Percentage 
1. Male 10 25% 
2. Female 30 75% 
 Total 40 100% 
 
TABLE ILLUSTRATING THE AGE DISTRIBUTION 
S.No Age in Years No.of Patients Percentage 
1. Upto 20 2 5% 
2. 21 – 40 10 25% 
3. 41 – 60 27 67.5% 
4. 61 and above 1 2.5% 
 Total 40 100% 
 
TABLE ILLUSTRATING THE PROGNOSIS 
S.No Prognosis No.of Patients Percentage 
1. Good 32 80% 
2. Fair 6 15% 
3. Poor 2 5% 
 Total 40 100% 
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BIOSTATISTICAL ANALYSIS 
 
The age and sex of the study subjects of pandu were classified and 
analysed.  The results of analysis and interpretations are posted in the 
following table. 
S.No Sex n 
Age 
‘t’ Significance 
95% of 
population 
mean age 
Mean S.D 
1 Male 10 47.0 15.6 0.075 P>0.05 - 
2 Female 30 47.4 12.7 - - - 
3 Total 40 47.3 13.25 - - 
43.0 to 
51.5 years 
 
 The mean ages between the sexes are not statistically significant 
(p>0.05).  The mean age of Pandu noi population will be living in 
between 43 to 51.5 years at 95% confidence interval. 
ANALYSIS OF RELATED VARIABLE  
The related variable of the disease Pandu is analysed with reference 
to before and after treatment of the drug AyaBringa Raja Karpam.The 
results are enumerated in the  following table. 
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Related variable results before and after treatment 
Sl.No Variable n 
Before After Mean of 
Difference
‘t’ Significance
Mean S.D Mean S.D
1 
Hb. gms 
/ dl 
40 9.44 0.80 10.41 1.1 0.97 13.767 P < 0.000 
2. 
MCV. 
Cu. Mic 
5 76.4 5.86 78.3 5.9 1.92 3.194 P < 0.05 
3. PCV% 5 36.6 3.6 40.0 5.1 3.44 5.085 P < 0.01 
 
The above analysis clearly show that there is highly statistically 
significant increase of Hb level among the study subjects after 
administration of the drug Aya bringa Raja Karpam. In correction of 
anaemia the drug is effective. It will also increase the level of MCV and 
PCV. The increase is also statistically significant (p < 0.05 and p < 0.01) 
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DISCUSSION 
 
 According to Siddha concept, the basic abnormality in Pandu Noi 
is due to increased state of Pitha humour. 
gpj;j ehb 
 ‘MNkjhd;aj;jp Ruk;ghz;L Nrhif 
 Mohd ……………………………… 
 ……………………………………….. 
 ……………………………………….. 
 etpd;wpl;lhH thrKdp etpd;wpl;lhNu”. 
      - mfj;jpaH 
 rpj;j kUj;Jt Neha; ehly;> Neha; Kjdhly; jpul;L. 
In Aya bringa Raja Karpam. Iron and Mandoor possess Astringent, 
Sour and Bitter taste. 
Astringent taste contains, Mann and Vazhi Pootham. Astringent 
taste (Thuvarppu) has the tendency to mitigate the harmful effects of the 
affected Pitha humour. 
JtHg;gpd; nra;if 
 ‘FUjp Rj;jp ahf;Fk; 
 nfhba gpj;jk; Nghf;Fk; 
 …………………………. 
 ………………………….. 
 FspHe;j JtHg;gpd; Ntiy.” 
    - rpj;j kUj;Jthq;fr; RUf;fk; g.vz;.40 
Sour taste has the property to induce appetite 
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Gspg;gpd; nra;if 
 
 ‘nrhpg;gh ndhpiaj; J}z;b tpLk; czitr; 
 rhpaha;r; nrhpg;gj; J}z;tpUg; GaHj;Jk; 
 …………………………………………… 
 …………………………………………… 
 Gspg;gpd; ngUik GfyTq; $LNkh.” 
      - kUj;Jt jdp ghly; 
               rpj;j kUj;Jthq;f RUf;fk; g.vz;. 32. 
Bitter taste helps in destroying intestinal worms. 
ifg;gpd; gz;Gk; nra;ifAk; 
“NtWfhuzk; tpisj;j T+z;ntWg; 
 Nghl;L kpay;gh Naw;f tpUk;ghr; 
 ……………………………………… 
 ……………………………………… 
 Flw;GO Fl;lk; nfhbaeQ;R 
 tha;ePUwy; mow;rpAk; jzpf;Fk; 
 …………………………………... 
 …………………………………… 
 msNthL nfhz;lhy; milAk; gaNd.”  
 kUj;Jt jdpg;ghly; 
 rpj;j kUj;Jthq;fr; RUf;fk; g.vz;. 36 
This explanation is arrived on the basis of the analysis of the 
Gunapadam aspect of the drug which correlate with that of the 
pharmacological  analysis and the clinical  assessment. 
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 Bio Chemical analysis shows the presence of Sulphate, Choride 
and Ferrous Iron. 
Ferrous Iron is easily absorbed. It is a valuable tonic and alterative. 
It aids cellular oxidation. Thus enhancing functional activity of all organs. 
It has great value in the treatment of  Pandu Noi ( Anaemia). 
 From Heavy Metal Analysis it is concluded that Aya Bringaraja 
Karpam contains,  
Fe – 7791      PPM            Cu – 25.6300    PPM  
Mn – 32.380  PPM           Zn – 6.9100       PPM  
Ni – 0.1320   PPM           Co – 0.2560       PPM  
Cd – 0.2010    PPM  Pb – 3.8880       PPM 
Hg – 0.2886    PPM  As – 1.9630       PPM 
 Pharmacological analysis shows Significant haematinic  
activity. 
 About 40 patients with Pandu noi were taken in the study out of 
this,  
Good response - 80%  
Fair response - 15% 
Poor response - 5% 
During the treatment, the patients had no signs and symptoms of 
toxic effects. 
 Biostatistical analysis also revealed that this drug has got 
significant effect in treating pandu noi.  
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SUMMARY 
 
 Ayabringa Raja Karpam was taken for this study to establish 
its efficacy in Pandu Noi, as an important aspect of this 
dissertation work. 
 A brief description pertaining to its Chemical aspect and 
Gunapadam aspect has been reviewed. 
 A review of literatures about the drug and its significance in 
medicine were collected. 
 In Bio-chemical analysis the drug contains Sulphate, Chloride 
and Ferrous Iron. 
 Heavy Metal analysis by AAS was also done.  
 Pharmacological analysis shows Significant haematinic  
activity. 
 From the clinical study the drug has got significant efficacy in 
treating Pandu Noi. During the clinical trial the patients showed 
no untoward effects. 
 Biostatistical analysis also revealed that this drug has got 
significant effect in treating pandu noi.  
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CONCLUSION 
  
 It is concluded that the drug Ayabringa Raja Karpam has got 
Significant effect in the treatment of Pandu Noi without producing any 
untoward effects.  
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IN – PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 1 IP No: 288 Name : Senduammal Age/Sex: 58/F Occupation: Factory Labour
From : 01-02-08 To: 11-03-08 No. of days treated : 41
Complaints and  
Duration INVESTIGATION 
Giddiness, 
Tiredness, 
Malaise present 
since 1 month 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 8500 cells / cumm Albumin : NIL TC: 8100 cells / cumm Albumin : NIL
DC:   P: 60 % L: 36% E: 4 % Sugar    : NIL DC:   P: 62% L: 30 % E: 8 % Sugar   : NIL
ESR 1/2hr :  2 mm Deposits: NAD ESR 1/2hr : 3 mm Deposits : NAD
         1 hr :  4 mm MOTION          1 hr : 5 mm MOTION
HB :  8 gms/ dl (54%)
Ova : Hook worm ova 
seen HB : 8.5 gms / dl (57%) Ova : NIL 
MCV :  69 cubic micron Cyst : NIL MCV : 71.1 cubic micron Cyst : NIL
PCV :  32% PCV : 34% RESPONSE
Sugar(R) :  100 mgs% Sugar (R): 97 mgs% Fair
Urea :  26 mgs% Urea : 28 mgs%
Cholesterol  :  158 mgs% Cholesterol : 161 mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 2 IP No: 493 Name : Muthammal Age/Sex: 59/F Occupation: Beedi worker
From : 19-02-08 To: 31-03-08 No. of days treated : 42
Complaints and  
Duration INVESTIGATION 
Giddiness, 
Tiredness, 
palpitations 
present since 2 
months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 10100 cells / cumm Albumin : NIL TC: 10000 cells / cumm Albumin : NIL
DC:   P: 63% L: 32% E: 5% Sugar    : NIL DC:   P: 65% L: 31% E: 4 % Sugar   : NIL
ESR 1/2hr :  7 mm Deposits: NAD ESR 1/2hr : 5 mm Deposits : NAD
         1 hr :  8 mm MOTION          1 hr : 6 mm MOTION
HB :  9.2  gms / dl (63%) Ova : NIL HB : 10 gms / dl (68%) Ova : NIL 
MCV :  74 cubic micron Cyst : NIL MCV : 75 cubic micron Cyst : NIL
PCV :  36.8% PCV : 40% RESPONSE
Sugar(R) :  126 mgs% Sugar (R): 125 mgs% Fair
Urea :  16 mgs% Urea : 18 mgs%
Cholesterol  :  128 mgs% Cholesterol : 128 mgs%
IN – PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 3 IP No: 407 Name : Mary Age/Sex: 50/F Occupation: Vegetable vender 
From : 12-02-08 To: 24-03-08 No. of days treated : 42 
Complaints and  
Duration INVESTIGATION 
Fatigue, Malaise, 
loss of appetite 
present since 5 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9700 cells / cumm Albumin : NIL TC: 9800 cells / cumm  Albumin :  NIL 
DC:   P: 60 % L: 38% E: 2 % Sugar    : NIL DC:   P: 66% L: 32 % E: 2 % Sugar   : NIL
ESR 1/2hr :  3 mm Deposits: NAD ESR 1/2hr : 2 mm Deposits :  NAD 
         1 hr :  5 mm MOTION          1 hr : 4 mm MOTION 
HB :  9.3 gms / dl (62%) Ova :  NIL HB : 10.5 gms / dl (71%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  129 mgs% Sugar (R): 128 mgs% Good
Urea :  29 mgs% Urea : 30 mgs%
Cholesterol  :  102 mgs% Cholesterol : 100 mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 4 IP No: 487 Name : Selvi Age/Sex: 38/F Occupation: House wife 
From : 28-02-08 To: 11-043-08 No. of days treated : 44 
Complaints and  
Duration INVESTIGATION 
Numbness, 
Angular 
stomatitis, 
Dyspnoea on 
exertion present 
since 3 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9800 cells / cumm Albumin : NIL TC: 9700 cells / cumm  Albumin :  NIL 
DC:   P: 62 % L: 32% E: 6 % Sugar    :  NIL DC:   P: 64% L: 34 % E: 2 % Sugar     : NIL 
ESR 1/2hr :  4 mm Deposits: NAD ESR 1/2hr : 4 mm Deposits :  NAD 
         1 hr :  6 mm MOTION          1 hr : 5 mm MOTION 
HB :  9.4 gms / dl(63%)  Ova :  NIL HB : 10.4 gms / dl(71%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  78 mgs% Sugar (R): 80 mgs% Good
Urea :  19 mgs% Urea : 21 mgs% 
Cholesterol  :  161 mgs% Cholesterol : 153 mgs% 
IN – PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 5 IP No: 779 Name : Lakshmi Age/Sex: 53/F Occupation: House wife 
From : 25-03-08 To: 08-05-08 No. of days treated : 45 
Complaints and  
Duration INVESTIGATION 
Giddiness, 
Malaise, 
Numbness 
present since 4 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9000 cells / cumm Albumin : NIL TC: 9200 cells / cumm  Albumin :  NIL 
DC:   P: 65 % L: 29% E: 6 % Sugar    : NIL DC:   P: 64% L: 32% E: 4 % Sugar   : NIL
ESR 1/2hr :  2 mm Deposits: NAD ESR 1/2hr : 2 mm Deposits :  NAD 
         1 hr :  3 mm MOTION          1 hr : 4 mm MOTION 
HB :  9.2gms / dl (62%) 
Ova :  Hook worm ova 
seen HB : 10.4 gms / dl (70%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  115 mgs% Sugar (R): 110 mgs% Good
Urea :  19 mgs% Urea : 21 mgs% 
Cholesterol  :  168 mgs% Cholesterol : 161 mgs% 
 
                    OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 1 OP No: 14498 Name : Shanthi Age/Sex: 18 / F Occupation: Student
From : 25 – 02- 08 To: 31–05-08 No. of days treated : 36
Complaints and  
Duration INVESTIGATION 
Angular 
Stomatitis, Loss 
of appetite, 
present since 2 
months. 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC:  10000 cells / cumm Albumin : NIL TC: 9900 cells / cumm Albumin : NIL
DC:   P: 58% L: 37% E: 5% Sugar    : NIL DC:   P: 57% L: 41% E: 2% Sugar   : NIL
ESR 1/2hr :   8mm Deposits: NAD ESR 1/2hr : 7mm Deposits : NAD
         1 hr :   10mm MOTION          1 hr : 8mm MOTION
HB :   10gms / dl (68%)
Ova : Hook worm 
ova seen HB : 11gms / dl (74%) Ova : NIL 
MCV :    Cyst : NIL MCV : Cyst : NIL
PCV :    PCV : RESPONSE
Sugar(R) :  111mgs% Sugar (R): 110mgs% Good
Urea :   25mgs% Urea : 26mgs%
Cholesterol  :   122mgs% Cholesterol : 120mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 2 OP No: 15096 Name : Mahamutha Age/Sex: 38/F Occupation: Factory labour
From : 27-02-08 To: 08-04-08 No. of days treated : 42
Complaints and  
Duration INVESTIGATION 
Giddiness, Loss 
of appetite, 
present since 2 
months. 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC:  10000 cells / cumm Albumin : NIL TC: 9800 cells / cumm Albumin : NIL
DC:   P: 64% L: 30% E: 6% Sugar    : NIL DC:   P: 65% L: 30% E: 5% Sugar   : NIL
ESR 1/2hr :   8mm Deposits: NAD ESR 1/2hr : 7mm Deposits : NAD
         1 hr :   15mm MOTION          1 hr : 14mm MOTION
HB :   10.7gms / dl (73%) Ova : NIL HB : 12gms / dl (81%) Ova : NIL 
MCV :    Cyst : NIL MCV : Cyst : NIL
PCV :    PCV : RESPONSE
Sugar(R) :  87mgs% Sugar (R): 90mgs% Good
Urea :   22mgs% Urea : 22mgs%
Cholesterol  :   155mgs% Cholesterol : 160mgs%
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 3 OP No: 15380 Name : Veerammal Age/Sex: 40 / F Occupation: House wife 
From : 28-02-08 To: 10-04-08 No. of days treated : 43 
Complaints and  
Duration INVESTIGATION 
Lasstiude,  Loss 
of appetite, 
present since 1 
month. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:  9000 cells / cumm Albumin : NIL TC: 9100 cells / cumm  Albumin :  NIL 
DC:   P: 65% L: 33% E: 2% Sugar    :  NIL DC:   P: 63% L: 35% E: 2% Sugar     : NIL 
ESR 1/2hr :   8mm Deposits:  NAD ESR 1/2hr :  5mm Deposits :  NAD 
         1 hr :   10mm MOTION          1 hr :  8mm MOTION 
HB :   10gms / d l (68%) Ova :  NIL HB :  11gms / dl (74%) Ova :  NIL  
MCV :    Cyst :  NIL MCV :   Cyst :  NIL 
PCV :    
  
PCV :   RESPONSE 
Sugar(R) :  70mgs% Sugar (R): 79mgs% Good
Urea :   19mgs% Urea :  20mgs% 
Cholesterol  :   164mgs% Cholesterol :  170mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 4 OP No: 15680 Name : Kathija Age/Sex: 61 / F Occupation: House wife 
From : 01-09-08 To: 31-03-08 No. of days treated : 32 
Complaints and  
Duration INVESTIGATION 
 Fatigue, 
Numbness 
present since 7 
months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8200 cells / cumm Albumin : NIL TC: 8400 cells / cumm  Albumin :  NIL 
DC:   P: 64% L: 30% E: 6% Sugar    : NIL DC:   P: 65% L: 33% E: 2% Sugar   : NIL
ESR 1/2hr :   5mm Deposits:  NAD ESR 1/2hr :  4mm Deposits :  NAD 
         1 hr :   10mm MOTION          1 hr :  6mm MOTION 
HB :   8gms / dl (54%) Ova :  NIL HB :  8.4gms / dl (56%) Ova :  NIL  
MCV :    Cyst :  NIL MCV :   Cyst :  NIL 
PCV :    
  
PCV :   RESPONSE 
Sugar(PP) :  84mgs% Sugar (PP): 85mgs% Fair
Urea :   16mgs% Urea : 16mgs% 
Cholesterol  :   142mgs% Cholesterol :  150mgs% 
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 5 OP No: 19932 Name : Veramma Age/Sex: 60/F Occupation: Fruit merchant
From : 01-03-08 To: 19-04-08 No. of days treated : 50
Complaints and  
Duration INVESTIGATION 
 Malaise, 
Dyspnoea On 
exertion 
Numbness 
present since 2 
months. 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 9600 cells / cumm Albumin : NIL TC: 9400 cells / cumm Albumin : NIL
DC:   P: 60% L: 35% E: 5% Sugar    : NIL DC:   P: 63% L: 33% E: 4% Sugar   : NIL
ESR 1/2hr :   6mm Deposits: NAD ESR 1/2hr : 5mm Deposits : NAD
         1 hr :   12mm MOTION          1 hr : 10mm MOTION
HB :   10.4gms / dl (70%)
Ova : Hook worm 
ova seen HB : 11.5gms / dl (78%) Ova : NIL 
MCV :    Cyst : NIL MCV : Cyst : NIL
PCV :    PCV : RESPONSE
Sugar(PP) :  85mgs% Sugar (PP): 80mgs% Good
Urea :   20mgs% Urea : 25mgs%
Cholesterol  :   190mgs% Cholesterol : 185mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 6 OP No: 15933 Name : Muthaiah Age/Sex: 58/M Occupation: Gold Smith
From : 01-03-08 To: 23-04-08 No. of days treated : 54
Complaints and  
Duration INVESTIGATION 
Numbness, 
anglar stomatitis 
giddiness 
present since 3 
months. 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 9500 cells / cumm Albumin : NIL TC: 9700 cells / cumm Albumin : NIL
DC:   P: 64% L: 34% E: 2% Sugar    : NIL DC:   P: 65% L: 31% E: 4% Sugar   : NIL
ESR 1/2hr :   6mm Deposits: NAD ESR 1/2hr : 10mm Deposits : NAD
         1 hr :   15mm MOTION          1 hr : 14mm MOTION
HB :   10.5gms / dl (71%) Ova : NIL HB : 11.6gms / dl (78%) Ova : NIL 
MCV :    Cyst : NIL MCV : Cyst : NIL
PCV :    PCV : RESPONSE
Sugar(R) :  96mgs% Sugar (R): 80mgs% Good
Urea :  25mgs% Urea : 16mgs%
Cholesterol  :  167mgs% Cholesterol : 160mgs%
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 7 OP No: 15931 Name : Lakshmi Age/Sex: 50/F Occupation: House wife 
From : 01-03-08 To: 25-04-08 No. of days treated : 56 
Complaints and  
Duration INVESTIGATION 
 Loss of appetite, 
Fatigue, 
Dyspnoea On 
exertion present 
since 4 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9800 cells / cumm Albumin : NIL TC: 9600 cells / cumm  Albumin :  NIL 
DC:   P: 62% L: 32% E: 6% Sugar    :  NIL DC:   P: 63% L: 31% E: 6% Sugar     : NIL 
ESR 1/2hr :   12mm Deposits:  NAD ESR 1/2hr :  10mm Deposits :  NAD 
         1 hr :   15mm MOTION          1 hr :  12mm MOTION 
HB :   10gms / dl (68%) Ova :  NIL HB :  11.2gms / d (76%) Ova :  NIL  
MCV :   76 cubic micron  Cyst :  NIL MCV :  80 cubic micron Cyst :  NIL 
PCV :   40% 
  
PCV :  44.8% RESPONSE 
Sugar(R) :  110mgs% Sugar (R): 120mgs% Good
Urea :  14mgs% Urea : 15mgs% 
Cholesterol  :   180mgs% Cholesterol :  180mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 8 OP No: 16441 Name : Mythili Age/Sex: 22/F Occupation: Fower Merchant 
From : 05-03-08 To: 18-04-08 No. of days treated : 45 
Complaints and  
Duration INVESTIGATION 
Angular 
Stomatitis, Lass 
itut present since 
2 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9300 cells / cumm Albumin : NIL TC: 9200 cells / cumm  Albumin :  NIL 
DC:   P: 64% L: 32% E: 4% Sugar    : NIL DC:   P: 63% L: 34% E: 3% Sugar   : NIL
ESR 1/2hr :   2mm Deposits:  NAD ESR 1/2hr :  5mm Deposits :  NAD 
         1 hr :   8mm MOTION          1 hr :  10mm MOTION 
HB :   10gms / dl (68%) Ova :  NIL HB :  11.3gms / dl (76%) Ova :  NIL  
MCV :  85 cubic micron  Cyst :  NIL MCV :  21 cubic micron Cyst :  NIL 
PCV :   40% 
  
PCV :  45.2% RESPONSE 
Sugar(PP) :  100mgs% Sugar (PP): 90mgs% Good
Urea :  18mgs% Urea : 16mgs% 
Cholesterol  :   173mgs% Cholesterol :  160mgs% 
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 9 OP No: 17076 Name : Packiam Age/Sex: 60/F Occupation: House wife
From : 06-03-08 To: 06-04-08 No. of days treated : 32
Complaints and  
Duration INVESTIGATION 
Loss of appetite, 
Fatigue present 
since 6 months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 8900 cells / cumm Albumin : NIL TC: 9000 cells / cumm Albumin : NIL
DC:   P: 64% L: 30% E: 6% Sugar    : NIL DC:   P: 64% L: 28% E: 4% Sugar   : NIL
ESR 1/2hr :   2mm Deposits: NAD ESR 1/2hr : 2mm Deposits : NAD
         1 hr :   8mm MOTION          1 hr : 8mm MOTION
HB :   8gms / dl (61%)
Ova : Hook worm 
ova seen HB : 8.4gms / dl ( 56%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  110mgs% Sugar (R): 100mgs% Fair
Urea :  15mgs% Urea : 17mgs%
Cholesterol  :   172mgs% Cholesterol : 165mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 10 OP No: 17073 Name : Gopal Age/Sex: 39/M Occupation: Factory Labour
From : 06-03-08 To: 16-04-08 No. of days treated : 42
Complaints and  
Duration INVESTIGATION 
Tiredness, 
Giddiness, 
Palpitaions, 
present since 1 
month 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 8000 cells / cumm Albumin : NIL TC: 8600 cells / cumm Albumin : NIL
DC:   P: 65% L: 32% E: 3% Sugar    : NIL DC:   P: 64% L: 33% E: 3% Sugar   : NIL
ESR 1/2hr :   2mm Deposits: NAD ESR 1/2hr : 3mm Deposits : NAD
         1 hr :   8mm MOTION          1 hr : 4mm MOTION
HB :   10.2gms / dl (69%) Ova : NIL HB : 11.4gms / dl (77%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(PP) :  100mgs% Sugar (PP): 90mgs% Good
Urea :  18mgs% Urea : 16mgs%
Cholesterol  :   170mgs% Cholesterol : 174mgs%
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 11 OP No: 16658 Name : Kadar Mohideen Age/Sex: 59/M Occupation: Black smith 
From : 07-03-08 To: 1-04-08 No. of days treated : 26 
Complaints and  
Duration INVESTIGATION 
Angular 
stomatitis, 
Numbness 
present since 1 
month 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8600 cells / cumm Albumin : NIL TC: 8700 cells / cumm  Albumin :  NIL 
DC:   P: 62% L: 34% E: 4% Sugar    :  NIL DC:   P: 63% L: 33% E: 4% Sugar     : NIL 
ESR 1/2hr :   12mm Deposits:  1-2 puscells ESR 1/2hr :  10mm Deposits :  NAD 
         1 hr :   15mm MOTION          1 hr :  13mm MOTION 
HB :   8.5gms / dl (57%) Ova :  NIL HB :  8gms / dl (54%) Ova :  NIL  
MCV :  78 cubic micron Cyst :  NIL MCV : 76.5 cubic micron Cyst :  NIL 
PCV :  34% 
  
PCV : 32% RESPONSE 
Sugar(PP) :  72mgs% Sugar (PP): 75mgs% Poor
Urea :  26mgs% Urea : 25mgs% 
Cholesterol  :   150mgs% Cholesterol :  160mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 12 OP No: 17247 Name : Mayandi Age/Sex: 47/M Occupation: Coolie 
From : 07-03-08 To: 25-04-08 No. of days treated : 50 
Complaints and  
Duration INVESTIGATION 
Dyspnoea on 
exertion, 
malaise, 
numbness 
present since 3 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9000 cells / cumm Albumin : NIL TC: 9100 cells / cumm  Albumin :  NIL 
DC:   P: 63% L: 32% E: 5% Sugar    : NIL DC:   P: 65% L: 32% E: 3% Sugar   : NIL
ESR 1/2hr :   6mm Deposits:  NAD ESR 1/2hr :  5mm Deposits :  NAD 
         1 hr :   12mm MOTION          1 hr :  7mm MOTION 
HB :   10gms / dl (68%) Ova :  NIL HB : 11.1gms / dl (74%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  78mgs% Sugar (R): 80mgs% Good
Urea :  17mgs% Urea : 15mgs% 
Cholesterol  :   147mgs% Cholesterol :  150mgs% 
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 13 OP No: 17179 Name : Pushpam Age/Sex: 60/F Occupation: Beedi worker
From : 07-03-08 To: 23-04-08 No. of days treated : 48
Complaints and  
Duration INVESTIGATION 
Angular 
stomatitis, Loss 
of appetite 
present since 4 
months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 9000 cells / cumm Albumin : NIL TC: 9200 cells / cumm Albumin : NIL
DC:   P: 59% L: 37% E: 4% Sugar    : NIL DC:   P: 60% L: 34% E: 6% Sugar   : NIL
ESR 1/2hr :   12mm Deposits: NAD ESR 1/2hr : 10mm Deposits : NAD
         1 hr :  13mm MOTION          1 hr : 12mm MOTION
HB :   8.4gms / dl (56%)
Ova : Hook worm 
ova seen HB : 9.5gms / dl  ( 64%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  108mgs% Sugar (R): 110mgs% Good
Urea :  13mgs% Urea : 29mgs%
Cholesterol  :   161mgs% Cholesterol : 170mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 14 OP No: 16481 Name : Athimulaperumal Age/Sex: 61/M Occupation: Vegetable vender  
From : 07-03-08 To: 17-04-08 No. of days treated : 44
Complaints and  
Duration INVESTIGATION 
Giddiness, 
tiredness present 
since 2 months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 9100 cells / cumm Albumin : NIL TC: 9000 cells / cumm Albumin : NIL
DC:   P: 60% L: 37% E: 3% Sugar    : NIL DC:   P: 62% L: 36% E: 2% Sugar   : NIL
ESR 1/2hr :   7mm Deposits: 1-2puscells ESR 1/2hr : 4mm Deposits : NAD
         1 hr :  12mm MOTION          1 hr : 8mm MOTION
HB :  10.5gms / dl (71%) Ova : NIL HB : 11.4gms / dl (77%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  120mgs% Sugar (R): 125mgs% Good
Urea :  22mgs% Urea : 25mgs%
Cholesterol  :   180mgs% Cholesterol : 160mgs%
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 15 OP No: 18031 Name : Rathina Age/Sex: 60/F Occupation: Beedi worker 
From : 11-03-08 To: 19-04-08 No. of days treated : 40 
Complaints and  
Duration INVESTIGATION 
Fatigue, 
Numbness, 
malaise present 
since 6 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8200 cells / cumm Albumin : NIL TC: 8100 cells / cumm  Albumin :  NIL 
DC:   P: 59% L: 37% E: 4% Sugar    :  NIL DC:   P: 58% L: 40% E: 2% Sugar     : NIL 
ESR 1/2hr :  6mm Deposits: NAD ESR 1/2hr : 5mm Deposits :  NAD 
         1 hr :  10mm MOTION          1 hr :  8mm MOTION 
HB :  9.4gms / dl (63%) Ova :  NIL HB :  10.6gms / dl (72%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  80mgs% Sugar (R): 80mgs% Good
Urea :  26mgs% Urea : 32mgs% 
Cholesterol  :   171mgs% Cholesterol :  160mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 16 OP No: 13104 Name : Kamalam Age/Sex: 54/F Occupation: Fruit Merchant 
From : 11-03-08 To: 26-04-08 No. of days treated : 47 
Complaints and  
Duration INVESTIGATION 
Malaise, 
Giddiness, 
Palpitations 
present since 3 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9000 cells / cumm Albumin : NIL TC: 9100 cells / cumm  Albumin :  NIL 
DC:   P: 65% L: 32% E: 3% Sugar    : NIL DC:   P: 65% L: 33% E: 2% Sugar   : NIL
ESR 1/2hr :  10mm Deposits: 1-2 pus cells ESR 1/2hr : 8mm Deposits :  NAD 
         1 hr :  18mm MOTION          1 hr :  12mm MOTION 
HB :  10gms / dl (68%) Ova :  NIL HB :  11gms / dl (74%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  139mgs% Sugar (R): 140mgs% Good
Urea :  19mgs% Urea : 20mgs% 
Cholesterol  :   160mgs% Cholesterol :  170mgs% 
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 17 OP No: 18313 Name : Nisha Age/Sex: 23/F Occupation: Student
From : 12-03-08 To: 15-04-08 No. of days treated : 35
Complaints and  
Duration INVESTIGATION 
Palpitations, 
Tiredness, 
Numbness 
present since 10 
months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 8100 cells / cumm Albumin : NIL TC: 8300 cells / cumm Albumin : NIL
DC:   P: 61 % L: 36 E: 3% Sugar    : NIL DC:   P: 64% L: 34% E: 2 % Sugar   : NIL
ESR 1/2hr :  1 mm Deposits: NAD ESR 1/2hr : 2 mm Deposits : NAD
         1 hr :  3 mm MOTION          1 hr : 4 mm MOTION
HB :  9 gms / dl (61%)
Ova : Hook worm ova 
seen HB : 9.4 gms / dl (63%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  111 mgs% Sugar (R): 110 mgs% Fair
Urea :  14 mgs% Urea : 14 mgs%
Cholesterol  :   168 mgs% Cholesterol : 150 mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 18 OP No: 18952 Name : Mariyaselvam Age/Sex: 28/m Occupation: Cook
From : 14-03-08 To: 08-05-08 No. of days treated : 56
Complaints and  
Duration INVESTIGATION 
Dyspnoea on 
exertion, 
Palpitations, 
Lassitude 
present since 1 
month 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 9800 cells / cumm Albumin : NIL TC: 9700 cells / cumm Albumin : NIL
DC:   P: 65% L: 30 % E: 5% Sugar    : NIL DC:   P: 64 L: 32% E: 4 % Sugar   : NIL
ESR 1/2hr :  2 mm Deposits: NAD ESR 1/2hr : 3 mm Deposits : NAD
         1 hr :  4 mm MOTION          1 hr : 5 mm MOTION
HB :  10.2 gms / dl (64%) Ova : NIL HB : 11.3 gms / dl (76%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  129 mgs% Sugar (R): 120 mgs% Good
Urea :  24 mgs% Urea : 30 mgs%
Cholesterol  :  180 mgs% Cholesterol : 160 mgs%
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 19 OP No: 18925 Name : Revathi Age/Sex: 36/F Occupation: House maid 
From : 14-03-08 To: 12-05-08 No. of days treated : 60 
Complaints and  
Duration INVESTIGATION 
Palpitations, 
angular 
stomatitis, 
Fatigue present 
since 1 month 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8000 cells / cumm Albumin : NIL TC: 8200 cells / cumm  Albumin :  NIL 
DC:   P: 62% L: 34% E: 4 % Sugar    :  NIL DC:   P: 61% L: 36% E: 3% Sugar     : NIL 
ESR 1/2hr :  2 mm Deposits: 1-2 pus cells ESR 1/2hr : 3 mm Deposits :  NAD 
         1 hr :  7mm MOTION          1 hr :  5 mm MOTION 
HB :  9.5 gms / dl (64%) Ova :  NIL HB : 11gms / dl (74%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  102mgs% Sugar (R): 110 mgs% Good
Urea :  22mgs% Urea : 18 mgs% 
Cholesterol  :  155gs% Cholesterol : 180 mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 20 OP No: 18896 Name : Raj Age/Sex: 58/m Occupation: Driver 
From : 14-03-08 To: 2-05-08 No. of days treated : 50 
Complaints and  
Duration INVESTIGATION 
Loss of appetite, 
Palpitations 
present since 2 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8900 cells / cumm Albumin : NIL TC: 9000 cells / cumm  Albumin :  NIL 
DC:   P: 64% L: 33% E: 3 % Sugar    : NIL DC:   P: 65% L: 32 % E: 3 % Sugar   : NIL
ESR 1/2hr :  7 mm Deposits: NAD ESR 1/2hr : 8 mm Deposits :  NAD 
         1 hr :  9 mm MOTION          1 hr :  15 mm MOTION 
HB :  8.5 gms/ dl (57%) Ova :  NIL HB : 9.7 gms / dl (66%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  110 mgs% Sugar (R): 120 mgs% Good
Urea :  35 mgs% Urea : 30 mgs% 
Cholesterol  :  170 mgs% Cholesterol : 180 mgs% 
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 21 OP No: 19203 Name : Dheivanai Age/Sex: 50/F Occupation: House wife
From : 15-03-08 To: 11-05-08 No. of days treated : 58
Complaints and  
Duration INVESTIGATION 
Dyspnoea on 
exertion, 
giddiness 
present since 3 
months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 8600 cells / cumm Albumin : NIL TC: 8700 cells / cumm Albumin : NIL
DC:   P: 60% L: 36% E: 4 % Sugar    : NIL DC:   P: 62% L: 36 % E: 2 % Sugar   : NIL
ESR 1/2hr :  2 mm Deposits: NAD ESR 1/2hr : 5 mm Deposits : NAD
         1 hr :  49 mm MOTION          1 hr : 5 mm MOTION
HB :  9 gms/ dl (61%)
Ova : Hook worm ova 
seen HB : 10.6 gms / dl (72%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  90 mgs% Sugar (R): 80 mgs% Good
Urea :  22 mgs% Urea : 25 mgs%
Cholesterol  :  157 mgs% Cholesterol : 160 mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 22 OP No: 19056 Name : Bharathi Age/Sex: 32/F Occupation: Tailor 
From : 15-03-08 To: 1-05-08 No. of days treated : 48
Complaints and  
Duration INVESTIGATION 
Tiredness, 
malaise, 
palpitations 
present since 3 
months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 9200 cells / cumm Albumin : NIL TC: 9100 cells / cumm Albumin : NIL
DC:   P: 64% L: 32% E: 4 % Sugar    : NIL DC:   P: 65% L: 33% E: 2 % Sugar   : NIL
ESR 1/2hr :  10 mm Deposits: NAD ESR 1/2hr : 8 mm Deposits : NAD
         1 hr :  12 mm MOTION          1 hr : 10 mm MOTION
HB :  9.6 gms/ dl (65%) Ova : NIL HB : 10.5 gms / dl (71%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  132 mgs% Sugar (R): 130 mgs% Good
Urea :  25 mgs% Urea : 20 mgs%
Cholesterol  :  160 mgs% Cholesterol : 158 mgs%
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 23 OP No: 19062 Name : James Age/Sex: 56/M Occupation: Factory Labor
From : 15-03-08 To: 8-05-08 No. of days treated : 55
Complaints and  
Duration INVESTIGATION 
Loss of appetite, 
Dyspnoea on 
exertion present 
since 2 months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 8700 cells / cumm Albumin : NIL TC: 8100 cells / cumm Albumin : NIL
DC:   P: 62% L: 35% E: 2 % Sugar    : NIL DC:   P: 64% L: 35% E: 1% Sugar   : NIL
ESR 1/2hr :  4 mm Deposits: NAD ESR 1/2hr : 3 mm Deposits : NAD
         1 hr :  10 mm MOTION          1 hr : 6 mm MOTION
HB :  10.6 gms/ dl (72%) Ova : NIL HB : 11.8 gms / dl (79%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  110 mgs% Sugar (R): 108 mgs% Good
Urea :  26 mgs% Urea : 20 mgs%
Cholesterol  :  163 mgs% Cholesterol : 168 mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 24 OP No: 19194 Name : Rasik Bhasha Age/Sex: 14/M Occupation: Student
From : 15-03-08 To: 8-05-08 No. of days treated : 55
Complaints and  
Duration INVESTIGATION 
Angular 
stomatitis, 
Dyspnoea on 
exertion, 
palpitations 
present since 3 
months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 8400 cells / cumm Albumin : NIL TC: 8400 cells / cumm Albumin : NIL
DC:   P: 60% L: 34% E: 6 % Sugar    : NIL DC:   P: 62% L: 32 % E: 6 % Sugar   : NIL
ESR 1/2hr :  2 mm Deposits: NAD ESR 1/2hr : 2 mm Deposits : NAD
         1 hr :  3 mm MOTION          1 hr : 4 mm MOTION
HB :  8 gms/ dl (54%)
Ova : Hook worm ova 
seen HB : 8.4 gms / dl (56%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  90 mgs% Sugar (R): 85 mgs% Fair
Urea :  30 mgs% Urea : 28 mgs%
Cholesterol  :  125 mgs% Cholesterol : 110 mgs%
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 25 OP No: 19175 Name : Dhanalakshmi Age/Sex: 59/F Occupation: Beedi worker 
From : 16-03-08 To: 25-04-08 No. of days treated : 41 
Complaints and  
Duration INVESTIGATION 
Giddiness, 
Fatigue present 
since 2 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9000 cells / cumm Albumin : NIL TC: 8900 cells / cumm  Albumin :  NIL 
DC:   P: 65% L: 29% E: 6 % Sugar    :  NIL DC:   P: 64% L: 31% E: 5% Sugar     : NIL 
ESR 1/2hr :  10 mm Deposits: NAD ESR 1/2hr : 7 mm Deposits :  NAD 
         1 hr :  12 mm MOTION          1 hr : 9 mm MOTION 
HB :  9 gms/ dl (61%)  Ova :  NIL HB : 10 gms / dl (68%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  80 mgs% Sugar (R): 95 mgs% Good
Urea :  21 mgs% Urea : 25 mgs% 
Cholesterol  :  107 mgs% Cholesterol : 111 mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 26 OP No: 19458 Name : Ahamad Meeran Age/Sex: 50/M Occupation: Vegetable vender  
From : 17-03-08 To: 04-05-08 No. of days treated : 49 
Complaints and  
Duration INVESTIGATION 
Giddiness, 
Malaise present 
since 3 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9200 cells / cumm Albumin : NIL TC: 9200 cells / cumm  Albumin :  NIL 
DC:   P: 62% L: 32% E: 6 % Sugar    : NIL DC:   P: 63% L: 34 % E: 3 % Sugar   : NIL
ESR 1/2hr :  3 mm Deposits: NAD ESR 1/2hr : 3 mm Deposits :  NAD 
         1 hr :  5 mm MOTION          1 hr : 6 mm MOTION 
HB :  8.6 gms/ dl (58%)  Ova :  NIL HB : 9.7 gms / dl (66%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  110 mgs% Sugar (R): 113 mgs% Good
Urea :  32 mgs% Urea : 28 mgs% 
Cholesterol  :  98 mgs% Cholesterol : 100 mgs% 
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 27 OP No: 19318 Name : Alima Age/Sex: 45/F Occupation: Beedi worker 
From : 17-03-08 To: 16-05-08 No. of days treated : 61 
Complaints and  
Duration INVESTIGATION 
Dyspnoea on 
exertion, 
palpitations, loss 
of appetite 
present since 1 
month 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9800 cells / cumm Albumin : NIL TC: 9700 cells / cumm  Albumin :  NIL 
DC:   P: 60 % L: 36% E: 4 % Sugar    :  NIL DC:   P: 61% L: 36% E: 3% Sugar     : NIL 
ESR 1/2hr :  1 mm Deposits: NAD ESR 1/2hr : 2 mm Deposits :  NAD 
         1 hr :  3 mm MOTION          1 hr : 5 mm MOTION 
HB :  10.1 gms/ dl (69%)  Ova :  NIL HB : 11.6 gms / dl (79%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  120 mgs% Sugar (R): 118 mgs% Good
Urea :  24 mgs% Urea : 27 mgs% 
Cholesterol  :  112 mgs% Cholesterol : 121 mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 28 OP No: 19489 Name : Dhivan Beevi Age/Sex: 58/F Occupation: House maid 
From : 18-03-08 To: 26-04-08 No. of days treated : 40 
Complaints and  
Duration INVESTIGATION 
Angular 
stomatitis, loss of 
appetite present 
since 2 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8000 cells / cumm Albumin : NIL TC: 8000 cells / cumm  Albumin :  NIL 
DC:   P: 63 % L: 32% E: 5 % Sugar    :  NIL DC:   P: 65% L: 31% E: 4% Sugar     : NIL 
ESR 1/2hr :  2 mm Deposits: NAD ESR 1/2hr : 2 mm Deposits :  NAD 
         1 hr :  3 mm MOTION          1 hr : 4 mm MOTION 
HB :  9 gms/ dl( 61%) 
Ova :  Hook worm ova 
seen HB : 8.5 gms / dl (57%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE
Sugar(R) :  122 mgs% Sugar (R): 115 mgs% Poor
Urea :  32 mgs% Urea : 30 mgs% 
Cholesterol  :  81 mgs% Cholesterol : 92 mgs% 
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 29 OP No: 19723 Name : Kaliammal Age/Sex: 54/F Occupation: Vegetable veder 
From : 18-03-08 To: 03-05-08 No. of days treated : 47 
Complaints and  
Duration INVESTIGATION 
Palpitations, 
giddiness, 
tiredness preset   
since 3 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9800 cells / cumm Albumin : NIL TC: 10000 cells / cumm  Albumin :  NIL 
DC:   P: 60 % L: 36% E: 4 % Sugar    :  NIL DC:   P: 62% L: 28 % E: 4 % Sugar     : NIL 
ESR 1/2hr :  10 mm Deposits: 1-2 pus cells ESR 1/2hr : 10 mm Deposits :  NAD 
         1 hr :  12 mm MOTION          1 hr : 12 mm MOTION 
HB :  10.2 gms/ dl (68%)  Ova :  NIL HB : 11.4 gms / dl (77%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  115 mgs% Sugar (R): 110 mgs% Good
Urea :  25 mgs% Urea : 21 mgs% 
Cholesterol  :  121 mgs% Cholesterol : 112 mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 30 OP No: 19736 Name : Sudali Age/Sex: 60/F Occupation: Fruit Merchant 
From : 18-03-08 To: 01-05-08 No. of days treated : 45 
Complaints and  
Duration INVESTIGATION 
Giddiness, 
Fatigue and 
Tiredness 
present since 2 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8000 cells / cumm Albumin : NIL TC: 8200 cells / cumm  Albumin :  NIL 
DC:   P: 65% L: 32% E: 3% Sugar    : NIL DC:   P: 62% L: 32% E: 6% Sugar   : NIL
ESR 1/2hr :  6 mm Deposits: NAD ESR 1/2hr : 5 mm Deposits :  NAD 
         1 hr :  12 mm MOTION          1 hr : 10 mm MOTION 
HB :  9.6 gms/ dl (65%)  Ova :  NIL HB : 10.8 gms / dl (68%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  120 mgs% Sugar (R): 118 mgs% Good
Urea :  24 mgs% Urea : 25 mgs% 
Cholesterol  :  110 mgs% Cholesterol : 110 mgs% 
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 31 OP No: 19612 Name : Chellammal Age/Sex: 52/F Occupation: Beedi Worker
From : 19-03-08 To: 02-05-08 No. of days treated : 45
Complaints and  
Duration INVESTIGATION 
Angular 
stomatitis, 
Dyspnoea on 
exertion present 
since 4 months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 9600 cells / cumm Albumin : NIL TC: 9700 cells / cumm Albumin : NIL
DC:   P: 65%% L: 33% E: 2% Sugar    : NIL DC:   P: 64% L: 35 % E: 1% Sugar   : NIL
ESR 1/2hr :  7 mm Deposits: NAD ESR 1/2hr : 4 mm Deposits : NAD
         1 hr :  8 mm MOTION          1 hr : 5 mm MOTION
HB :  10.2 gms/ dl (69%)
Ova : Hook worm ova 
seen HB : 11.3 gms / dl (76%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  120 mgs% Sugar (R): 120 mgs% Good
Urea :  25 mgs% Urea : 25 mgs%
Cholesterol  :  108 mgs% Cholesterol : 95 mgs%
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu 
S. No: 32 OP No: 11557 Name : Jeya Age/Sex: 31/F Occupation: Beedi Worker
From : 18-03-08 To: 03-05-08 No. of days treated : 47
Complaints and  
Duration INVESTIGATION 
Malaise, 
Dyspnoea on 
exertion present 
since 2 months 
BEFORE TREATMENT AFTER TREATMENT
BLOOD URINE BLOOD URINE
TC: 9700 cells / cumm Albumin : NIL TC: 9600 cells / cumm Albumin : NIL
DC:   P: 62% L: 34% E: 4 % Sugar    : NIL DC:   P: 60% L: 38 % E: 2 % Sugar   : NIL
ESR 1/2hr :  2 mm Deposits: NAD ESR 1/2hr : 3 mm Deposits : NAD
         1 hr :  5 mm MOTION          1 hr : 6 mm MOTION
HB :  9 gms/ dl (61%) Ova : NIL HB : 10 gms / dl (68%) Ova : NIL 
MCV :   Cyst : NIL MCV : Cyst : NIL
PCV :   PCV : RESPONSE
Sugar(R) :  100 mgs% Sugar (R): 110 mgs% Good
Urea :  28 mgs% Urea : 30 mgs%
Cholesterol  :  91 mgs% Cholesterol : 108 mgs%
OUT- PATIENTS 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 33 OP No: 20026 Name : Pappa Age/Sex: 43/F Occupation: Tailor 
From : 23-03-08 To: 06-05-08 No. of days treated : 48 
Complaints and  
Duration INVESTIGATION 
Angular 
stomatitis, Loss 
of appetite 
present since 2 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9100 cells / cumm Albumin : NIL TC: 10000 cells / cumm  Albumin :  NIL 
DC:   P: 58 % L: 38% E: 4 % Sugar    :  NIL DC:   P: 62% L: 32 % E: 6 % Sugar     : NIL 
ESR 1/2hr :  5 mm Deposits: NAD ESR 1/2hr : 4 mm Deposits :  NAD 
         1 hr :  10 mm MOTION          1 hr : 7 mm MOTION 
HB :  8.4 gms/ dl (56%)  Ova :  NIL HB : 9.5 gms / dl(64%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  120 mgs% Sugar (R): 110 mgs% Good
Urea :  26 mgs% Urea : 24 mgs% 
Cholesterol  :  94 mgs% Cholesterol : 103 mgs% 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 34 OP No: 20113 Name : Muthu lakshmi Age/Sex: 45/F Occupation: Fruit Merchant 
From : 20-03-08 To: 26-04-08 No. of days treated : 38 
Complaints and  
Duration INVESTIGATION 
Fatigue, 
Palpitations, 
tiredness present 
since 3 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8700 cells / cumm Albumin : NIL TC: 9000 cells / cumm  Albumin :  NIL 
DC:   P: 62 % L: 35% E: 3 % Sugar    : NIL DC:   P: 64% L: 34 % E: 2 % Sugar   : NIL
ESR 1/2hr :  3 mm Deposits: NAD ESR 1/2hr : 3 mm Deposits :  NAD 
         1 hr :  6 mm MOTION          1 hr : 6 mm MOTION 
HB :  10 gms/ dl (68%) Ova :  NIL HB : 11.2 gms / dl (75%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  95 mgs% Sugar (R): 100 mgs% Good
Urea :  25 mgs% Urea : 26 mgs% 
Cholesterol  :  161 mgs% Cholesterol : 147 mgs% 
OUT- PATIENTS 
 
DRUG: Ayabringa Raja Karpam DIAGNOSIS: Pandu  
S. No: 35 OP No: 20014 Name : Parvathi Age/Sex: 52/F Occupation: Flower Merchant 
From : 20-03-08 To: 29-04-08 No. of days treated : 41 
Complaints and  
Duration INVESTIGATION 
Palpitations, 
Loss of appetite 
present since 2 
months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9800 cells / cumm Albumin : NIL TC: 9700 cells / cumm  Albumin :  NIL 
DC:   P: 63 % L: 34% E: 3 % Sugar    :  NIL DC:   P: 62% L: 36 % E: 2 % Sugar     : NIL 
ESR 1/2hr :  25 mm Deposits: NAD ESR 1/2hr : 2 mm Deposits :  NAD 
         1 hr :  4 mm MOTION          1 hr : 3 mm MOTION 
HB :  9.8 gms/ dl( 66%) 
Ova : Hook worm ova 
seen HB : 11 gms / dl (74%) Ova :  NIL  
MCV :   Cyst :  NIL MCV :  Cyst :  NIL 
PCV :   
  
PCV :  RESPONSE 
Sugar(R) :  80 mgs% Sugar (R): 85 mgs% Good
Urea :  20 mgs% Urea : 22 mgs% 
Cholesterol  :  119 mgs% Cholesterol : 108 mgs% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
